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Abstract
In this thesis, we developed two synthetic biology frameworks to facilitate the con-
struction of useful genetic circuits, with a focus on circuits that sense miRNAs.
miRNAs are an attractive biomarker for sensing since they regulate virtually all bi-
ological pathways in plants and animals, and because miRNA sensors can be easily
designed by incorporating sequences complementary to the miRNA into a genetic
circuit. Therefore, circuits that sense endogenous miRNAs can dynamically respond
to cellular signaling or classify between cell types. However, the development of
genetic circuits, and especially multi-input miRNA sensors, has traditionally been
iterative, costly, and time-consuming.
To this end, we have developed a framework to measure miRNA activity and
generate accurate predictions for sensors with multiple miRNA inputs. We started
by building the largest library of miRNA sensors to date (620 sensors) and used the
library to measure miRNA activity in several cell lines. We then constructed multi-
input sensors and determined design rules for predicting their function, namely that
miRNAs repress targets synergistically in opposite UTRs and antagonistically within
the same UTR.
In our second framework, we developed a ‘one-pot’ method for high-information
transfection and analysis that allows researchers to quickly determine performance
of many tuned circuit variants in a single well. We used our one-pot method to
quickly characterize a variety of genetic elements and to optimize the design of a
miRNA sensor with inverted logic, a circuit topology we found difficult to design
using traditional methods.
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Finally, we incorporated synthetic miRNAs into the genome and used miRNA
sensors to measure changes in endogenous gene expression in live cells, enabling
modular sensing of transcription. These advances contribute to our knowledge of
miRNA regulation, accelerate the design, construction, and testing of genetic circuits,
and improve our ability to sense dynamic biological processes.
Thesis Supervisor: Ron Weiss
Title: Professor of Biological Engineering and EECS
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Chapter 1
Technologies enabling miRNA
sensing
1.1 Introduction and background
Synthetic biology aims to build new and useful systems from biological components.
While applications of synthetic biology are incredibly diverse - ranging from produc-
tion of biofuels to engineering of the immune system to treat cancer - the central
principles for designing and testing biological systems are unifying. In general, re-
searchers will mine and characterize genetic ‘parts’ that perform a biological process
(for instance activating or repressing transcription), generate models for composing
multiple parts together into higher order systems termed genetic circuits, physically
construct genetic circuits, test the performance of the genetic circuits, and modify
the models according to the new results. These steps form the basis of a design-
build-test-learn (DBTL) cycle that allows iterative improvements towards a given
specification. To date, many major advances have been made at each of the DBTL
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steps, accelerating the pace at which functional genetic circuits can be implemented.
Even so, continued efforts to more accurately model and predict genetic circuits are
required to make it feasible to understand and engineer systems that meet or surpass
the complexity already possible with natural systems. In this thesis, we have worked
to expand the characterization, modeling, and testing knowledge base to include
miRNAs, small RNA molecules important for regulation. We believe several of the
developments shown here are also translatable to other areas in synthetic biology,
while also advancing the potential for smarter therapeutics that can actively respond
to changes in miRNA signaling.
1.1.1 Classification of live cells in synthetic biology
In many fields, classification is achieved with a ‘classifier’ which takes in several
attributes comprising an observation and determines which type or category that
observation belongs to. Examples of classifiers in medicine and biology include mea-
surements of expression of multiple genes for diagnostics, computer vision for pathol-
ogy, distinguishing between species in taxonomy, and classification of different cell
types. Classification of cell types is of particular interest in many application areas,
for instance using biomarker expression to distinguish cancerous cells from normal
ones, or to identify intermediate cell types in processes like stem cell differentiation
or reprogramming. However, classification is often performed with fixed cells or cell
lysate since techniques like high throughput RNA-seq or microarrays require access
to cellular RNA or DNA. This limitation uncouples classification from the ability
to initiate downstream effects in live cells and hampers followup experiments with
a particular subset of cells. Also, live cell classification would enable therapeutics
to respond to signaling changes to potentially reduce off-target effects or actuate
16
dynamic outputs in cells. Therefore, we are interested in developing live cell clas-
sifiers that can respond to biomarkers and restrict expression of a signal to only a
particular cell state (e.g. cells in a cell cycle stage, in a certain differentiated state,
or exhibiting abnormal signaling) or cell type (e.g. to mitigate off-target effects by
expressing toxic proteins in cancer cells rather than normal cells, or to reduce off-
target expression in liver to reduce side effects). Circuits that can exploit cell-state
and cell-type classification will be immensely more useful than those that cannot,
since large gains in safety, efficacy, and circuit complexity would be possible. We
are especially interested in using miRNAs as biomarkers for cell classification due
to the ability to easily measure miRNA activity using reporters with Watson-Crick
complementarity.1
1.1.2 miRNAs
microRNA (miRNA) molecules are short sequences of non-coding RNA that are
important for post-transcriptional regulation of mRNA. miRNAs are typically tran-
scribed from DNA as primary miRNA transcripts by RNA polymerase II. Primary
transcripts may include multiple miRNAs as a cluster and may be expressed from
intergenic regions of the genome or from introns or untranslated regions (UTRs) of
genes2. The sequence encoding the miRNA forms a stem loop structure; a portion
of the stem encodes the particular miRNA which is ∼22 bp in length and may be
located either toward the 5’ and/or 3’ end of the loop depending on the particu-
lar miRNA3. The primary transcript is then processed into a pre-miRNA transcript
which retains only the stem loop structure by the microprocessor complex which con-
tains Drosha and DiGeorge Critical Region 8 (DGCR8). The pre-miRNA transcript
is then exported from the nucleus into the cytoplasm by exportin, a process which
17
requires Ran-GTP. A Dicer complex cleaves the loop portion of the transcript leaving
short double stranded RNA with ∼2bp 3’ overhangs4,5. Finally, the mature miRNA
guide strand is loaded into the RNA induced silencing complex (RISC) which then
mediates mRNA destabilization or translational repression of transcripts bearing a
miRNA target site6. Target sites often correspond to regions complementary to the
seed sequence (nucleotides 2-8) of the miRNA, though less canonical binding can
occur if other factors like signficant complementarity outside of the seed are met.7,8
Many advances have been made in characterizing miRNA concentration and ac-
tivity in cell lines. Landgraf et al. sequenced over 350 small RNA library preparations
cloned from a variety of tissues in humans, mice and rats9. Cloning frequency was
taken as a measure of miRNA expression and correlated well with concentration
measured by Northern blot. However, the amount of information gained from the
experiments was relatively small compared to modern RNA-seq approaches, and the
authors noted potential biases in the cloning protocol which may limit comparisons
to other datasets. In another study, expression of 847 miRNAs was assayed in the
NCI-60 cell lines using microarrays10. Though only 495 unique miRNAs were de-
tected and only moderate correlation was observed in the four cell lines with existing
expression data, cell lines were generally clustered according to miRNA expression
and miRNAs remained differentially expressed according to tissue type. However,
information about miRNA sensor performance that can be extracted from these
studies of miRNA abundance is limited since correlations between miRNA abun-
dance and apparent activity is weak11. Nevertheless, measures of abundance remain
important for estimating whether a miRNA is active until more detailed miRNA ac-
tivity measurements can be produced. One area where high throughput sequencing
strategies have been crucial is the identification of thousands of potential miRNAs
in humans, with several hundred of these meeting established criteria for designation
18
as high confidence miRNAs12. Moreover, methods like Argonaute CLIP-seq13 and
CLASH14 have enabled the high-throughput discovery of miRNA target sites across
the transcriptome.
Initial experiments reported that miRNAs can act to translationally repress their
targets,15 while later studies found that miRNAs can also cause miRNA degrada-
tion.16,17 As a result, there has been debate as to which miRNA repression mecha-
nisms may dominate and in what contexts.18 Researchers have used microarrays and
RNA-seq from polysomes to conclude that effects from translational inhibition are
more modest compared to effects from changes in mRNA quantity.19,20 Timing effects
have also been shown, with translational inhibition showing greater effects compared
to mRNA degradation only at shorter timepoints.21 Following these studies, sequenc-
ing to determine poly(A) length (PAL-seq) was able to show that the difference in
repression mechanism could be due mainly to shortening of the poly(A), where at
early developmental stages shortening of the poly(A) acts mainly to decrease transla-
tional initiation and at later developmental stages acts to decrease mRNA concentra-
tion.6 As a result, the current understanding of miRNA repression mechanism is that
translational repression accounts for rapid but low magnitude responses to miRNA,
while mRNA deadenylation and subsequent degradation account for the majority
of effects at later time points.22 Others have also noted that different mRNA iso-
forms may also affect the degree of translational inhibition.23 The current model for
miRNA repression involves Argonaute (Ago) binding to TNRC6 which also inter-
acts with poly(A)-binding protein (PABPC) and recruits the CCR4-NOT complex
which deadenylates the mRNA, resulting in mRNA decapping and degradation.24
The CCR4-NOT complex also recruits DDX6 which may inhibit translation.25
miRNAs are understood to mediate most of their effects on endogenous targets
at target sites within the 3’ UTR. However, analysis of CLIP-Seq datasets or target
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site conservation suggest the presence of many CDS and 5’ UTR target sites, albeit
at lower frequency than targets in the 3’ UTR.26,27 Measurement of miRNA effects
on targets in the CDS across the transcriptome show small but significant effects
on their targets, and enhance regulation from targets in the 3’ UTR.28 Similarly,
mRNAs with miRNA targets in the 5’ and 3’ UTRs exhibit enhanced regulation27
and mRNAs with targets introduced into the 5’ UTR can repress as well as targets
in the 3’ UTR.29 As a result, characterizing the effects of target sites outside of the
3’ UTR should be important, especially for synthetic biology where target sites can
be placed wherever they may be most effective. Of related interest is the notion that
translational inhibition appears to occur through blocking of initiation or ribosome
drop-off near the start site,30–32 and the demonstration that LIN41 RNA binding
protein silences mRNA using tranlsational repression when binding the 5’ UTR and
mRNA degradation for the 3’ UTR.33 These results set the stage for our study of
synthetic miRNA sensors that have miRNA targets within the 5’ and 3’ UTRs.
1.1.3 miRNA sensors and classifiers
As a result of the number of miRNAs and prevalance of target sites, miRNAs can
serve as useful biomarkers for cell type and cell state.34,35 Therefore, researchers
have worked towards developing sensors to detect diseases ranging from cancer to
Alzheimer’s disease and heart disease, often for circulating miRNAs.36–38 A natu-
ral extension for miRNA sensing is to apply genetically-encoded sensors in live cells
to provide information about cell state in real time or for long-term monitoring.
These genetically-encoded miRNA sensors offer several advantages important for re-
search purposes, most significantly, the ability to directly actuate transcriptional
responses.1,35,39,40 Our group has demonstrated a miRNA-based synthetic DNA cir-
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cuit for distinguishing a given cell line from a set of six other background cell lines.35
The basic sensor unit was designed as a construct containing four tandem repeats
of the sequence perfectly complementary to the miRNA of interest (called a miRNA
target site ‘set’) located in the 3’ UTR of a gene of interest. miRNA low sensors
(which provide output when the sensed miRNA activity is low) were developed as
a fluorescent reporter (DsRed) followed by miRNA target sites while high sensors
(which provide output when miRNA activity is high) were constructed with a LacI
repressor followed by miRNA target sites controlling the output (Fig. 1-1). Pre-
vious studies have shown four target site repeats to be sufficient for repression of
targets with further increases in the number of targets having diminishing effects on
repression and greater potential for unwanted miRNA titration effects.1,41,42 Multiple
low and high sensors may be combined to form multi-input miRNA classifiers with
greater cell-type specificity as shown in Figure 1-2.
miRNA sensors should ideally exhibit the following properties: significant in-
crease or decrease in expression within a desired range of miRNA expression activity,
minimal titration effects on endogenous miRNA activity, and output specific to only
the miRNA of interest. These characteristics may be obtained with optimal design
of the underlying logic function and proper tuning of expression (eg. by promoter
strength, repressor strength, or small molecule induction), and are especially impor-
tant in multi-input sensors. Though expression changes in single sensors are typically
modest (∼2 to 10-fold), with the proper design of multi-input miRNA profilers greater
specificity can be achieved.35
The use of miRNA sensors to distinguish cells in a variety of conditions be-
gan with Brown et al.1 Knockdown was shown 1) in dendritic cells induced with
lipopolysaccharide (LPS) compared to a no LPS control using a sensor consisting of
GFP followed by four repeats of miR-155 target sites, 2) in hepatocytes and Kupffer
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Figure 1-1: miRNA sensors and classifiers
A. An ideal classifier. Illustration showing behavior of an ideal classifier with out-
put exclusively in target cells and not background cells; B. Circuit diagram of an
example low sensor. With high activity of miR-A, reporter expression is knocked
down, producing little output. With low activity of miR-A, reporter expression is
unsuppressed; C. Circuit diagram of an example high sensor. With high activity of
miR-B, repressor expression is knocked down, allowing the reporter to be expressed.
With low activity of miR-B, repressor expression is unsuppressed and the reporter
is repressed effectively.
cells compared to endothelial cells in mouse liver using GFP followed by miR-142-
3p and miR-122a target sites, and 3) in embryoid bodies using separate sensors for
miR-372, miR-302a, and miR-124a. This study demonstrated the utility of using
miRNA sensors for actuating cell-state and cell-type specific responses, despite the
limited number of miRNAs that were tested.
An advance in the number of miRNAs tested for activity was made by Mullokan-
dov et al.,11 with the use of pooled single sensor transduction into cells followed by
fluorescence-activated cell sorting and next generation sequencing to determine en-
22
Figure 1-2: Multi-input miRNA classifier design and function
A. Design of a multi-input miRNA sensor for distinguishing HeLa cells by Xie et
al.35 A combination of LacI and FF4 miRNA was used as the repressor. Repressor
expression was activated by separate activators not shown here. Reporter was a
DsRed reporter or hBax apoptosis regulator. miRNA identities were as follows,
A: miR-141, B: miR-142-3p, C: miR-146a, D: miR-21, E: miR-17, F: miR-30a; B.
DsRed fluorescence for HeLa cells compared to 6 background cell lines. Expression
was at least 5-fold higher in HeLa cells compared to the cell line with next greatest
expression; C. Selective killing of HeLa cells. Apoptosis was induced preferentially
in HeLa cells compared to HEK293 cells when the reporter was replaced by the hBax
protein.
richment of miRNAs in high sensor expression or low sensor expression bins. Sensors
with significant enrichment in low sensor expression showed downregulation when
tested by conventional flow cytometry. The pooling approach allowed 291 miRNA
target sites (both perfectly complementary and bulged versions) to be tested simul-
taneously per cell line, a much greater number than had been tested previously.
Interestingly, only 40% of measured miRNAs had significant activity in the three
cell lines tested. miRNAs that were more abundantly expressed were more likely
to show suppressive activity (80% of suppressive miRNAs were expressed above 100
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reads per million), though abundance and activity remained poorly correlated even
in this regime. Perfectly complementary target sites were generally more suppressed
than bulged target sites and are likely to demonstrate lower probability for miRNA
titration effects.42 One limitation to this approach includes limited resolution of the
degree of repression for an individual miRNA in a given condition, since enrich-
ment is only measured across 4 expression bins. While the statistical significance for
miRNA activity could be determined, fold-changes in activity - an important metric
for design of multi-input circuits - were difficult to quantify.
Another development included the use of adeno-associated virus (AAV) miRNA
sensors to measure activity of 115 miRNAs for 12 cell lines43. The authors again
demonstrated limited correlation between miRNA abundance and activity on the
AAV platform. Ability to distinguish cell states using this method was also shown as
expected changes in miRNA activity profiles were obtained when inducing K562 cells
with 12-O-tetradecanoylphorbol-13-acetate. Benefits for the AAV platform include
low cost and simple storage, but drawbacks include small circuit size and complexity
in preparation.
1.1.4 Limitations and ways forward
Despite these studies, our understanding of how to efficiently design genetically en-
coded miRNA sensors, especially those sensing multiple miRNAs simultaneously, has
been limited. Existing models of miRNA sensors have explained the threshold-like
nature of miRNA repression, but have been largely explanatory rather than predic-
tive - thus limiting their use for sensor design.41,44 Additionally, the existing data
measuring miRNA activity has used fold enrichment metrics which are not ideal for
generating predictions.11 As a result, our work has focused on building a synthetic
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biology framework for measuring miRNA activities, generating rules for combining
miRNA activities for sensors responding to multiple miRNAs, and then comparing
predictions to measurements from multi-input miRNA sensors.
Using synthetic biology techniques to probe design rules has been an effective
way to study biological systems.45 For example, in E. coli, the study of combinato-
rial promoters with shuffled transcription factor (TF) binding sites and copy num-
bers elucidated several design rules, including the limits of regulation and effects
of repressor and activator locations.46,47 Another study where transcriptional and
translational efficiencies were varied using promoters and RBSs showed how those
parameters contributed to noise in expression.48 In mammalian systems, researchers
have studied how chromatin regulators dynamically control gene expression using
synthetic fusion of chromatin regulators to a DNA binding protein. They found
that each regulator silences or reactivates in an all-or-nothing fashion, and could be
modeled by stochastic traversal through three states: active, reversibly silent, and
irreversibly silent.49 Study of the bone morphogenetic protein (BMP) pathway has
shown that the complex system involving 20 ligand and 7 receptor types could be
explained by competitive receptor-ligand interactions, resulting in complex behavior
in some ways reminscent of a neural network with hidden layers.50 As a result, the
pathway can give many different outputs depending on the combination of input
ligands. In another example, reconstitution of Hedgehog signaling gradients using
engineered sender and receiver cells and resulting models were able to explain what
signaling activities were essential to gradient generation.51 Specifically the PTCH
receptor required bifunctional intracellular and extracellular inhibition to recapitu-
late robust and fast responses to morphogens. And finally, a paper demonstrating
a synthetic system for titration of miRNA using additional target sites showed that
ceRNA was possible only with an extremely large (non-physiological) amount of tar-
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gets introduced.52 Therefore, our work described here using miRNA sensors to probe
the limits of miRNA repression serves as another example where synthetic biology
can contribute to knowledge of how a biological system functions.
1.2 miRNA sensor architecture and assembly
1.2.1 DNA assembly methods
A fundamental part of synthetic biology today involves the cloning and assembly of
genetic circuits using DNA. This allows genetic ‘parts’ including promoters, insula-
tors, protein coding sequences, and transcriptional terminators (among others) to be
placed within designated positions so that the correct functionality can be achieved.
Once DNA has been assembled, downstream steps like transformation, transfection,
or in vitro transcription or translation are then possible.
To assemble circuits for mammalian cells, we initially planned to use existing
hierarchical DNA assembly methods. A Gateway-Gibson method53 would allow for
promoters and genes to be assembled into a common backbone, but with a few
caveats. First, the sequences surrounding the promoter-gene pair cannot be easily
changed, constraining the circuits to only those that do not require regulation of
sequences like the 5’ and 3’ UTRs or insulators. One possible workaround would
be to append the UTR sequences to the promoter or gene sequences but this would
require the cloning of many different gene/UTR combinations, drastically reducing
the modularity of such a cloning system. Since miRNA sensors require insertion of
miRNA target sites into the UTRs, such a system would not be amenable to miRNA
sensor cloning.
The mammalian Modular Cloning (mMoClo) system54 remedies several of the
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limitations of the Gateway-Gibson system. In the mMoClo system, each insulator,
promoter, 5’ UTR, coding sequence, 3’ UTR, and poly-A sequence is inserted into
its own plasmid, designated as plasmid level 0 (or pL0). Then transcription units
(TUs) are assembled into a level 1 (pL1) plasmid which contains one of each of
the pL0 parts. This assembly is mediated by a Golden-Gate step55 where a type IIS
restriction enzyme, usually BsaI, which generates unique matching overhangs on only
parts that should be assembled adjacently to each other. After this step, a level 2
plasmid (pL2) can be assembled using a different type IIS restriction enzyme, to give
a final plasmid encoding multiple TUs. The mMoClo system should be sufficient to
allow for assembly of the most complex genetic circuits that have been demonstrated
in mammalian cells to date. However, we encountered some restrictions, with the
largest being that the efficiency of pL2 plasmid assembly fell significantly as more
transcription units were added.
As a result, we modified the mMoClo system to use Gibson assembly for pL2’s
instead of Golden Gate, since Gibson assembly is better able to assemble several
large fragments together (Fig. 1-3).*56 Moreover, this approach allows pL2 plasmids
to incorporate the expression vectors from Gateway-Gibson assembly in case those
have already been assembled previously. As an aside, other assembly techniques are
arising as possible future alternatives to Gibson, notably ligase cycling reaction and
twin primer assembly which should enable 12 or more fragments to be assembled at a
time.56,57 Also, we built several pL1 plasmid backbones with Gibson sequences reverse
complemented such that orientation of transcription units could be switched. A final
modification involved changing the overhang between promoter and 5’ UTR from
AATG to CAGA, in order to eliminate the possibility for an upstream open reading
*Work initiated by Jin Huh in the Weiss lab
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frame. Changing this overhang increased output by 2-fold, a moderate increase but
potentially important for outputs that need to be highly expressed in cells for a
phenotype (Figure 1-4*).
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Figure 1-3: Golden Gate-Gibson assembly of multi-TU circuits.
This diagram illustrates the two assembly steps that comprise much of the assembly
framework used in this thesis. In the first Golden Gate step, genetic elements encoded
on plasmid level 0 (pL0) vectors - including insulators, promoters, 5’ UTRs, coding
sequences, 3’ UTRs, and poly-A sequences - are assembled into transcription units
(TUs). This assembly is performed using a type IIS restriction enzyme to generate
unique matching overhangs for each of these genetic elements, indicated here by
the different colors. T4 ligase can then ligate the matching overhangs to generate
the complete circular DNA. The resulting plasmids are designated plasmid level 1
(pL1). If multiple transcription units are required to be on a single construct, the
*Data can be found within folder /jgam/Data/flow/2015-04-08_Extra_ATG/
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pL1 plasmids can be digested with I-SceI restriction enzyme to expose 45 bp long
regions (S1, S2, ... S(z+1), Sx) that are used for homology in Gibson assembly. In
Gibson assembly, a 5’ exonuclease chews back DNA ends to generate long overhangs
which anneal to matching overhangs on other pL1’s. A polymerase fills in any gaps
generated by the exonuclease and a DNA ligase eliminates nicks in the DNA. The final
product of the Gibson assembly therefore encodes expression of multiple transcription
units necessary for function of the genetic circuit.
Figure 1-4: AATG overhang in mMoClo reduces expression by approxi-
mately 2-fold.
In an experiment to determine the effect of the AATG overhang present in the mam-
malian MoClo workflow,54 we constructed a single plasmid encoding hEF1a-mKate2
and hEF1a-EBFP2 with either an AATG overhang between promoter and 5’ UTR
for the mKate2 TU or an AAAG overhang. The construct with the AATG overhang,
which contains and extra ATG upstream of the start codon for mKate2, showed ∼2-
fold reduced expression across all positive transfection levels, demonstrating that the
AATG overhang should be changed to obtain higher possible expression levels and
dynamic range. Values represent geometric means for mKate2 fluorescence binned
across EBFP2 fluorescence.
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1.2.2 DNA assembly using microfluidics
In addition to advancing the molecular biology platform, we also prototyped the
use of microfluidics to scale down the assembly reaction volumes, reducing cost and
increasing throughput. In our system, a ‘ring-mixer’ was built using conventional
fabrication with polydimethylsiloxane (PDMS) and controlled using an open-source
controller with 32 programmable channels. In this design, a circular ring can be
loaded with up to three different liquids (e.g. DNA, enzyme mix, buffer) using dead-
end filling. Then valves can seal off the ring and mixing can be performed using
three channels that act as a peristaltic pump. After incubating the reaction, the
mixture can be flowed out, collected, and transformed into e. coli for propagation.
The ring-mixer uses approximately 10-fold less reaction volume compared to tradi-
tional reactions (300-650 nL compared to 2-10 uL) and we were able to demonstrate
assembly using all four different assembly methods we tested: ligation, Gateway,
Gibson, and Golden Gate. Note that while efficiency was decreased in each format
(fewer colonies for ligation, Gateway, Gibson; lower proportion of correct colonies for
Golden Gate) further optimization of microfluidic assembly protocols could allow for
efficiencies to more closely match the larger format in the future (Table 1.1).
We tested the biological function of DNA assembled either microfluidically or in
the conventional format. For each assembly, function was similar in both formats,
showing that useful biological data could be obtained from microfluidically-assembled
DNA. Thus we demonstrated that microfluidics could be used to scale down diverse
types of of assembly reactions, and should be instrumental in accelerating large-scale
assemblies in the future.*
*For further information, see Appendix 6.1 and our article "Open-source, community-driven
microfluidics with Metafluidics" in Nature Biotechnology (2017)
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Assembly
Method
Number
of Parts
Final
Size (bp)
cfu/uL
(𝜇fl. vs tube)
% Correct
(𝜇fl. vs tube)
Ligation 2 5,362 7.0e3 vs 5.6e4 100% vs 100%
Gateway 2 3,479 2.5e3 vs 1.1e4 73% vs 75%
Gibson 4 4,708 2.6e2 vs 1.7e4 90% vs 100%
Golden Gate 5 5,571 5.1e4 vs 4.8e4 64% vs 85%
Table 1.1: Assembly efficiency with microfluidic assembly compared to
conventional format.
Comparison of efficiency between microfluidic and conventional DNA assembly shows
moderate drops (<10-fold) in the microfluidic format for all assemblies besides Gib-
son. Golden Gate assembly shows mostly comparable efficiency between both for-
mats, indicating that future microfluidic assembly would require less optimization
compared to the other assemblies.
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Figure 1-5: Ring mixer microfluidic device for DNA assembly.
(a) Photograph of the ring mixer device with chambers filled with food coloring.
Green indicates chambers where DNA, enzymes, and buffer can be loaded. Red
indicates control valves control valves. Blue indicates valves for mixing. (b-e)
Different stages of DNA assembly with the ring mixer. DNA, enzymes, and buffer
are loaded in the device with dead end filling (b), the reaction is mixed using valves
with are sequentially actuated to induce peristalsis (c), the reaction is incubated at
the temperature required (d), and the final reaction product is flowed out of the
device (e). (f) Image of the 32-channel open source microfluidic controller used to
operate the ring mixer. Solenoid and constant pressure outlets are highlighted. (g)
Internal layout of the microfluidic controller. An Arduino and breadboard controls
four sets of eight solenoid valve banks.
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Figure 1-6: Results from assembly of genetic constructs in a microfluidic
ring mixer device.
(a) Schematic of BioBrick-based ligation assembly. (b) Constitutive GFP fluo-
rescence with ligation-assembled circuit. GFP fluorescence was compared for Es-
cherichia coli transformed with microfluidic (four clones) and tube-assembled (three
clones) circuits to E. coli lacking the circuit (negative control). When compared to
cells lacking the circuit, both microfluidic and tube clones showed similar (>50-fold)
increased fluorescence, with microfluidic clones exhibiting 58-fold increased fluores-
cence and tube clones showing 70-fold increased fluorescence. (c) Schematic of BP
Gateway Assembly. (d) Constitutive EGFP fluorescence with Gateway-assembled
circuit. EGFP expression was measured by flow cytometry for microfluidic (four
clones) and tube (three clones) assembled circuits. Microfluidic and tube clones
demonstrated >100-fold increased fluorescence compared to cells lacking the EGFP
expression plasmid and did not show significantly different fluorescence relative to
each other. (e) Schematic of Gibson assembly. (f) Cell-density-dependent gene ex-
pression with Gibson-assembled circuit. Following dilution from overnight culture
at time zero, the fraction of cells expressing mCherry decreased to ∼20% after 4
hours. This percentage then rebounded as cell density increased starting at OD600 =
0.2. Microfluidic (five clones) and tube-assembled (three clones) reactions performed
similarly, with no significant difference in the percentage of mCherry-positive cells in
5/8 time points. Of the time points with significantly different expression (indicated
with asterisks) the greatest discrepancy was at 3 h with a 9.6% difference in per-
centage of cells expressing mCherry. (g) Schematic of Golden Gate Assembly. (h)
aTc induction of GFPmut3b with Golden Gate–assembled circuit. With both mi-
crofluidic and tube-assembled circuits, addition of aTc induced more than a tenfold
increase in GFPmut3b fluorescent signal in TetR-expressing cells. Microfluidic and
tube-assembled circuits showed similar behavior with no significant difference in the
induced and uninduced cases. Error bars indicate s.d.
1.2.3 Golden Gate - PCR - Gibson Assembly
In addition to microfluidics, we also prototyped accelerated DNA assembly methods
to make the build portion of the DBTL cycle less of a potential bottleneck. We
identified intermediate propagation steps in e. coli as one of the largest areas for
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improvement. Namely, if the propagation steps could be eliminated, complex circuits
containing multiple transcription units could be assembled in a single day, rather than
the several day long process currently required. For a typical hierarchical assembly
the following steps and times are needed for each hierarchical step: transcription
units (i.e. promoters driving genes, along with surrounding regulatory elements)
are assembled (several hours), DNA transformed into e. coli cells (1 hr), colonies
grown on agar plates (16 hrs), colonies picked and grown in liquid media (12 hrs),
DNA extracted from cells (1hr). With the propagation steps removed, assembly of
multi-TU circuits (i.e. two hierarchical steps) could be accelerated from a ∼60 hour
process to a ∼10 hour one, a significant improvement.
We initially tested whether we could circumvent intermediate propagation steps
by simply taking the assembly products from the first step and instead of transform-
ing them, using them directly for the second assembly step. We reasoned that if
this initial step, a Golden Gate assembly in our framework, were efficient enough,
there may be sufficient amounts of correct assemblies to allow for downstream Gib-
son assembly. However in our initial tests we were unable to recover significant
numbers of correctly assembled constructs with multiple transcription units. We
then sought to use cell-free amplification steps to replace amplification in e. coli. In
this protocol, Golden Gate assembly products were used as template for PCR reac-
tions using primers based on the Gibson sequences identified earlier53. Then PCR
products could be used directly for Gibson assembly to produce multi-TU plasmids
(Fig. 1-7a). After this assembly protocol, we identified DNA bands on agarose gel
matching the expected product size of ∼4 kb. After transforming Gibson products
into e. coli, selecting with Kanamycin, and counting colonies expressing GFP and/or
mCherry from the two TUs assembled together, we found that constructs were cor-
rectly and efficiently assembled at a rate of 95.8%. The efficiency and number of
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colonies were similar to the positive control reaction where the transcription units
were obtained from PCR of sequence validated plasmid, rather than a Golden Gate
assembly product (Table 1.2).
Therefore we demonstrated a proof of concept for faster assembly where propaga-
tion of assembly products is achieved using cell-free techniques. Testing of assembly
with many more TUs should be conducted to determine the limits for the Golden
Gate - PCR - Gibson method. Since we conducted the proof of concept reactions,
others have shown the ability to assembly up to six transcription units using a similar
protocol.58 We anticipate that similar procedure could be used to speed up MoClo
protocols, if pL1 plasmids were modified to have distinct regions for PCR amplifi-
cation outside of the Golden Gate cut sites. Other interesting future directions may
include the use of rolling circle amplification (RCA) or other methods, in order to
circumvent the final propagation step in e. coli to obtain transfection-ready DNA.
Products from RCA would likely need to be digested with restriction enzyme prior
to transfection to allow for delivery into cells and the nucleus, but RCA would likely
be faster than growing and harvesting from bacteria.
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Figure 1-7: Assembly of multi-TU plasmids without intermediate vectors.
(a) Assembly diagram for Golden Gate - PCR - Gibson protocol. Two different
Golden Gate reactions were separately performed to make templates encoding con-
stitutive bacterial expression of GFP and mCherry. The Golden Gate products were
used directly for PCR without a purification step using primers based on the Gibson
sequences (B1, B2, B3, and B4). The two resulting PCR products were combined
with PCR products encoding antibiotic resistance for Kanamycin and the bacterial
origin, then used in Gibson assembly to give a single plasmid encoding both GFP
and mCherry. (b) Agarose gel for assembly products. Lane 1 shows the final as-
sembly product for Golden Gate - PCR - Gibson, with a band at the expected 4 kb
product along with other side products. Lane 2 indicates the positive control with
PCR from sequence validated plasmid template (instead of Golden Gate product),
followed by Gibson assembly. Lane 3 is a negative control for the PCR inputs with-
out conducting Gibson assembly; all fragments were around 1 kb in length. Lane 4
shows a negative control where Gibson assembly was conducted without addition of
GFP or mCherry TUs. The single band is at 2kb as expected of a linear product
containing only KanR and the origin.
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GFP mCherry Neither Both % correct
only only
GG-PCR-Gib 5 4 3 271 95.8
PCR-Gib 3 5 1 186 95.4
Table 1.2: Assembly efficiency with Golden Gate-PCR-Gibson assembly.
Counts of colonies expressing GFP and mCherry show highly efficient assembly with
either the Golden Gate - PCR - Gibson (GG-PCR-Gib) assembly or the positive
control with PCR then Gibson (PCR-Gib).
1.3 Delivery of miRNA sensors in vitro
In mammalian cells, one of the simplest methods to deliver exogenous DNA (or other
molecules like RNA and protein) into cells to express genetic circuits is through
transient transfection. Commonly a cationic lipid or polymer is complexed to the
negatively charged DNA which are endocytosed by cells, before endosomal escape
of the complexes and import of DNA into the nucleus.59,60 Chemical transfection
methods are generally safe, easy to perform, and inexpensive,61 and for these reasons
we chose to use chemical transfection for our large-scale measurements of miRNA
activity.
In order to scale down and simplify these measurements, we used a reverse
transfection method62 to make many replicates of ‘transfection plates’ onto which a
DNA/transfection reagent mix is spotted. These transfection plates allow for trans-
fection of cells simply by plating cells into them. Since many such plates can be made
at a time and stored for later use, new cell lines can be rapidly tested without having
to prepare the transfection mix each time. Here we adapted the reverse transfection
protocol to 96-well plates, enabling measurements via flow cytometry with a suitable
plate sampler. While microscopy could be used to measure fluorescence as in the
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original reverse transfection procedure, many more cells can be collected using flow
cytometry without having to store large image files and conduct more complicated
image processing steps. Briefly, our reverse transfection protocol involves mixing a
specified amount of DNA with a modified effectene reagent and then adding gelatin.
A large batch of each mix can be made at a time (e.g. >100 uL) and 4 uL spotted
into wells in a 96-well plate. Plates are then covered with sterile covers and can be
stored at -80C until cells are added. In this way, we reverse transfected HEK293FT,
HeLa, and HepG2 cells with the full miRNA low sensor library.
It should be noted that many cell lines and cell types - especially primary or non-
dividing cells - demonstrate low transfection efficiency with chemical transfection.
Alternative platforms exist for transducing these cells including 96-well electropo-
ration63 and AAV or other viruses.43 Though since our work in developing design
rules for multi-miRNA repression was more foundational and could be performed in
easy-to-transfect cell lines, we chose to focus on easier transfection methods.
1.4 Sensor designs for in vivo measurements
In order to expand the types of cells and tissues we can measure, we constructed
miRNA sensors with alternate outputs for miRNA activity measurements in vivo
and ex vivo.* These sensors use a bi-directional CMV promoter to drive Nluc-
mNeonGreen with regulation from miRNA target sites in the 3’ UTR and also
constitutive Fluc-TagBFP as a reference signal (Fig. 1-8) This delivery platform
would allow the usual flow cytometry measurements using mNeonGreen and Tag-
BFP signals, and those data would be amenable to analysis and modeling discussed
*In collaboration with Sophie Strobel and Jin Huh
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later in Chapter 2. The addition of NanoLuc and firefly luciferase allow for measure-
ments from luciferase assays and bioluminscence imaging, which can be done in vivo
or ex vivo. The bi-directional promoter allows for a smaller design, with the total
length of 5.3 kb excluding bacterial origin and antibiotic resistance on the plasmid
backbone. Finally, the plasmid contains sequences for integration and propagation
in an HSV delivery platform, allowing for delivery of the miRNA sensor into hard to
transfect cells or in vivo models. These sensors should enable researchers to measure
miRNA activity in more directly related to application areas like disease models and
therapeutics.
NeonGrNluc
(E2A)
FlucTagBFP
(GSG) LacZ or 
miRNA targets
CMV-Bi
NlucNeonGr
(GSG)
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Figure 1-8: Design of a miRNA sensors for in vivo and ex vivo.
We designed miRNA low sensors for use beyond in vitro experiments. These con-
structs express both fluorescent proteins and luciferase such that measurements can
be made using flow cytometry, fluorescent microscopy, or bioluminescence. Two ver-
sions were constructed where Nluc was linked to mNeongreen either with a 2A linker
or by making a fusion. In both cases, TagBFP was fused to Fluc since we only had
one existing construct with those two proteins linked.
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Chapter 2
Accurate predictions of multi-input
miRNA sensor activity
miRNAs regulate a majority of protein-coding genes, affecting nearly all biological
pathways. However, many aspects of miRNA biology have not been quantitatively
characterized, including frequency and potency of target sites outside of the 3’ UTR,
the impact of target site location on repression mechanism, composition rules for mul-
tiple target sites, and limits of cooperativity for genes regulated by many miRNAs.
To this end, we explore miRNA biology at a quantitative single-cell level using a li-
brary of 620 miRNA sensors and reporters that are regulated by many miRNA target
sites at different positions. Interestingly, we found that miRNA target site sets within
the same untranslated region exhibit combined miRNA activity described by an an-
tagonistic relationship while those in separate untranslated regions show synergy.
Our resulting Antagonistic/Synergistic (Ant/Syn) computational model generated
significantly enhanced prediction of activity for miRNA sensors containing many
miRNA targets, accelerating development of sophisticated sensors for clinical and
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research applications. These results shed light on the aforementioned understudied
but important aspects of miRNA biology.
2.1 Overview of miRNA repression and models
microRNA (miRNA) molecules are short sequences of non-coding RNA that are im-
portant for post-transcriptional regulation of mRNA. Despite active study of miR-
NAs since their discovery, several aspects of miRNA repression remain unknown
or controversial.18 For instance, many of the proteins and mechanisms involved in
miRNA repression and interactions between them have yet to be elucidated.25,64
Also, most studies have focused on miRNA target sites in the 3’ UTR,65 but recent
research has shown that targets in the coding sequence and 5’ UTR can be impor-
tant for modulating activity, especially in combination with other target sites.27,28,66
Due to incomplete study of these interactions between target sites, there has been
a lack of consensus for the importance of target sites outside of the 3’ UTR and
also insufficient knowledge to generate design rules and models for miRNA target
site composition. To address these needs, we created a large library of reporter con-
structs with composable miRNA target sites and used them in various combinations
to explore the effects of multi-miRNA regulation from 5’ and 3’ targets. We found
that miRNA target site interactions follow an Antagonistic/Synergistic (Ant/Syn)
model where sets of miRNA target sites exhibit antagonistic interactions within the
same UTR (i.e. the amount of knockdown depends strictly on the miRNA target sites
with highest activity), and synergistic interactions across UTRs (i.e. knockdown is a
multiplicative combination of miRNA target sites). In contrast to previous compu-
tational models,41,44 our Ant/Syn model accurately predicts simultaneous repression
effects from many different miRNAs.
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miRNA repression mechanisms are varied and complex, with molecular players
including the Argonaut proteins, GW182, PABPC, the CCR-NOT complex, the
PAN2-PAN3 complex, and decapping proteins.25 Recent evidence shows even more
possible interactions with DDX6, phosphorylation by CSNK1A1 and dephosphory-
lation by the ANKRD52-PPP6C complex.64,67 Further complicating matters is the
fact that miRNAs can mediate multiple modes of regulation including deadenyla-
tion, decapping, cleavage, and translational repression. Here we use highly expressed
synthetic miRNA sensors to probe the limits of miRNA regulation, since quanti-
tative measurements made at biological extremes can provide mechanistic insight
otherwise difficult to obtain via conventional knockout or sequencing based tech-
niques.18,45 Our results suggest that the repression mechanisms for targets in the 5’
UTR and 3’ UTR may be distinct (e.g. translational repression in the 5’ UTR and
mRNA destabilization in the 3’ UTR).
Importantly, our Ant/Syn model accurately captures repression behavior for tran-
scripts simultaneously regulated by many different miRNAs. Nature is replete with
examples of such highly miRNA-regulated genes; on average 7.3 different miRNAs
repress each miRNA-regulated gene and 47 distinct genes are regulated by >40 miR-
NAs,68 with p21Cip1/Waf1 experimentally verified to be targeted by 28 miRNAs.69
Additionally, emerging evidence indicates a class of transcripts regulated by simul-
taneous 5’ and 3’ UTR targets of the same miRNA.27 Based on our observation in
synthetic circuits of synergistic interactions across UTRs even with targets for dif-
ferent miRNAs, we propose that this class of 5’ and 3’-regulated transcripts should
be broadened to include those with targets for different miRNA sequences.
Our results contribute to an enhanced quantitative understanding of miRNA bi-
ology which can then be applied to create better nucleic acid-based therapeutics (e.g.
ones that are regulated dynamically by complex biomarker profiles). We are espe-
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cially interested in using miRNAs as indicators of cell type and cell state, since there
are thousands of distinct miRNAs which regulate >5,300 genes across almost all cel-
lular pathways.34,70,71 We and others have shown that genetically encoded miRNA
sensors can be constructed by placing miRNA target sites in the UTRs of a re-
porter.1,35,39,40 While most efforts have focused on sensing a single miRNA, our new
approach more closely mimics endogenous biological regulation in that many miR-
NAs can regulate a single transcript, improving specificity and redundancy. Several
studies have used miRNA profiles to identify diseases including cancer36, Alzheimer’s
disease,37 and heart disease.38 Genetically encoded miRNA sensors (which sense a
single miRNA input) and cell classifiers (which sense multiple miRNA inputs simul-
taneously) can provide information about disease state, actuate responses in cells
specifically expressing either a diseased or healthy miRNA profile,1,35,39 distinguish
between subtypes of cells in vivo,40 and help biologists study complex processes like
stem cell differentiation.72
The desire for sophisticated miRNA classifier designs that perform increasingly
more complex operations necessitates a deeper understanding of the composition
rules that govern regulation of transcripts by many miRNAs. In this study we in-
troduce miCAD - a workflow for measuring output of single-input miRNA sensors
in cell lines, characterizing miRNA activity from miRNA sensor data using a bio-
chemical model, utilizing the measured miRNA activity to make accurate predictions
of multi-input miRNA classifiers using the Ant/Syn to inform better designs, and
testing the best classifier candidates in cells. The accurate predictions generated
by miCAD reduce or eliminate the need for multiple iterations of physical classifier
designs by instead simulating a large range of classifier designs in silico and testing
only the best candidate(s) experimentally. Interestingly, the use of our Ant/Syn
model in miCAD often leads to improved classifier designs that are counterintuitive.
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For instance, classifiers may perform dramatically better with rearranged target sites
or even with fewer target sites, depending on the application. These and other de-
sign rules, both intuitive and counterintuitive, can help explain regulation of natural
endogenous transcripts and improve the design of new sensor circuits, illustrating
the power of convergence between quantitative biological modeling and analytical
synthetic circuit design.
2.2 miRNA activity characterization and modeling
We designed, constructed, and tested a miRNA sensor library containing all 620
sequences of mature human miRNA designated as high confidence in miRBase 21.12
Our library enables high-information-content screening of miRNA activity in cells
and also serves as a source for sequence-validated templates of miRNA targets when
building multi-input sensors. We synthesized miRNA target site sets bearing four
repeats of perfectly complementary sequence to the miRNA and inserted them into
the 3’ UTR of a reporter construct (Fig. 2-1a). Throughout this work, a miRNA
target site “set” refers to four repeats of a given miRNA target site. We chose to
include four target sites per set since minimal increase in dynamic range was obtained
with >4 targets (Fig. 2-10, 2-11). We chose to include perfectly complementary
target sites to reduce the possibility of miRNA sponging effects42 and increase the
dynamic range of repression. The resulting single-input sensors demonstrate up
to several-hundred-fold dynamic range, indicating the utility of miRNAs as potent
biomarkers (Fig. 2-1a). To our knowledge, ours is the largest miRNA sensor library
reported to date (the previous largest containing target sites for 291 miRNAs11)
and the only one allowing for Golden Gate assembly55 from single-input sensors into
multi-input classifiers in a single assembly step. The library will be available on
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Addgene for researchers to use in advancing the understanding of miRNA biology
and the development of better DNA and RNA-based therapies.
We implemented a computational miRNA repression model to better understand
and quantify the behavior of our sensors and classifiers. The model for single-input
sensors is based on previous deterministic models41,44 for miRNA activity, which
we extended to multi-input sensors using the Ant/Syn model. At the single-input
level, the model comprises the following reactions: 1) mRNA and protein molecules
for two fluorescent reporters are transcribed and translated at first order rates and
are degraded, 2) mKate2 reporter mRNA may be reversibly bound by a miRNA-
containing complex which may then catalytically degrade the bound mRNA, 3)
parameters corresponding to miRNA concentration (𝑀 , the total effective number
miRNA molecules either free or bound to reporter mRNA), and Michaelis constant
(𝐾𝑚 = ⟨𝑘𝑜𝑓𝑓 + 𝑘𝑐𝑎𝑡⟩/𝑘𝑜𝑛, a measure related to the repression strength per miRNA
molecule) are fit using fluorescence data obtained experimentally from our sensors
and together accurately describe the behavior of a given miRNA sensor (Fig. 2-1b).
In concordance with previous models41,44, our model predicts thresholding behavior
with three output regimes when sensing a single miRNA. At low EBFP2 expression
(i.e. low transfection efficiency) a repressed regime exists where mKate2 is signifi-
cantly repressed relative to EBFP2. At high EBFP2 expression, an excess of reporter
mRNA is present and saturates the miRNA machinery, resulting in a derepressed
regime. And at intermediate EBFP2 expression, a threshold regime switches between
repressed and derepressed behavior. Note that in this model we omit the effects of
cellular division and associated dilution, since the other rate constants within the
model operate at much faster time scales (ie. 48 hours for division compared to min-
utes to hours for other rates). Relatedly, it may be interesting generally explore the
dynamics of gene expression and maturation of fluorescent proteins and their effects
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on measurements from miRNA sensors. Such analysis may be especially important
when designing miRNA sensors that act in a cascade or toggle.
We tested the ability of our single-input repression model to explain changes to
experimental perturbations of 𝑀 and 𝐾𝑚. For decreasing 𝐾𝑚, our model predicts
no shift in threshold region - only a decrease of output within the repressed region
(Fig. 2-1c, left). We modulated 𝐾𝑚 experimentally by varying the number of target
sites for miR-21-5p in the sensor. Ase expected from the model, we observed that
increasing the number of target sites increased 𝑘𝑜𝑛, resulting in a decrease in 𝐾𝑚
and increase in repression (Fig. 2-1c, right). This result was also confirmed for
endogenous high activity miRNA in HEK293FT and HeLa cells (Fig. 2-10). For
increasing total miRNA concentration (𝑀), the model predicts a shift in threshold
region to the right and a concomitant decrease of output within the repressed region
(Fig. 2-1d, left). We modulated 𝑀 by transfecting various amounts of miR-21-
5p mimic in HEK293FT cells which have low endogenous miR-21-5p activity. The
expected decrease in output was observed across increasing miR-21-5p amounts (Fig.
2-1d, right).
To experimentally determine the values of 𝑀 and 𝐾𝑚 for each of our miRNA
sensors, we used a reverse transfection protocol62 to introduce our library of sensor
plasmids into common cell lines HEK293FT and HeLa. We then used computa-
tional methods to generate fits of 𝑀 and 𝐾𝑚 for each miRNA sensor in both cell
lines, generating a database of miRNA activities. Fits based on the model captured
the effects of miRNA-mediated repression well as indicated by low and normally
distributed errors (Fig. 2-12). Most miRNA sensors exhibited low or no miRNA
activity, consistent with previous reports of miRNA sensor measurements in several
cell lines (Fig. 2-9).11 To compare miRNA activity to miRNA expression in our cell
lines, we submitted HEK293FT and HeLa for small RNA sequencing and estimated
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miRNA expression levels using existing computational tools.73 miRNA activity was
weakly correlated with miRNA expression (Fig. 2-9), again consistent with observa-
tions in other cell lines.11 We also show that miRNA activities measured using the
sensor library are reproducible, with two biological replicates showing good correla-
tion of a 𝑀/𝐾𝑚 metric which describes the maximal fold repression of a sensor due
to miRNA activity (Fig. 2-9). Analysis of miRNA activities in HEK293FT, HeLa,
and HepG2 helped reveal miRNAs specific to each cell line relative to the others,
which we later used to construct a HEK293FT cell classifier (Table 2.1).
2.3 miRNA target site sets exhibit antagonistic in-
teractions within a UTR and synergistic inter-
actions across UTRs
Following the characterization of single-input miRNA sensors, we sought to use the
obtained parameters to make predictions for more complicated multi-input cell clas-
sifiers. Because our initial purely synergistic model did not provide accurate pre-
dictions for multi-input sensor function, we evaluated models that include additive,
antagonistic, or synergistic interactions (Fig. 2-2). These three types of interactions
were implemented as in the Chou-Talalay method74, which comprises a standard set
of equations used to determine whether inhibitors interact with each other. Additive
predictions were made assuming mutually exclusive inhibitors, antagonistic predic-
tions were made using similar assumptions but with a Hill coefficient value near zero,
and synergistic predictions were made by multiplying contributions from each target
site set (Fig. 2-2b,c).
We then tested 3-input sensors (Fig. 2-3a) encoding several combinations of
55
representative low and high activity miRNA target site sets in the 3’ UTR of the
output and compared obtained data to the predictions (Fig. 2-3b). Antagonistic
interactions best predicted the multi-input data as indicated by lower maximal fold
error and mean squared error, while additive and synergistic predictions consistently
overestimated miRNA activity (Fig. 2-3c). Interestingly, inclusion of up to three
high activity target sets (12 target sites) had minimal effect on increasing repression
further than the single highest activity target set, i.e. the 3-input sensor exhibits
activity reflective of only the highest activity target set.
To fully explore the general composition rules for miRNA target sets, we tried
spacing target sets further apart or placed them in separate UTRs and investigated
whether interactions were antagonistic, additive, or synergistic. We first tested sep-
arating target sets withing the 3’ UTR with spacers up to 600bp but still observed
antagonistic interactions even with the longest spacers (Fig. 2-11). In contrast, we
found that miRNA target sets in the 5’ UTR exhibited synergistic miRNA repression
when combined with target sets in the 3’ UTR (Fig. 2-4). The synergistic interac-
tions we observed suggest that cooperativity may be important for RISC binding or
repression when target site sets are placed in different UTRs. Based on these results
we hypothesized that models for predicting miRNA activity would need to take into
account miRNA target set position in addition to 𝑀 and 𝐾𝑚.
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2.4 A novel Ant/Syn model uses miRNA activity
to predict multi-input miRNA classifier perfor-
mance
Next we tested whether we could generate more accurate predictions than previous
repression models by taking into account antagonistic interactions of miRNA target
sites within UTRs and synergistic interactions across UTRs. This novel model,
which we term an Ant/Syn model, first calculates (on a per transfection marker
basis) the antagonistic interactions within each of the UTRs (approximated as the
minimum reporter expression observed for any single-input sensor within one UTR)
and then calculates the synergistic interactions between the UTRs by multiplying the
contributions of each UTR to obtain the final output (Fig. 2-14). This is in contrast
to the antagonistic-only model where only maximal repression for any single miRNA
is taken, or the synergistic-only model where all contributions for each miRNA target
site are multiplied, regardless of UTR position.
To test the Ant/Syn model experimentally, we built several variants of 4-input
miRNA sensors (i.e. classifiers) bearing two miRNA target site sets in the 5’ UTR and
two miRNA target sets in the 3’ UTR (Fig. 2-5a). We selected twelve miRNA target
sites for study based on their miRNA activity measured from single-input sensors -
four each of high, medium, and low activity miRNAs. We assembled and assayed
reporter expression of 36 different 4-input sensors in HEK293FT cells representing a
diverse panel of activities (Table 2.2), one example of which is shown in Fig. 2-5b. In
all 36 tested cases, the Ant/Syn model predicted final output similarly or better than
the antagonistic-only or synergistic-only models (Fig. 2-5c). For all classifiers with
behavior accurately predicted by the synergistic-only model, the antagonistic-only
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model underestimated activity, while classifiers with behavior accurately predicted
by the antagonistic-only model had activity overestimated by the synergistic model.
2.5 miRNA sensors and classifiers based on Ant/Syn
guidelines
We next investigated whether the Ant/Syn model could be used to design better
single-input sensors and multi-input cell classifiers containing miRNA targets in both
5’ and 3’ UTRs which would allow sensors and cell classifiers to leverage antagonistic
and synergistic interactions to obtain better sensitivity or specificity in classifying
different cell types. Such multi-input constructs also inform how endogenous miRNAs
could utilize 5’ UTR target sites to enhance conventional activity from the 3’ UTR.27
We built two versions of a sensor containing multiple target sets for miR-21-5p, which
shows high activity in HeLa and HepG2 cells but low activity in HEK293FT cells.
In one variant, target site sets were placed in only the 3’ UTR, while in another
variant, sets were placed in both the 5’ and 3’ UTRs. We also constructed a 3-input
cell classifier containing target sites for miR-21-5p, miR-23a-3p, miR-106b-3p where
targets were either all in the 3’ UTR or separated into different UTRs (Fig. 2-6a).
When separately transfected into HEK293FT, HeLa, and HepG2 cells, all sensors
and classifiers showed reporter knockdown in HeLa and HepG2 cells and retained
high reporter expression in HEK293FT cells as expected (Fig. 2-6b). The classifiers
with targets in separate UTRs showed a marked reduction in reporter expression for
off-target cells at high transfection levels resulting in greater on/off ratio (280-fold
on/off for miR-21-5p, 210-fold for 3-input), in contrast to classifiers with targets
only in the 3’ UTR (14-fold on/off for miR-21-5p, 29-fold for 3-input). Thus our new
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constructs with target sets in both UTRs achieved approximately 20-fold (miR-21-5p
sensor) and 7-fold (3-input classifier) improved on/off ratio, compared to constructs
with target sets in only the 3’ UTR. We also observed a reduction in false positive
output consistent with the synergistic interactions anticipated for miRNA target sets
placed in separate UTRs. We then tested whether we could enhance classification in
a mixture of cell types. We chose to test in a co-culture of HEK293FT, HeLa, and
HepG2 cells where HEK293FT cells expressed genomically integrated EYFP in order
to provide an independent measure of whether cells classified as HEK293FT by our
classifiers were indeed HEK293FT in origin (Fig. 2-15). Reporter expression in co-
culture was similar to that in separate transfections, with classifiers designed to utilize
synergistic interactions exhibiting reduced false positive rate at high transfection
levels (Fig. 2-6c). Moreover, quantification of sensitivity and specificity shows that
while sensitivity was high (>95%) for all designs, specificity was improved (>85%)
only in the new designs based on the Ant/Syn model (Fig. 2-6c). We chose to
place only miR-21-5p target sets into the 5’ UTR of these classifiers to minimize the
length of the 5’ UTR - reducing the potential for 5’ UTR structure effects on reporter
expression - while still utilizing synergism across UTRs.
While it is possible to duplicate all miRNA target sites across both UTRs, this
may not be desirable in cases where there is a size constraint, where target sites
bear an ‘ATG’ (which can initiate translation of an upstream ORF), or when it is
important to have synergistic interactions for different miRNA species (with dupli-
cated target sets only the single miRNA species with highest activity would show
synergism). Moreover target site duplication can be adjusted to optimize the trade-
off between sensitivity and specificity according to whichever is more important for
the given application. For example, high sensitivity may be more important for cell
classifiers designed to specifically kill cancer cells to reduce the chance of cancer cells
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escaping, while high specificity may be more important for classifiers designed to
induce differentiation of a particular cell type at a particular differentiation stage
(e.g. driving liver differentiation in a subset of cells in the endoderm but absolutely
not elsewhere). We tested several variants of cell classifiers with and without target
site duplication and examined the effects of duplication on classifier sensitivity and
specificity. The Ant/Syn model predicts that high sensitivity and lower specificity
will be obtained by removing target set duplication from both UTRs, which we ob-
served in the data (Figure 2-7). The effects of miRNA target location and duplication
were further analyzed using ROC curves (Figure 2-8). Again, classifiers with targets
in both UTRs demonstrated improved accuracy and area under the curve (AUC)
compared to those with targets in only the 3’ UTR (Figure 2-8a-b), while those with
target set duplication showed tradeoffs between specificity and sensitivity (Figure
2-8c) and in certain cases improved performance without target duplication (Figure
2-8d). These results also suggest that some endogenous transcripts may use target
sites in the 5’ UTR to tune sensitivity and specificity when responding to miRNA
activity.
2.6 Discussion
We report miCAD, a framework for making accurate predictions of multi-input
miRNA sensors using parts level characterization. Several aspects of miRNA target
regulation comprise our current design framework. First, concatenation of miRNA
target sites in a UTR increases repression of a target reporter up to approximately
4 repeats (Fig. 2-10, 2-16). 1-2 repeats are often insufficient to obtain significant
repression and 3-4 repeats may be required even with high activity miRNAs, sug-
gesting possible roles of cooperativity on miRNA repression. Second, concatenating
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target ‘sets’ of different miRNAs within the 3’ UTR does not result in increased re-
pression, indicating an antagonistic interaction where the combined activity reflects
only the miRNA target set with the greatest activity. Third, target sets in both
5’ and 3’ UTRs exhibit synergistic interactions which can be approximated as the
multiplication of fold repression contribution from the 3’ UTR with that from the 5’
UTR. Finally, antagonistic and synergistic interactions are combined into our pro-
posed Ant/Syn model. Based on our observations, the Ant/Syn model is better able
to explain data from a panel of 4-input classifiers than either the antagonistic-only
or synergistic-only models. It may be interesting in the future to further explore if
there are specific situations (individual miRNAs, combinations of miRNAs, certain
miRNA activity regimes, etc.) where the Ant/Syn model makes better or worse pre-
dictions. Though such work may require testing of more than the 36 combinations we
analyzed here. Our model represents a considerable advance compared to previous
computational models of miRNA activity41,44 in that it accurately models circuits
that respond to multiple different miRNAs.
We also examined the potential for cooperative effects when concatenating mul-
tiple target sites into sets.75 Interestingly, we observed apparent cooperativity across
target sites for miRNAs even when different target sites are interleaved to make new
mixed target sets. In other words, a set of interleaved target sites for four differ-
ent high activity miRNAs represses similarly to a set of four targets of the same
high activity miRNA (Fig. 2-16). This effect suggests that cooperativity could be
mediated by Ago-Ago or Ago-protein-Ago interactions. One proposed protein me-
diator is GW182 which can interact with multiple Ago molecules simultaneously,
forming a complex containing many Ago molecules.76–79 When one miRNA target
site-containing transcript is bound by Ago, other Ago molecules within the complex
are more likely to bind the transcript, enabling cooperative repression (Fig. 2-17).
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One potential complication for this model is that cleavage-independent repression
mechanisms (e.g. mRNA deadenylation, target sequestration) should dominate over
cleavage-dependent mechanisms. Otherwise each target site could be independently
cleaved when bound by Ago2, leading to synergistic repression contributions for
each target site. Since addition of exogenous siRNA along with complementary tar-
get sites was able to enhance repression of transcripts already containing three high
activity target sets (i.e. siRNA targets act independently of miRNA targets), our
data suggests that there could be two different repression mechanisms for siRNA
and miRNA even when target sites are perfectly complementary, with siRNA uti-
lizing cleavage and miRNA using cleavage-independent mechanisms (Figure 2-18).
While siRNA and miRNA are known to repress via different mechanisms for endoge-
nous transcripts80, mechanisms for synthetic sensors with perfectly complementary
target sites have been less studied. Other relevant evidence in plant biology suggests
that cleavage-independent mechanisms like translational inhibition are important
even though most miRNA target sites in plants are perfectly complementary81 and
it has been suggested that non-cleaving repression may be the default mechanism for
miRNA repression in both mammals and plants, despite near-perfect complemen-
tarity for the latter.82 Additionally, examples of miRNA-RISC complexes lacking
cleavage capability have been described previously83. For instance, usage of Arg-
onaut proteins 1, 3, or 4, which lack the cleavage capability of Ago2, could explain
the antagonistic behavior we observed. In that case, processes downstream of Arg-
onaut binding like sequestration, deadenylation, or translational repression could be
the bottleneck for downregulation, which would explain why target site sets do not
act independently. Future studies using overexpression or knockdown/knockout of
Ago2 could potentially shed light on whether usage of other Argonauts besides Ago2
can explain why we observed Ant/Syn behavior.
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In general we and others29 have observed that miRNA target site sets placed in
the 5’ UTR showed similar repression levels to those in the 3’ UTR. However, the
role of 5’ UTR miRNA target sites in endogenous transcripts has not been studied
extensively. Since there appears to be ample potential for effective miRNA regulation
at the 5’ UTR, it appears likely that endogenous miRNA-mRNA targets within
the 5’ UTR should be more abundant than the six validated examples currently
described in the literature.84 Several studies have shown miRNA repression in 5’
UTRs could be important in some transcripts, even though such repression is less-
studied than that in the 3’ UTR despite hundreds of possible 5’ target sites revealed
by computational predictions.27,29 For comparison, the number of predicted target
sites in the 3’ UTR is on the same order of magnitude (though several fold greater)
when the same computational approach is used.27 Analysis of CLIP-seq data has
also identified hundreds of thousands of target sites in CDS and 5’ UTR regions in
mammals.26 Thus miRNA regulation of 5’ UTRs may be an understudied aspect of
miRNA biology and we provide a model that predicts the effects of such regulation.
Our observation of synergistic interactions across UTRs supports the notion that
endogenous transcripts bearing miRNA targets in both UTRs, termed miBridges,
would have enhanced repression.27 Moreover, it may be possible that miBridges are
not limited to transcripts bearing target sites for the same miRNA molecule in both
UTRs, since we observed that different miRNA targets still exhibit synergistic inter-
actions when placed in opposite UTRs (Figs. 2-4 and 2-5) and that combinations
of different miRNAs act similarly to combinations with the same miRNA (Fig. 2-
16). In this case miBridges could be a more general and common motif in biology,
where miRNA targets in the 5’ UTR enhance regulation in the 3’ UTR, similarly to
measured effects from targets in the CDS to those in the 3’ UTR.28
An important remaining question is whether there is a predominant repression
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mechanism for targets in the 5’ UTR and whether the mechanism is different than
that in the 3’ UTR. The observation of distinct synergistic and antagonistic behav-
ior based on whether target sites are on separate or the same UTRs suggests that
distinct mechanisms for miRNA repression may exist for targets in the 5’ UTR com-
pared to the 3’ UTR, otherwise we would expect to observe only antagonistic effects
even with target sets in separate UTRs. The repression effects we observed could be
explained if target sites in separate UTRs separately saturate distinct repression ma-
chinery (e.g. different subunits of the CCR4-NOT complex mediating deadenylation
or translational repression). Indeed, numerical simulation of models incorporating
shared or separate repression machinery were able to recapitulate the antagonistic
and synergistic interactions respectively (Fig. 2-19). There are several alternative
explanations for the mechanistic basis for the Ant/Syn behavior we observed. We
tested whether steric effects (Fig. 2-11), miRNA sponging (Fig. 2-20), and inherent
biological repression limits (Fig. 2-18) could explain the antagonistic interactions,
though none were able to. Results from our and other studies29 suggest that syner-
gistic effects across UTRs could be due to the use of separate repression machinery
depending on the UTR location. Since targets in the 3’ UTR are generally consid-
ered to mediate mostly mRNA destabilization22, it is possible that targets in the 5’
UTR act mostly to translationally repress the targeted transcript (Fig. 2-17). In the
3’ UTR of endogenous transcripts, approximately 6% to 26% of miRNA repression
has been attributed to translational repression.22 However, due to closer proximity
of 5’ UTR targets to translational machinery, it may be possible that a majority of
repression there is due to translational repression. Interestingly, for the RNA bind-
ing protein LIN41 in C. elegans, different modes of repression have been observed
depending on UTR location (i.e. translational repression in the 5’ UTR and mRNA
destabilization in the 3’ UTR).33 Results for LIN41 combined with our data, pro-
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vide the attractive hypothesis that other RNA binding proteins like Ago may use a
similar mechanism to mediate different modes of repression depending on location
within the UTRs. Our results highlight the need for further studies on elucidating
differences between repression from the 5’ UTR, 3’ UTR, and coding region for both
synthetic miRNA sensors and endogenous transcripts.18
Also, we hypothesize that antagonistic interactions could act to reduce noise
and increase redundancy in highly regulated genes, since if the miRNAs have similar
activity, a decrease in activity of any single miRNA would not have significant impact
on gene expression. This is in contrast to the stereotypical additive or independent
(i.e. synergistic) models where fluctuation of any single miRNA would have effects on
gene expression, propagation of noisy miRNA activity toward target gene expression.
This mechanism of noise reduction could work in tandem with other modes where
miRNAs can suppress noise at the network level.85 As such, it may be possible that
highly miRNA-regulated genes use antagonistic interactions within the same UTR to
help reject noise and use synergistic interactions across UTRs to increase repression.
In summary, we describe the development of miCAD, which uses a new Ant/Syn
model taking into account miRNA target set number, location, and interactions in
order to accurately predict the behavior of multi-input miRNA sensors from well-
characterized single-input sensors. In contrast to previous methods yielding fold
enrichment metrics11, characterization via miCAD provides highly detailed infor-
mation of miRNA activity across a wide spectrum of transduction efficiencies and
output levels, allowing accurate predictions of multi-input miRNA classifier function
using our novel Ant/Syn miRNA repression model. miCAD contributes to synthetic
biology by enabling predictable responses to miRNA inputs, and to biology by show-
ing that miRNA repression must take into account location and number of target
sites.
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Figure 2-1: A biochemical model explains miRNA repression measured
using miRNA sensors.
(a top) A schematic of the single-input miRNA low sensors used in this study.
Four repeats of perfectly complementary target sites are placed in the 3’ UTR of
the mKate2 fluorescent reporter. EBFP2 serves as a transfection marker. (a left)
Fluorescence microscopy in HEK293FT cells for a control sensor with miRNA tar-
get sites with no activity (FF4) compared to a sensor with target sites for a high
activity miRNA (miR-106a-3p). Cells expressed both mKate2 and EBFP2 with the
no miRNA activity sensor, while mKate2 fluorescence was greatly reduced in the
presence of a high activity miRNA. Both images are merged blue and red channels.
(a right) Corresponding flow cytometry data in HEK293FT cells for no activity
(red) and high activity (purple) sensors. Data for a positive control using exoge-
nous siRNA to repress mKate2 is shown for reference (blue). Light scatter points
correspond to data; dark points represent median values for data binned by EBFP2
fluorescence; lines indicate fits to the data using a biochemical model; dashed line
shows modeling results with absolutely zero miRNA activity. Fluorescence is shown
in terms of arbitrary units and with logicle scaling for the axes86. (b) The single-
input repression model annotated with relevant species and rate constants. Each
cell is transfected with some number of plasmids (𝑁) which are transcribed (at rate
𝑘𝑡𝑟𝑠) and translated (at rates 𝑘𝑡𝑙𝑛,𝐸𝐵𝐹𝑃2 and 𝑘𝑡𝑙𝑛,𝑚𝐾𝑎𝑡𝑒2) to yield fluorescent pro-
teins. mKate2 transcripts may be reversibly bound by a miRNA-containing complex
(𝑚𝑖𝑅𝑓𝑟𝑒𝑒) forming a bound species (𝑚𝑚𝐾𝑎𝑡𝑒2,𝑚𝑖𝑅). When bound, mKate2 transcripts
can be catalytically degraded at some rate (𝑘𝑐𝑎𝑡). Two parameters, effective miRNA
concentration (𝑀) and Michaelis constant (𝐾𝑚) fully characterize miRNA activity.
RNA and protein species are non-specifically degraded at a fixed rate. All rate con-
stants except for 𝑀 and 𝐾𝑚 are approximated from literature values (Table 2.3).
(c left) Model predictions for decreasing 𝐾𝑚 while holding 𝑀 constant. As 𝐾𝑚
decreases, repression increases while switching threshold is maintained. (c right)
Experimental perturbation of 𝐾𝑚. HEK293FT cells, which exhibit low endogenous
miR-21-5p activity, were transfected with sensors containing varying numbers of tar-
get sites for miR-21-5p and varying amounts of exogenous miR-21-5p mimic. As the
number of target sites was increased (decreasing 𝐾𝑚), repression increased as pre-
dicted. (d left) Model predictions for increasing 𝑀 while holding 𝐾𝑚 constant. As
𝑀 increases, the switching threshold increases and repression increases as a result.
(d right) Experimental perturbation of 𝑀 . As miR-21-5p mimic concentration is
increased, repression increased as predicted.
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Figure 2-2: Methods for combining miRNA activities in predictions of
multi-input low sensors.
(a) Schematics for 0-input control (gray), 1-input (blue and red), and 2-input
miRNA sensors (yellow/purple/green stripe) single and two-input sensors The 1-
input miRNA sensors are first characterized, and the characterization used to pre-
dict the behavior of multi-input sensors. (b) Equations based on the Chou-Talalay
method adapted here for predicting miRNA activity of multi-input sensors ac-
cording to antagonistic, additive, and synergistic interactions. Predictions of free
mKate2 mRNA concentration for the three interaction types (𝑚𝑎𝑛𝑡.(𝑛), 𝑚𝑎𝑑𝑑.(𝑛),
and 𝑚𝑠𝑦𝑛.(𝑛)) are computed based on the characterized output of 𝑘 different miR-
NAs (𝑚𝑖(𝑛)). All mKate2 mRNA concentration predictions are functions of the
number of plasmids (n) in the cell, which is proportional to EBFP2 fluorescence.
𝑚𝑛𝑒𝑔.(𝑛) refers to the output of the negative control where no miRNA target sites
are present. (c) Calculation of 2-input predictions from single-input activity. Colors
for the curves correspond with those from (a). The repression curve for the nega-
tive control construct without target sites (black) is shown for reference. miRNA
repression curves are illustrated for different single miRNAs (blue and red), which
are generated by fitting 𝑀 and 𝐾𝑚 to sensor data using the single-input model il-
lustrated in Figure 2-1. The blue and red single-input repression curves intersect
because in this example miRNA #1 exhibits lower 𝑀 and 𝐾𝑚 but higher 𝑀/𝐾𝑚
compared to miRNA #2, leading to greater repression at lower EBFP2 expression
levels and vice versa. Antagonistic predictions (yellow) closely follow the miRNA
68
with highest activity (minimal mKate2 expression) for a given level of EBFP2 ex-
pression, additive predictions (purple) are similar but with increased overall activity
when the two constituent miRNAs have similar individual activity, and synergistic
predictions (green) always exhibit higher miRNA activity than either antagonistic
or additive predictions. Generally, discrepancy between the two types of predictions
varies depending on the number and miRNA activities of the single-inputs, with
greater discrepancies when many similar activity single-inputs are combined.
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Figure 2-3: Interactions between miRNA target site sets in the 3’ UTR
sensors appear antagonistic.
(a) Schematic for single-input sensors bearing one set of target sites (top) and
3-input sensors bearing three different sets of target sites (bottom) where all miRNA
target sites are located in the 3’ UTR. (b top)miRNA repression data and model fits
for different single-input sensors. Plots are ordered by increasing number of high ac-
tivity miRNA target site sets. miRNA activities are denoted as low (L), high (H), or
very high (H*). (b bottom) Comparison of predicted miRNA repression to data ob-
tained for 3-input sensors. Predictions for 3-input sensors are computed based on 𝑀
and 𝐾𝑚 parameters measured from single-input sensors. Using the assumption that
miRNA target sites act antagonistically yields predictions (red) which are equivalent
to taking the maximum activity (minimum mKate2 expression) of the three single-
input sensors for each EBFP2 expression level. Additive predictions (gray dashed)
are made using the Chou-Talalay method. Synergistic predictions are made by mul-
tiplying fold repression from each of the single-input sensors within each EBFP2
transfection bin. Predictions using the antagonistic or additive models are markedly
better than those from an synergistic model, indicating that miRNA repression for
multi-input sensors is not the simple multiplicative effect. While antagonistic and
additive models were close in these example, predictions can diverge drastically when
several miRNA inputs are combined and when input activities are very similar. (c)
Analysis of prediction errors for 3-input sensors. Errors are measured by computing
the maximum fold difference between predictions and data across all bins of EBFP2
expression (max fold error) or by computing the mean squared error (MSE). For
both metrics and for all tested combinations of low/high/very high (*) activity miR-
NAs, antagonistic interaction explains the data better than an additive or synergistic
interaction.
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Figure 2-4: Positioning miRNA target site sets in separate UTRs yields
synergistic interactions
(a) Diagram of tested constructs bearing target sites in 5’ UTR only (red), 3’ UTR
only (blue), both 5’ and 3’ UTRs (purple), and no target sites (gray; shown as black
in panel b). Constructs were designed to sense endogenous miRNAs with detectable
activity in the tested cell line (HEK293FT). (b) miRNA repression data (circles)
and model fits (lines) obtained for each of the four constructs with miR-106a-3p
target sites, miR-519c-3p target sites, or a combination of the two. Constructs
bearing target sites in both 5’ and 3’ UTRs showed greater repression than
constructs with target sites in only a single UTR, demonstrating a synergistic effect
not observed in constructs where target site sets were confined to the 3’ UTR only.
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Figure 2-5: Ant/Syn model provides accurate predictions of 4-input
miRNA classifiers.
(a) Diagrams for 4-input sensors with associated logic for combining miRNA
activity annotated for the antagonistic-only model (top row), synergistic-only model
(middle row), and Ant/Syn model (bottom row). Two sets of distinct miRNA target
sites were placed in each 5’ and 3’ UTR. (b) Example 4-input predictions based
on single-input data. Rows across panels depict analysis of the sensor configuration
in panel a. Single-input miRNA sensor data and model fits are shown for each of
the four miRNAs (left column). Predictions are made separately for the 5’ and
3’ UTRs (center column) by taking the maximum activity for any single sensor
(antagonistic-only model and Ant/Syn model) or alternatively by multiplying fold
changes (synergistic-only model) in each transfection marker bin. Final predictions
are made (right column) by combining activities from 5’ and 3’ UTRs by multiplying
fold changes for each UTR (synergistic-only model and Ant/Syn model) or by taking
maximum activity (antagonistic-only model). For this example, miR#1 = miR-
17-5p, miR#2 = miR-31-3p, miR#3 = miR-519a-3p, and miR#4 = miR-16-5p.
All 36 miRNA target combinations tested with associated predictions and data can
be found in Figures 2-22 through 2-25. (c) Comparison of error in antagonistic-
only, synergistic-only, and Ant/Syn model predictions for 36 different classifiers.
Errors calculated as mean squared error between prediction and obtained data are
plotted for each of the three possible comparisons. Additionally, points are colored
by the degree of miRNA activity underestimation or overestimation according to
the model plotted along the x axis (i.e. top row colored by antagonistic-only model
errors, middle row by synergistic-only model error, bottom row by Ant/Syn model
errors), resulting in six total graphs. For all 36 tested combinations of miRNAs,
errors from the Ant/Syn model were similar or better than those from the other two
models, as shown by most points falling within upper-left triangle. In comparison,
the antagonistic-only model tended to underestimate repression and the synergistic-
only model tended to overestimate repression.
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Figure 2-6: miRNA target site position affects cell classifier performance
substantially.
(a) Circuit diagrams for miRNA classifiers to distinguish HEK293FT cells from
HeLa and HepG2. Two pairs of classifiers were tested, some encoding miRNA tar-
gets only in the 3’ UTR and others with one set of miR-21-5p targets moved to
the 5’ UTR. miRNAs exhibiting high activity in HeLa and HepG2 cells but not
HEK293FT were selected for inclusion. (b) Fluorescence observed after separate
transfections of the corresponding classifiers from (a) into HEK293FT, HeLa, and
HepG2 cells. Expression of mKate2 reporter remained high in HEK293FT cells for
all classifiers, but knockdown of mKate2 in HeLa and HepG2 was enhanced only
when miR-21-5p targets were placed in the 5’ UTR (columns 2 and 4) compared
to the 3’ UTR (columns 1 and 3), likely due to the synergistic interactions ob-
tained from miRNA targets in different UTRs. Subsampled raw data are indicated
as light points and binned data/fits are indicated as dark points/lines. Subsam-
pling was performed to normalize the number of cells within each EBFP2 expression
level bin in order to minimize effects of transfection efficiency on sensitivity and
specificity measurements. (c) Classification of three cells lines in co-culture for-
mat. HEK293FT cells with genomically integrated constitutive expression of EYFP
were co-cultured with HeLa and HepG2. Transfections were performed in cell mix-
tures for each classifier. After flow cytometry, gating for EYFP+ and EYFP- cells
was used to determine whether each cell was HEK293FT or HeLa/HepG2 in origin.
Subsampled data is shown along with dotted lines that demarcate three regions in-
dicating fluorescent value ranges used for determining whether cells were classified
as HEK293FT (RT: right top), HeLa/HepG2 (RB: right bottom), or undetermined
due to low transfection levels (L: left). Sensitivity or true positive rate is calculated
using 𝑇𝑃/(𝑇𝑃 + 𝐹𝑁) = [𝑅𝑇+]/([𝑅𝑇+] + [𝑅𝐵+]), specificity or true negative rate
is calculated using 𝑇𝑁/(𝑇𝑁 +𝐹𝑃 ) = [𝑅𝐵−]/([𝑅𝐵−] + [𝑅𝑇−]), and accuracy is cal-
culated using (𝑇𝑃 + 𝑇𝑁)/(𝑇𝑃 + 𝐹𝑃 + 𝐹𝑁 + 𝑇𝑁) = ([𝑅𝑇+] + [𝑅𝐵−])/([𝑅𝑇+] +
[𝑅𝑇−]+ [𝑅𝐵+]+ [𝑅𝐵−]) where TP, FN, TN, and FP denote the number of cells that
are true positive, false negative, true negative, and false positive respectively while
+ and − denote EYFP+ and EYFP- respectively. Classifiers with separate target
sites in 5’ and 3’ UTR were better able to distinguish different cell types by reducing
off-target expression. Quantification of sensitivity and specificity shows that while
sensitivity and accuracy remained high for all classifiers, greater specificity (>85%)
was obtained only with classifiers bearing miRNA target sites in both UTRs.
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Figure 2-7: Ant/Syn model predicts the effects of target site position and
number on the trade-off between sensitivity and specificity.
Several classifiers were tested in order to further explore the effect of target set po-
sition and duplication on classifier sensitivity, specificity, and accuracy. We chose
to sense three different miRNAs: miR-21-5p and let-7a-5p have high activity in
HeLa and slight activity in HEK293FT, miR-25-3p has medium activity in HeLa and
HEK293FT. In this example, miR-25-3p would be important for classifying against
a third cell type not shown here (e.g. glioma87). (a-b) To test the effects of miRNA
target set duplication on classification, versions of 2-input classifiers were built con-
taining sets of target sites for let-7a-5p and miR-21-5p together in both UTRs for
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a total of four target sets (a), or in separate UTRs for a total of two target sets
(b). Output in the classifier with four target sets was dominated by synergy between
miR-21-5p activity from both UTRs, resulting in very low output in HeLa (which
exhibits high miR-21-5p activity) and high specificity (97%). However, this high
specificity required a slight trade-off in sensitivity (91%) since output in HEK293FT
(which exhibits slight miR-21-5p activity) was reduced with target site duplication.
In contrast, high sensitivity (99%) but lower specificity (79%) was obtained with the
classifier with only a single set of each miRNA target (b) since output in HEK293FT
cells was attenuated by only one miR-21-5p target set. (c-d) Classifiers similar to
(a-b) were built containing sets of target sites for miR-21-5p and miR-25-3p with du-
plication (c) and without (d). Again duplication resulted in high specificity (100%)
but with a significant trade-off in sensitivity (44%) due to synergistic effects from
both sets of miR-25-3p targets, which allows two medium activity target sets to
exhibit high activity when combined in HEK293FT cells. Also, miR-25-3p targets
contain an ATG sequence resulting in further reduction in output. In contrast, the
classifier with only two target sets avoided multiplicative effects from miR-25-3p and
introduction of uORFs. These effects result in greatly improved sensitivity (82%)
with the classifier containing only two target site sets, at a cost of slightly reduced
specificity (87%). The latter classifier also showed higher overall accuracy (84%
compared to 72%).
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Figure 2-8: ROC curves for classifiers illustrate specificity and sensitivity
tuning by miRNA target set location and number.
Receiver operator characteristic (ROC) curves derived from data in Figs. 2-6 and
2-7 were generated by varying the mKate2 threshold used to classify HEK293FT cells
and then calculating sensitivity and specificity at each threshold. For reference, in-
dicated circles along the curves show sensitivity and specificity at the fixed threshold
of 102 used for Figs. 2-6 and 2-7. (a) Circuit diagrams and ROC curves for miRNA
classifiers with varying target site position as tested in Fig. 2-6. Circuit shading
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color corresponds to ROC curve color. The classifier with miR-21-5p target sets in
different UTRs (red) shows greater maximal accuracy compared to that with target
sites in only the 3’ UTR (blue) as indicated by nearer approach towards the upper
left and greater area under the curve (AUC = 0.9947 vs 0.9895). At the example 102
mKate2 threshold, both circuits prioritized sensitivity somewhat at the expense of
some specificity. (b) Similarly, the 3-input classifier with miR-21-5p in the 5’ UTR
and miR-23a-3p and miR-106b-3p in the 3’ UTR (purple) exhibits better overall
classification than the variant with target sets in only the 3’ UTR (yellow), with
an AUC of 0.9952 and 0.9881 respectively. Again, at the 102 mKate2 threshold cir-
cuits prioritized sensitivity over specificity. (c) Circuit diagrams and ROC curves for
miRNA classifiers with or without target site duplication across UTRs for let-7a-5p
and miR-21-5p. Data for (c) and (d) corresponds to that from Fig. 2-7. Both classi-
fier variants show similar maximum accuracy when classifying between HEK293FT
and HeLa cells, though at the example threshold of 102 the variant without dupli-
cation (red, AUC = 0.9833) prioritizes sensitivity while the variant with target set
duplication (blue, AUC = 0.9750) prioritizes specificity as shown previously. See
inset for magnified view of region where sensitivity and specificity are tuned. (d)
For classifiers with target sites for miR-25-3p and miR-21-5p, the circuit without
duplication (purple, AUC = 0.9235) exhibits better classification compared to that
with duplication (yellow, AUC = 0.7018), since repression was determined by both
miR-25-3p and miR-21-5p rather than being dominated by miR-21-5p and also since
potential uORFs are avoided by removing miR-25-3p targets from the 5’ UTR (both
effects enhance sensitivity).
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Figure 2-9: Low sensor library data in HEK293FT and HeLa cells.
(A,B) A miRNA activity metric of 𝑀/𝐾𝑀 derived from parameter fits is plot-
ted against miRNA expression data in reads per million (RPM) obtained by high
throughput sequencing. Similarly to other results comparing miRNA activity and
abundance, a poor correlation between the two measures is observed for both cell lines
tested here. While several hypotheses exist for the discrepancy (ceRNA hypothesis,
cellular localization, miRNA modifications) the extent of contributions from each of
these and other possible effects is yet to be determined. (C) miRNA expression for
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the two cell lines are plotted against each other. Many miRNAs are differentially
expressed between the two lines. (D) miRNA activity observed using our sensors in
HEK293FT and HeLa are plotted. Several miRNAs show greater activity in HeLa vs
HEK293FT (HeLa-specific) and a few show greater activity in HEK293FT vs HeLa
(HEK293FT-specific). Note the difference between expression data in (C) vs activity
data in (D) (E) The reproducibility of the 𝑀/𝐾𝑀 metric was tested by repeating
two biological replicates of reverse transfection in HEK293FT cells and parameter
fitting of the low sensor library. The 𝑀/𝐾𝑀 metric appears reproducible over the
two replicates suggesting 𝑀/𝐾𝑀 may be used as a proxy for miRNA activity if a
single measure for activity is required. High throughput sequencing was performed
using the NEBNext small RNA kit according to the manufacturer’s protocol and se-
quencing was performed using an Illumina HiSeq 2000. Analysis was performed using
cutadapt to trim the 5’ SR adapters, fastq-multx to demultiplex, cutadapt to trim
the 3’ SR adapter and barcodes, followed by miRExpress88 to quantify miRNA ex-
pression based on sequences in miRBase 213. (F) Correlation coefficient and p-values
were calculated for groups of either high activity (M/Km >0.1, red) and low activity
(M/Km <0.1, blue) sensors in HEK293FT. Both groups show statistically signifi-
cant correlation though there was a large reduction in correlation for low activity
sensors, limiting reproducibility in low activity ranges. However, it should be noted
that miRNA activities within this low regime (M/Km between 0.01 and 0.1) behave
similarly with little detectable repression. Variance for low activity measurements
may be due to noise in model fitting or amplified by the log transform.
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Figure 2-10: Enhanced repression by cooperation with up to four target
sites.
In both HEK293FT and HeLa cells, combining up to four miR-106a-3p target sites
together to form a set results in greater repression. However, further increase from
4x to 8x repeats does not result in further cooperative effects (see figure 2-11). In-
terestingly, 1x and 2x repeats show very little activity. These results suggest that
the 4x repeats we used for our sensor library is a close to optimal balance that can
achieve sufficient repression without incurring excessive DNA synthesis cost.
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Figure 2-11: Effect of spacer length on miRNA low sensors.
To determine whether antagonistic miRNA activities within the 3’ UTR are due to
steric effects, several variants of a low sensor with miRNA target site sets spaced by
different distances were built and tested. For all spacer lengths, sensors with two
sets of target sites performed the same as a sensor with only a single set of target
sites, indicating almost complete antagonistic miRNA activity for spacers as long as
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600 bp - approximately the same length that separates target sites in sensors with
target sets across UTRs which show synergistic activity (figure 2-3). This result
rules out steric or length-dependent effects for observed antagonism. Assembly was
performed using LSBr as backbone and LSB/JG107 providing miRNA target sites,
with JG106 providing different length spacers derived from mKate2 coding sequence.
Transfections were performed in HEK293FT cells which possess high endogenous
miR-106a-3p activity
87
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Figure 2-12: Goodness of fit for the miRNA repression model.
After transfection of miRNA low sensor libraries into HEK293FT cells, we sought
to determine whether observed miRNA activities could be adequately explained by
a simple repression model. After fitting 𝑀 and 𝐾𝑀 to the data, residuals and a
histogram of the residuals was plotted for several miRNAs with different activities.
Residuals are relatively constant across EBFP2 expression levels and centered about
zero, with slightly increased variance at high transfection levels. While minor devi-
ations were found in some cases, most of the data is captured by the model.
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Figure 2-13: The model explains different miRNA repression curve shapes
Four miRNA sensors demonstrating distinct miRNA repression curves are plotted
post transfection into HEK293FT cells and after inning analysis. These shapes can
be explained by different combinations of 𝑀 and 𝐾𝑀 . For miR-103a-3p, the
threshold between repressed/unrepressed regions is low, indicative of a low 𝑀 ,
while magnitude of repression is relatively high, indicative of a low 𝐾𝑀 . For
miR-106a-3p, 𝐾𝑀 is similarly low since greater repression is observed, but the
threshold region is shifted far to the right resulting in high 𝑀 . For miR-127-3p, no
apparent activity is observed which is reflect in both a high 𝐾𝑀 and low 𝑀 . For
miR-223-3p, a slight repression across all transfection levels indicates that the
threshold is far to the right (high 𝑀) but repression magnitude is low (low 𝐾𝑀).
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Figure 2-14: Workflow for predictions based on a synergistic-only repres-
sion model vs the Ant/Syn model.
An illustration of the mathematical operations used to make predictions for
synergistic-only vs Ant/Syn models is shown. In this example for HEK293FT cells,
miR #1 = hsa-miR-363-3p, miR #2 = hsa-miR-196a-5p, miR #3 = hsa-miR-33b-
5p, miR #4 = hsa-miR-340-5p. 1) Single input data are binned according to EBFP2
fluorescence and medians taken. 2) Parameters are fit to the binned data, generating
the basis for all predictions using those miRNAs. 3) The 5’ UTR prediction is calcu-
lated by multiplying the fold changes from miR #1 and miR #2 from the no activity
reference point for each EBFP2 fluorescence level (synergistic model) or by taking
the minimum mKate2 fluorescence within miR #1 or miR #2 for each EBFP2 level
(Ant/Syn model). 4) 3’ UTR prediction is made similarly to the 5’ UTR prediction
except using miR #3 and miR #4. 5) The final prediction is determined by mul-
tiplying fold changes from the two separate UTR predictions again relative to the
no activity reference. 6) Data observed by transfecting the 4-input sensor construct
into cells is compared to the prediction made only from single-input sensor data.
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Figure 2-15: Gating of EYFP+ cells (HEK293FT) from EYFP- cells
(HeLa and HepG2).
We used HEK293FT cells expressing EYFP from the genome to determine whether
cells in coculture were indeed HEK293FT or HeLa/HepG2. (a) The same sensors and
classifiers from Figure 2-5 are shown. Data for each construct is shown in the column
below the respective circuit diagram. (b) Histogram of EYFP for cocultured cells
is illustrated. Cells that could be unambiguously assigned to EYFP+ and EYFP-
populations are colored purple and red respectively. (c) Data from Figure 2-5 with
the EYFP+ and EYFP- cells colored in the same fashion as (b).
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Figure 2-16: Antagonistic effects are maintained in miRNA sets contain-
ing distinct target sites.
To further explore the antagonistic activity contributions from sets of miRNA tar-
gets, we constructed miRNA sets composed of three different high activity miRNAs.
Single input sensor data are plotted (upper left) and data for the corresponding
3-input classifier designs are plotted (upper right) for reference. We observed that
concatenating up to four repeats of these target sets had negligible effect on observed
activity for set A [miR-15b-5p, miR-18a-5p, miR-92a-3p] and minimal effect for set
B [miR-106a-3p, miR-25-3p, miR-144-3p] (bottom). We also tested single repeats
for sub sets of miRNAs in sets A and B. We found that at least two target sites were
required to see significant repression. A minimal trend towards increased activity
with increasing numbers of target sets exists for set B likely due to slightly mis-
matched activity, as miR-106a-3p has slightly higher activity than either miR-25-3p
or miR-144-3p. The maintenance of antagonistic effects even when miRNA targets
96
are different from each other suggests that possible mechanism for antagonism could
be strong cooperative effects between Ago molecules that is not dependent on miRNA
sequence, which is saturable at high numbers of target sites. One possibility is Ago-
TNRC6 complexes containing many Ago molecules allowing for cooperative binding
of Agos bearing different miRNA. Further exploration into the extent of complexes
containing multiple Agos may be warranted in future studies.
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Figure 2-17: Speculative mechanistic model for miRNA repression ob-
served in this study.
We present a speculative model that explains observations made in this study. Rel-
ative mKate reporter mRNA concentrations are shown above the coding sequence
cartoon while relative translation levels per mRNA molecule are shown below. Ar-
row widths denote the amount of flux through a given step and gray arrows show
the proposed rate limiting step for a given sensor. Argonaut molecules and miRNA
target sites are colored according to miRNA loaded into the Ago molecule or bearing
matching sequence to the target respectively. Dotted lines denote Agos that share
the same repression machinery. We hypothesize that miRNA target sites within the
3’ UTR mainly act to deadenylate, degrade, or sequester mRNA transcripts without
affecting translation and vice versa for target sites within the 5’ UTR. However the
model does not strictly require assignment of these degradation pathways, only that
repression mechanisms for the two UTRs be distinct enough that they do not sig-
nificantly share resources and can separately saturated by addition of many miRNA
target sites. Future models may swap or substitute repression mechanisms as fur-
ther data becomes available. a-e) The model involves cooperative binding of Ago to
miRNA target sites. This cooperativity is necessary to explain why little repression
is observed for sensors bearing 1-2 miRNA target sites but significant repression for
those bearing 3-4 or more targets (Fig. 2-10). The data suggest that at low numbers
of targets, binding of Ago to reporter transcripts is the rate limiting step - resulting
in low numbers of transcripts that can be deadenylated/degraded/sequestered. f-i)
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Addition of up to 8 of the same miRNA target site or 4 each two or three different
miRNA target sites in blocks or interleaved fashion all resulted in similar repression
to sensors with only 4 strong miRNA targets (Fig. 2-2, 2-11, 2-16). These data
suggest that inclusion of target sites above ∼4 repeats results in saturation of repres-
sion machinery and that degradation is not likely to be simple cleavage mediated by
Ago2 as this would be unlikely to result in saturation at such low numbers of target
sites. Instead, the data suggest that Ago binds to other factors that repress the
transcript and these other factors can be saturated. j-l) We observed that miRNA
targets within the 5’ UTR repress independently (i.e. synergistically) targets within
the 3’ UTR. We propose that a separate repression mechanism exists for 5’ UTR
miRNA targets, here we show one possibility: translational repression either at ini-
tiation or elongation. With four miRNA targets within the 5’ strong repression is
observed and with the same set of 4x miRNA targets within the 5’ and 3’ UTRs
a combined effect on repression is observed (Fig. 2-3). In our speculative model,
the combined effect is a result of both reduced mKate2 mRNA concentration and
translation levels per mRNA and that binding of Ago to one UTR cooperatively en-
hances binding to the other UTR. m) For our 4-input miRNA sensors, we observed
antagonism within the UTRs and synergy across UTRs, again supporting the notion
that miRNA target sites within the 5’ and 3’ UTRs repress by separate mechanisms
and are independently saturable (Fig. 2-4).
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Figure 2-18: Antagonistic interactions not due to repression limits
Several variants of miRNA sensors bearing sets of 4x miRNA target repeats and
also a set of 4x FF4 target sites within the 3’ UTR were tested in HEK293FT cells
with and without FF4 siRNA. In all cases, addition of FF4 siRNA was able to
further knockdown mKate2 expression, showing that repression is not complete with
three sets of high activity miRNA targets. Interestingly, FF4 knockdown seemed to
take place in addition to knockdown from endogenous miRNAs (i.e. more synergistic
rather than antagonistic), suggesting distinct mechanisms for reporter repression
with siRNA and miRNA.
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Figure 2-19: Speculative ODE model for antagonistic and synergistic re-
pression.
We propose general ordinary differential equation (ODE) models describing repres-
sion from miRNAs when repression machinery is shared, generating an antagonistic
interaction, or distinct, generating a synergistic interaction. a) The model for an-
tagonistic interactions includes mKate transcripts that can be reversibly bound by
different miRNA-RISC molecules [miR1] and [miR2] to form bound complexes. The
bound complexes can then form inhibited complexes after reversible binding with
a shared pool of repression machinery. Inhibited complexes can also be irreversibly
degraded, eliminating the mKate transcript and regenerating the miRNA and re-
pression machinery. b) Results from a numerical simulation of the model described
in (a) with two similar miRNAs. miRNAs are present at concentrations of either 0
or 10,000 molecules per cell. As expected from an antagonistic interaction, the addi-
tion of miR2 results in minimal further repression compared to miR1 alone since the
repression machinery is saturated at concentrations provided by miR1 itself. c) The
ODEs used in (a) and (b) are listed here for reference. d) The model for synergistic
interactions is similar to that for the antagonistic model, with the exception that the
repression machinery for miR1 and miR2 are distinct, since in this case miR1 and
miR2 would have target sites in opposite UTRs (in this example miR1 in the 5’ UTR
and miR2 in the 3’ UTR). Note that initial D2 = D for the antagonistic model, since
both D2 and D2 are concentrations for the repression machinery associated with the
3’ UTR. For simplicity, we also set D1 = D since we generally observe that repression
from 5’ target sites is similar to that from 3’ target sites, though this equivalence
102
is not required for a synergistic interaction to be observed. e) In the simulation
corresponding to the model in (d), miR2 is able to contribute to further repression
of mKate compared to miR1 alone, since repression machinery not shared between
the two miRNAs. This behavior is descriptive of a synergistic relationship. f) The
ODEs used in (d) and (e) are listed here. Equations are similar to (c) except that
there are two terms for repression machinery [D1] and [D2].
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Figure 2-20: Minimal resource sharing between miRNA sensors of related
and unrelated miRNAs.
To test whether transfection of miRNA sensors has measurable effect on repression
of other miRNA targets, a ’decoy’ sensor encoding miR-106a-3p target sites along
with a separate hEF1a-EYFP transfection marker was built. Sequential transfection
of the decoy sensor followed by one of nine low sensors was conducted in HEK293FT
cells. Cells were binned from low to high EYFP expression - indicating low to high
levels of decoy sensor - and traditional EBFP2 vs mKate2 plots were constructed. For
all tested sensors, including related (miR-106a-3p, miR-106a-5p, miR-106b-3p, miR-
104
106b-5p) and unrelated (miR-144-3p, miR-15b-5p, miR-7-5p, let-7b-3p) sensors, no
trend was seen across different decoy sensor levels. If resource sharing was apparent,
less miRNA activity would be observed for higher levels of decoy sensor, but this was
not the case. These results suggest that miRNA sensors impart low or undetectable
levels of resource sharing on other targets.
105
EBFP2
-102 0 102 103 104
m
Ka
te
2
-102
0
102
103
104
miR-21-5p (3' UTR)
miR-21-5p (5' UTR)
miR-21-5p with uORF (5' UTR)
miR-21-5p with in frame uORF (5' UTR)
30nt27nt27nt27nt
3’ end of promoter miR-21-5p target start of mKate2
upstream ATG
29nt27nt27nt27nt
miR-21-5p (5’ UTR)
miR-21-5p with uORF (5’ UTR)
miR-21-5p with in frame uORF (5’ UTR)
Figure 2-21: Repression of sensors bearing targets with and without
uORFs.
miRNA low sensors were constructed bearing four repeats of miR-21-5p in the 3’
UTR (blue circles), or 5’ UTR (red, yellow, purple circles). Since miR-21-5p does
not have ATGs, several ATGs were added between the miR-21-5p target sites in some
sensors. Extra bases were added to separate the ATGs by a number of bases divisible
by three. The distance between the last ATG and the true reporter start codon was
either divisible by three (purple circles) or not (yellow circles). We observed a 2-
fold drop in fluorescence when out of frame ATGs were added that was partially
recovered when the ATGs were then shifted into frame. When using miRNA targets
containing ATGs, altering the sensor design to keep them in frame may allow better
measurements of miRNA activity.
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Figure 2-22: Predictions for Ant/Syn model
miRNA activity data and predictions using Ant/Syn model for 36 different 4-input
classifiers. Predictions are shown for 5’ UTR only (blue lines), 3’ UTR only (green
lines), combined prediction (red lines), and data (red circles). In general,
predictions explain observed miRNA activity well.
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5' = miR-142-3p, miR-99a-3p;
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Figure 2-23: Predictions for antagonist-only model
miRNA activity data and predictions using antagonistic-only model for 36 different
4-input classifiers. Predictions are shown for 5’ UTR only (blue lines), 3’ UTR only
(green lines), combined prediction (red lines), and data (red circles). In general,
predictions generated by the antagonistic-only model underestimate observed
miRNA activity.
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Figure 2-24: Predictions for the synergistic-only model
miRNA activity data and predictions using synergistic-only model for 36 different
4-input classifiers. Predictions are shown for 5’ UTR only (blue lines), 3’ UTR only
(green lines), combined prediction (red lines), and data (red circles). In general,
predictions generated by the synergistic-only model overestimate observed miRNA
activity.
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Figure 2-25: Comparison of predictions for all three models
Direct comparison between the three models for 36 different 4-input classifiers. In
most cases, the Ant/Syn model best explains the data while the antagonistic-only
model underestimates activity and the synergistic-only model overestimates
activity.
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HEK HeLa HepG2 miRNAs
293FT
High Low Low miR-16-5p, miR-18a-5p, miR-519c-3p, miR-520c-3p
Low High Low miR-27b-3p, miR-29b-3p, miR-98-5p
Low Low High miR-16-5p, miR-10a-3p, miR-106b-3p, miR-142-5p
Low High High miR-16-5p, miR-21, miR-23a-3p, miR-130a-3p, miR-29c-3p
Table 2.1: Best candidate miRNAs with specific activities among tested
cell lines.
miRNAs listed here were considered for construction in HEK293FT classifiers. Clas-
sifiers with highest on/off predicted by miCAD were constructed and tested in cells.
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Plasmid Name miRNA 1 miRNA 2 miRNA 3 miRNA 4
UTR Location 5’ UTR 5’ UTR 3’ UTR 3’ UTR
GG Overhang Q3-Q5 Q5-Q9 Q1-Q3 Q3-Q2
JG324 miR-17-5p (H) miR-31-3p (H) miR-519a-3p (H) miR-15b-5p (H)
JG325 miR-17-5p (H) miR-31-3p (H) miR-519a-3p (H) miR-16-5p (M)
JG326 miR-17-5p (H) miR-31-3p (H) miR-519a-3p (H) miR-340-5p (L)
JG327 miR-17-5p (H) miR-31-3p (H) miR-32-5p (M) miR-16-5p (M)
JG328 miR-17-5p (H) miR-31-3p (H) miR-32-5p (M) miR-340-5p (L)
JG329 miR-17-5p (H) miR-31-3p (H) miR-33b-5p (L) miR-340-5p (L)
JG330 miR-17-5p (H) miR-16-5p (M) miR-519a-3p (H) miR-15b-5p (H)
JG331 miR-17-5p (H) miR-16-5p (M) miR-519a-3p (H) miR-16-5p (M)
JG332 miR-17-5p (H) miR-16-5p (M) miR-519a-3p (H) miR-340-5p (L)
JG333 miR-17-5p (H) miR-16-5p (M) miR-32-5p (M) miR-16-5p (M)
JG334 miR-17-5p (H) miR-16-5p (M) miR-32-5p (M) miR-340-5p (L)
JG335 miR-17-5p (H) miR-16-5p (M) miR-33b-5p (L) miR-340-5p (L)
JG336 miR-17-5p (H) miR-99a-3p (L) miR-519a-3p (H) miR-15b-5p (H)
JG337 miR-17-5p (H) miR-99a-3p (L) miR-519a-3p (H) miR-16-5p (M)
JG338 miR-17-5p (H) miR-99a-3p (L) miR-519a-3p (H) miR-340-5p (L)
JG339 miR-17-5p (H) miR-99a-3p (L) miR-32-5p (M) miR-16-5p (M)
JG340 miR-17-5p (H) miR-99a-3p (L) miR-32-5p (M) miR-340-5p (L)
JG341 miR-17-5p (H) miR-99a-3p (L) miR-33b-5p (L) miR-340-5p (L)
JG342 miR-1-3p (M) miR-16-5p (M) miR-519a-3p (H) miR-15b-5p (H)
JG343 miR-1-3p (M) miR-16-5p (M) miR-519a-3p (H) miR-16-5p (M)
JG344 miR-1-3p (M) miR-16-5p (M) miR-519a-3p (H) miR-340-5p (L)
JG345 miR-1-3p (M) miR-16-5p (M) miR-32-5p (M) miR-16-5p (M)
JG346 miR-1-3p (M) miR-16-5p (M) miR-32-5p (M) miR-340-5p (L)
JG347 miR-1-3p (M) miR-16-5p (M) miR-33b-5p (L) miR-340-5p (L)
JG348 miR-1-3p (M) miR-99a-3p (L) miR-519a-3p (H) miR-15b-5p (H)
JG349 miR-1-3p (M) miR-99a-3p (L) miR-519a-3p (H) miR-16-5p (M)
JG350 miR-1-3p (M) miR-99a-3p (L) miR-519a-3p (H) miR-340-5p (L)
JG351 miR-1-3p (M) miR-99a-3p (L) miR-32-5p (M) miR-16-5p (M)
JG352 miR-1-3p (M) miR-99a-3p (L) miR-32-5p (M) miR-340-5p (L)
JG353 miR-1-3p (M) miR-99a-3p (L) miR-33b-5p (L) miR-340-5p (L)
JG354 miR-142-3p (L) miR-99a-3p (L) miR-519a-3p (H) miR-15b-5p (H)
JG355 miR-142-3p (L) miR-99a-3p (L) miR-519a-3p (H) miR-16-5p (M)
JG356 miR-142-3p (L) miR-99a-3p (L) miR-519a-3p (H) miR-340-5p (L)
JG357 miR-142-3p (L) miR-99a-3p (L) miR-32-5p (M) miR-16-5p (M)
JG358 miR-142-3p (L) miR-99a-3p (L) miR-32-5p (M) miR-340-5p (L)
JG359 miR-142-3p (L) miR-99a-3p (L) miR-33b-5p (L) miR-340-5p (L)
Table 2.2: miRNA target combinations for sensors with targets in the 5’
UTR.
miRNA names, UTR location, and golden gate overhangs are listed. miRNA activi-
ties in HEK293FT cells are indicated as high (H), medium (M), or low (L)
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Rate Value Unit (per cell) Description Reference
𝑘𝑡𝑟𝑠 7 mRNAs/hour transcr rate 89,90
𝑘𝑑𝑒𝑔,𝑚 0.5 1/hour mRNA degr. rate 91,92
𝑘𝑡𝑙𝑛,𝐸𝐵𝐹𝑃2 5 proteins/mRNA/hr EBFP2 transl. rate 90
𝑘𝑡𝑙𝑛,𝑚𝐾𝑎𝑡𝑒2 5 proteins/mRNA/hr mKate2 transl. rate 90
𝑘𝑑𝑒𝑔,𝐸𝐵𝐹𝑃2 0.5 1/hour EBFP2 degr. rate 93
𝑘𝑑𝑒𝑔,𝑚𝐾𝑎𝑡𝑒2 0.5 1/hour mKate2 degr. rate 93
𝐾𝑀 various molecules Michaelis constant 94
𝑀 various molecules total effective 95
miRNA concentration
Table 2.3: Rate constants used for miRNA repression model
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Designation Sequence Description
Q1 GCTT miRNA target overhang 1
Q2 CAAC miRNA target overhang 2
Q3 CAGA miRNA target overhang 3
Q4 TGTG miRNA target overhang 4
Q5 GAGC miRNA target overhang 5
Q6 AACG miRNA target overhang 6
Q7 CTTC miRNA target overhang 7
Q8 AGAC miRNA target overhang 8
Q9 AGGT miRNA target overhang 9
Qa GGAG overhang between backbone and insulator
Qb TACT overhang between insulator and promoter
Qc CAGA overhang between promoter and 5’ UTR
Qd AGGT overhang between 5’ UTR and gene
Qe GCTT overhang between gene and 3’ UTR
Qf CAAC overhang between 3’ UTR and poly A
Qg CGCT overhang between poly A and backbone
Table 2.4: Golden Gate overhangs used for assembly
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2.7 Modeling
The model as described includes reactions listed in equations 2.1 to 2.5. In each cell,
the number of plasmids is assumed to be a constant value such that the steady state
approximation can be made.
𝑘𝑡𝑟𝑠𝑁 − 𝑘𝑑𝑒𝑔,𝑚[𝑚𝐸𝐵𝐹𝑃2] = 0 (2.1)
𝑘𝑡𝑙𝑛,𝐸𝐵𝐹𝑃2[𝑚𝐸𝐵𝐹𝑃2]− 𝑘𝑑𝑒𝑔,𝐸𝐵𝐹𝑃2[𝐸𝐵𝐹𝑃2] = 0 (2.2)
𝑘𝑡𝑟𝑠𝑁 − 𝑘𝑑𝑒𝑔,𝑚[𝑚𝑚𝐾𝑎𝑡𝑒2]− 𝑘𝑜𝑛,𝑚𝑖𝑅[𝑚𝑚𝐾𝑎𝑡𝑒2][𝑚𝑚𝑖𝑅] + 𝑘𝑜𝑓𝑓 [𝑚𝑚𝐾𝑎𝑡𝑒2,𝑚𝑖𝑅] = 0 (2.3)
𝑘𝑡𝑙𝑛,𝑚𝐾𝑎𝑡𝑒2[𝑚𝑚𝐾𝑎𝑡𝑒2]− 𝑘𝑑𝑒𝑔,𝑚𝐾𝑎𝑡𝑒2[𝑚𝐾𝑎𝑡𝑒2] = 0 (2.4)
𝑘𝑜𝑛,𝑚𝑖𝑅[𝑚𝑚𝐾𝑎𝑡𝑒2][𝑚𝑚𝑖𝑅]− 𝑘𝑜𝑓𝑓 [𝑚𝑚𝐾𝑎𝑡𝑒2,𝑚𝑖𝑅]− 𝑘𝑐𝑎𝑡[𝑚𝑚𝐾𝑎𝑡𝑒2,𝑚𝑖𝑅] = 0 (2.5)
The total concentration of miRNA is the summation of both free (𝑚𝑚𝑖𝑅) and
bound (𝑚𝑚𝐾𝑎𝑡𝑒2,𝑚𝑖𝑅) species. The Michaelis constant is used as a lump parameter,
fitting only two parameters to characterize miRNA activity minimizes the risk of
overfitting.
𝑀 = [𝑚𝑚𝑖𝑅] + [𝑚𝑚𝐾𝑎𝑡𝑒2,𝑚𝑖𝑅] (2.6)
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𝐾𝑚 =
𝑘𝑐𝑎𝑡 + 𝑘𝑜𝑓𝑓
𝑘𝑜𝑛
(2.7)
Use of additional lumped parameters 𝛼 to 𝛿 simplifies the form of equation 2.12.
These lumped parameters have constant value for all miRNA sensors regardless of
miRNA activity since they depend only on rates of transcription, translation, and
degradation of unbound mKate2 and EBFP2 species.
𝛼 =
𝑘𝑡𝑟𝑠
𝑘𝑑𝑒𝑔,𝑚
(2.8)
𝛽 =
𝑘𝑐𝑎𝑡
𝑘𝑑𝑒𝑔,𝑚
(2.9)
𝑁 =
𝑘𝑑𝑒𝑔,𝑚𝑘𝑑𝑒𝑔,𝐸𝐵𝐹𝑃2
𝑘𝑡𝑟𝑠𝑘𝑡𝑙𝑛,𝐸𝐵𝐹𝑃2
[𝐸𝐵𝐹𝑃2] = 𝛾[𝐸𝐵𝐹𝑃2] (2.10)
[𝑚𝐾𝑎𝑡𝑒2] =
𝑘𝑡𝑙𝑛,𝐸𝐵𝐹𝑃2
𝑘𝑑𝑒𝑔,𝑚𝐾𝑎𝑡𝑒2
[𝑚𝑚𝐾𝑎𝑡𝑒2] = 𝛿[𝐸𝐵𝐹𝑃2] (2.11)
The solution for mKate2 concentration takes a quadratic form for a single-input
miRNA sensor. The two parameters quantifying miRNA activity are 𝑀 and 𝐾𝑚.
[𝑚𝐾𝑎𝑡𝑒2] =
𝛿
2
(
√︀
(−𝛼𝛾[𝐸𝐵𝐹𝑃2] + 𝛽 *𝑀 +𝐾𝑚)2 + 4𝛼𝛾𝐾𝑚[𝐸𝐵𝐹𝑃2])
+
𝛿
2
(𝛼𝛾[𝐸𝐵𝐹𝑃2]− 𝛽𝑀 −𝐾𝑚)
(2.12)
To obtain predictions for combined miRNA activity for two-input (or more) sen-
sors, several approaches can be taken. While numerical simulation could be used,
its implementation would be relatively slow here. We chose to use a more general
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approach borrowed from combination of (drug) inhibitors where combinations are
divided into three classes of interactions: additive - where effects from each inhibitor
alone can be ’summed’ to obtain the combined effect since inhibitors are assumed
not to interact with each other, synergy - where the combined effect is greater than
the sum of each inhibitor alone, and antagonism - where the combined effect is
less than the sum of each inhibitor alone. General equations for combining miRNA
activities using these three classes of interactions have been previously described74
and are given as follows, where 𝑚𝑎𝑑𝑑., 𝑚𝑠𝑦𝑛𝑒𝑟𝑔., and 𝑚𝑎𝑛𝑡𝑎𝑔. refer to mKate2 con-
centrations resulting from the combination of 𝑖 different miRNAs which individually
repress mKate2 concentration to levels 𝑚𝑖. 𝑚𝑛𝑒𝑔. refers to the mKate2 concentration
in the negative control case where the sensor contains no miRNA target sites. For
the antagonistic case, the limit as the Hill coefficient (𝑛) approaches zero is taken
since that is the case of perfect antagonism, where combined activity simply reflects
the highest activity present in the individual sensors. Values for 𝑚𝑎𝑑𝑑., 𝑚𝑠𝑦𝑛𝑒𝑟𝑔., and
𝑚𝑎𝑛𝑡𝑎𝑔. are predicted across the entire range of EBFP2 expression (which serves as
a transfection marker) since repression of mKate2 is often threshold-like and depen-
dent on transfection levels. Example predictions using the three equations are shown
in Figure 2-2.
1
𝑚𝑎𝑑𝑑.
=
𝑛∑︁
𝑖=1
1
𝑚𝑖
− 𝑛− 1
𝑚𝑛𝑒𝑔.
(2.13)
𝑚𝑠𝑦𝑛.
𝑚𝑛𝑒𝑔.
=
𝑛∏︁
𝑖=1
𝑚𝑖
𝑚𝑛𝑒𝑔.
(2.14)
lim
𝑛→0
(︂
1−𝑚𝑎𝑛𝑡.
𝑚𝑎𝑛𝑡.
)︂1/𝑛
= lim
𝑛→0
𝑘∑︁
𝑖=1
(︂
1−𝑚𝑖
𝑚𝑖
)︂1/𝑛
(2.15)
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Equation 2.15 should be equivalent to taking the maximum miRNA activity (min-
imal mKate2 expression) for constituent miRNAs at each level of EBFP2 expression,
such that:
𝑚𝑎𝑛𝑡.
𝑚𝑛𝑒𝑔.
= 𝑚𝑖𝑛
{︂
𝑚1
𝑚𝑛𝑒𝑔.
, . . . ,
𝑚𝑘
𝑚𝑛𝑒𝑔.
}︂
(2.16)
2.8 Design considerations
One design consideration to note is that miRNA sensors bearing target sites in the
5’ UTR can present challenges for a subset of miRNA target sites bearing an ‘ATG’
sequence (e.g. 176 of our 620 high confidence miRNA target sites contain an ‘ATG’).
In these cases, introduction of upstream open reading frames (uORFs) could result
in reporter mKate2 knockdown that is not due to true miRNA activity. We tested
several variants of sensors bearing miR-21-5p target sites (which do not contain a
natural ‘ATG’ sequence) in the 5’ UTR, and also added either no uORFs, out of
frame uORFs, or in frame uORFs in order to determine the possible contributions
to knockdown (Fig. 2-21). By introducing additional nucleotides between miRNA
target sites to place the uORFs in frame with mKate2 we observed that about half
of the lost fluorescence could be recovered. In certain applications, this recovery may
allow for miRNA targets bearing ATGs to be placed within the 5’ UTR with small
alterations.
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Chapter 3
miRNA gene tags for measuring
transcription
Biologists are increasingly making use of diverse types of measurements (e.g. steady
state levels or transcription rates of RNA, steady state levels or translation rates of
protein, and modifications, accessibility, or higher order conformation of DNA). At
the same time, synthetic biologists are trying to use these measurements as inputs to
live cells in order to actuate appropriate responses. In mammalian cells, the ability to
sense and respond to endogenous expression levels in a modular fashion would enable
complex behavior that is more temporal in nature. These ‘embedded’ circuits could
serve as an interface between different biological processes, for instance sensing when
iPS cells are have undergone differentiation to definitive endoderm, and inducing
transcription factors to promote downstream differentiation to hepatocytes. A key
part of these embedded circuits that is under active research is what signals can be
reliably sensed and how to do so. Established examples of sensing include the expres-
sion of luciferase to gauge deliver and expression of nucleic acids delivered in vivo,
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in situ hybridization, and the MS2-MCP system for labeling RNA.96 Active areas of
research include toehold-mediated RNA strand displacement97 and modular protein
sensing to activate transcription.98 An ideal sensing technology would allow modu-
lar sensing of several genes simultaneously and result in a change of RNA and/or
protein levels (if using transcriptional or translational regulation respectively). How-
ever, many of the above examples are not strictly modular and can only actuate
fluorescent signals (e.g. ISH, MS2-MCP) while others are difficult to design and may
require significant tuning for each sensor (e.g. RNA strand displacement, protein
sensors).
Instead, we propose using miRNA sensors - which are easy to design and highly
modular - to sense gene expression. To accomplish this, genes are tagged at their
genomic locus with an artificial miRNA sequence, such that when a gene is tran-
scribed, the miRNA is also transcribed and can be measured with a miRNA sensor
(Fig. 3-1). In theory, the miRNA sensors can sense multiple miRNA sensors at the
same time, using a combination of previously discussed miRNA high sensors and the
Ant/Syn repression model. Additionally, the miRNA sensor output can be chosen
to provide easy single-cell in vitro measurements (e.g. fluorescent proteins), in vivo
measurements (e.g. luciferase), or actuation of downstream signals (e.g. a transcrip-
tion factor). Here we show a proof of concept for how these ‘miRNA gene tags’ can
provide useful measurements of gene activity in live cells.
3.1 Background and challenges
miRNA gene tags require several technologies for implementation, including miRNA
sensors, design of artificial miRNAs, and reliable integration of miRNA tags into
endogenous genes. Since we discuss miRNA sensors at length in Chapter 2 and
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(× n genes)
Figure 3-1: miRNA gene tag overview
miRNA gene tags generally involve the introduction of artificial miRNA sequences
in the introns or near the 3’ end of endogenous genes (to avoid nonsense mediated
decay). In general this is achieved by generating double strand breaks (DSB) in
a target way using CRISPR or TALENs, integration into the genome using repair
templates of single- or double-stranded DNA with homology arms flanking a sequence
for the miRNA hairpin (red), then using a miRNA sensor to sense the activity of
the artificial miRNA, which should relate to transcription of the endogenous gene.
Several genes (n) could be tagged with different miRNA sequences, allowing several
distinct miRNA sensors or classifiers to sense many endogenous genes in a highly
modular way.
design of artificial miRNAs in Chapter 4, we focus on the latter challenge here.
Segments of DNA can be inserted into the genome of human cells in several
ways. Whereas methods like lentivirus and piggyBac transposons integrate their
payload randomly, tagging individual genes requires targeted integration. Targeted
integration has most commonly been achieved using nucleases based on zinc fingers,
TALEs, and most recently CRISPR/Cas9. These nucleases introduce double-strand
breaks at designated sequences which are repaired with homologous recombination
(HR), given a repair template containing the sequence to be inserted flanked by
homologous regions. However, HR is less efficient than alternative repair mecha-
nism non-homologous end joining (NHEJ), meaning that most cells will not contain
126
the desired insertion (in some measures efficiency is 0.05-0.3% for HR compared to
0.6-1.3 for NHEJ).99 As a result, cells bearing the edit must be selected (e.g. with
antibiotic selection) or clonally sorted. While some efforts to knock down NHEJ have
increased the efficiency of HR,100 targeted editing still remains a significant problem
for integrating genetic circuits into the genome. Efforts in our lab to create genomic
landing pads in common cell lines have made integration of large payloads into pre-
defined loci significantly easier.101 However, for miRNA gene tags, payloads will often
need to be integrated near endogenous genes without the use of antibiotic selection,
since introduction of enhancer and promoter elements may disrupt endogenous gene
regulation.* In the work that follows, we screened many different single cell colonies
after gene editing to obtain cells with the targeted integration, though in the future
hybridization and other approaches may allow efficient sorting of edited cells.
A final challenge involves combining the miRNA gene tag and miRNA sensor
technologies, along with activation or repression of endogenous genes, to show that
transcription of endogenous genes can be measured through the gene tag system. In
this work we show that this function is possible in Sox2 and RHOXF2 genes with a
strong FF4 artificial miRNA.
3.2 Initial design of miRNA gene tag
The original gene tag cell line was constructed starting from a HEK293-based cell
line with genomically integrated expression of an FF4 sensor. This starting cell line
designated YQ4035 was then modified to include FF4 artificial miRNA expression
*Demonstrated by collaborators at Thermo Fisher, Jon Chesnut (Jon.Chesnut@thermofisher.
com) and Sanjay Kumar (Sanjay.Kumar2@thermofisher.com)
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immediately downstream of the Sox2 locus, followed by constitutive expression of
zerocin resistance from a CMV promoter.* This modification was carried out by
introducing double strand breaks with Cas9 then repairing with an HR template
with homology arms of 500bp. Expression of zeocin was flanked by LoxP sites so that
after antibiotic selection and expression of Cre recombinase, the zeocin cassette could
be excised, resulting in final cells bearing Sox2 tagged with FF4 and also expressing
the associated FF4 sensor (Fig. 3-2).† Integration of FF4 with zeocin selection
resulted in a cell line with approximately 10-fold reduced mKate levels compared
to YQ4035 cells, presumably due to upregulation of Sox2 from activating elements
from the CMV promoter driving zeocin. Upregulation of Sox2 was confirmed with
qPCR. At this stage, no change in BFP fluorescence was observed, suggesting that
changes in mKate were not due to error originating from the FF4 sensor. Following
excision of zeocin selection by Cre, mKate fluorescence rose to levels approximately
one third of that from YQ4035. After excision, Sox2 expression assayed by qPCR
showed decrease back to original levels. It is possible that mKate levels did not
recover completely to original ones due native expression of Sox2 repressing mKate
with the FF4 gene tag.
Following construction of the Sox2 gene tag cell line, we at the Weiss lab sought to
test whether measurements of perturbations of Sox2 expression could be measured
from the FF4 sensor. We initially tested the use of TALE fusions to KRAB and
VP64 guided to Sox2, but these fusions did not produce detectable changes in mKate
expression of the sensor.‡ We then tested fusions with dCas9 (KRAB, VP160, VPR)
and found that the FF4 responded to activation and repression of Sox2 with down or
*Construction of initial cell line was performed by collaborators at Thermo Fisher
†Sox genetag cell line is designated as line 2-7
‡Data can be found in /jgam/Data/flow/2014-10-11_Gene_tag_initial
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upregulation of mKate by approximately 2-fold, which is the trend expected from the
genetag circuit (Fig. 3-2).* Negative controls without gRNA did not show effects
on mKate fluorescence, again as expected. It should be noted that the positive
control with FF4 siRNA showed greater repression of mKate at approximately 10-
fold, indicating that expression of FF4 from endogenous promoters was not as great
as may be desired for maximum dynamic range.
3.3 Gene tag to measure RHOXF2 transcription
Following successful results with Sox2, we sought to refine gene tags in several ways.
First we wanted to eliminate the need for antibiotic selection and Cre excision, since
for instance in iPS cells it would be undesirable to inadvertently change expression of
transcription factors being tagged. We also wanted to expand the range of genes that
have been tagged and test the possible dynamic range of miRNA gene tags. Therefore
we attempted to tag genes (OCT4, ASCL1 and RHOXF2) that have been shown
to be activated by a dCas9-VPR fusion (as much as 18,000-fold activation).102 We
built backbones JG193, JG194, and JG195 that contain 500bp homology arms and
which also contain Golden Gate assembly sites so that any miRNA (or combinations
of miRNAs) can be assembled between the homology arms. We assembled FF4
expression into these repair template vectors and used PCR to generate linear DNA,
before using Cas9 to edit YQ4035 cells with the gene tags. Following editing we
sorted cells into single wells and allowed them to recover (reaching confluency in
a 96-well plate) before splitting and lysing a portion of the cells in preparation for
genomic PCR. Following genomic PCR, we identified a clone (2-10) appearing to have
*Data can be found in /jgam/Data/flow/2016-03-11_GenTag_KRAB_new_param
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heterozygous integration the RHOXF2 gene tag as indicated by higher mass bands
on an agarose gel.* Unfortunately, the other genes did not show clones with apparent
insertions of the gene tag, indicating that future improvements in the efficiency of
homologous recombinations will be necessary for efficient production of gene tag cell
lines.
With the RHOXF2 gene tag we were able to show that activation of RHOXF2
with dCas9-VPR produced as much as a 10-fold decrease in mKate2 but only in
a subpopulation of cells, suggesting that activation with dCas9-VPR may be more
stochastic compared to more traditional transcriptional activators (Fig. 3-3). Re-
pression of RHOXF2 with dCas9-KRAB showed minimal effect perhaps because
RHOXF2 is minimally expressed such that repression does not significantly decrease
transcription, an observation that would support previous findings that genes with
greatest potential for activation tend to have minimal background expression.102
3.4 Discussion
Here we have shown that miRNA gene tags can be used to modulate expression from
a reporter in response to changes in endogenous transcription. With future optimiza-
tions, miRNA gene tags could allow for robust temporal programs that both measure
and module endogenous biological processes more closely. With enough orthogonal
miRNA gene tags for many different genes, entire biological pathways could be mon-
itored simultaneously. However several challenges remain for miRNA gene tags to
be incorporated in useful circuits. The on/off ratio would likely need to be improved
to increase the dynamic range for downstream regulation. This may be achieved to
*jgam/Data/Gels/2016-10-12
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some degree by optimizing the design of gene tags, including the hairpin structure,
position within UTRs or introns and the distance from the endogenous gene, and
the artificial miRNA sequence itself. Alternatively, construction of an ‘operational
amplifier’ in cells could be used to amplify smaller signals from gene tags into larger
changes in the downstream part of the circuit. Though operational amplifiers would
be a significant research undertaking in it’s own right, and be applicable to many
areas within synthetic biology. Gene tags also require highly efficient and targeted
integration into the mammalian genome ideally without antibiotic selection, which
remains an active area of research within biology. Technology like CRISPR has made
targeted edits easier, but not efficient enough to the point of allowing techniques like
Multiplex Automated Genomic Engineering (MAGE) due in part to the long growth
times for mammalian cells. As such, large-scale genome-wide integration of miRNA
gene tags will likely need to wait until targeted modifications become more efficient.
In the near term, improvements may come in the form of overexpression of genes in-
volved in homologous recombination like RS-1 or RAD51103 or knockdown of NHEJ
components.100 Nevertheless, miRNA gene tags should enable study and manipu-
lation of biological processes in the near term and, combined with other synthetic
biology technology, organisms in the future.
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Figure 3-2: Gene tag measurements from endogenous Sox2.
(left) Diagram of Sox2 gene tag integration process. The repair template contains an
FF4 hairpin and CMV-Zeo cassette flanked by LoxP sites. Double strand breaks were
introduced with CRISPR-Cas9 and the repair template was integrated into a fraction
of cells with homologous recombination. Cells were selected with zeocin to increase
the proportion of cells with successful integrations and clonal population of cells
isolated, then the zeocin cassette was removed by introducing Cre into the cells. Since
cells initially contained integrated expression of an FF4 sensor, the final cells contain
all components necessary for sensing transcription with gene tags. (A-I) Density
plots of miRNA gene tag output with transcriptional activation and repression or
controls. (A) Transcriptional repression with targeted dCas9-KRAV of Sox2 results
in production of less FF4, resulting in ∼2-fold increased levels of mKate output in
the transfected cells (EYFP positive cells). (B) Transcriptional activation of Sox2
using targeted dCas9-VP160 increases the production of FF4 which reduces mKate
levels by ∼2-fold. (C) Transcriptional activation of Sox2 with targeted dCas-VPR
increases the production of FF4 which reduces mKate levels also ∼2-fold. (D-H)
Exclusion of gRNA, a dCas9-fusion, or both, results in minimal changes in mKate
output in EYFP positive cells. (I) A positive control with delivery of FF4 siRNA
with hEF1a-EYFP results in large reduction in mKate output.
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Figure 3-3: miRNA gene tag in RHOXF2.
(top) Integration of the RHOXF2 genetag without antibiotic selection. A similar
repair template for RHOXF2 was synthesized and assembled, in which the homology
arms for RHOXF2 surround a LacZ cassette with Golden Gate overhangs so any
artificial miRNA hairpin can be inserted. For simplicity we inserted FF4 so that the
same cells with integrated FF4 sensor could be used. Following CRISPR and repair
of cells, clones were isolated and screened for insertion using genomic PCR. (bot-
tom) Flow cytometry data with dCas9-KRAB-mediated repression, dCas9-VP160
activation, dCas9-VPR activation, FF4 siRNA, and no effector samples (from left to
right). Each sample contains EYFP as a transfection marker. RHOXF2 gene tag
shows minimal response to repression with KRAB, perhaps because baseline expres-
sion of RHOXF2 is minimal. Response to activation by VP160 was also minimal,
but interestingly a subpopulation of cells showed large decreases in mKate expression
with VPR, perhaps because VPR strongly activates transcription from endogenous
genes. Controls with FF4 siRNA and just EYFP show the expected behavior.
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Chapter 4
One-pot optimization of genetic
circuits
4.1 Abstract
Recent advances in single-cell and pooled approaches are greatly enhancing our abil-
ity to build and test genetic systems for studying and manipulating biology. However,
since existing approaches are often complex, time-consuming and expensive, we de-
vised a ‘poly-transfection’ method that yields multi-dimensional datasets using sim-
ple modifications to inexpensive transfection protocols. Using poly-transfection, we
demonstrate rapid optimization of useful genetic systems including gene activation
by dCas9-fusion and a miRNA classifier for distinguishing cell types.
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4.2 Introduction
Projects in synthetic biology typically use a design-build-test-learn (DBTL) cycle to
obtain a genetic circuit with the desired behavior.104,105 Initially, a candidate circuit is
designed either using computer-aided design tools or in an ad hoc manner, depending
on whether parts have been fully characterized in the context of interest. With each
iteration of the cycle, performance of the current circuit is observed and potential
improvements to the next generation of circuits are proposed based on suspected
failure modes. However, as circuits become increasingly sophisticated, the number
of possible failure modes increases and it becomes more difficult to determine the
source and nature of failure mode(s) for a given circuit.106 Moreover the time to
complete each DBTL cycle can take on the order of weeks to months depending
on the model organism and experimental setup,107,108 while the gradient descent-
like behavior of the DBTL cycle can result in a final design reflective of a local
maximum.109,110 These limitations necessitate methods that quickly explore the full
design space possible to a genetic circuit, in order to determine which tuned circuit
variants meet the desired specifications, ideally in a single DBTL iteration.111–113
Current and developing methods to fully explore design spaces are often technically
complex, requiring large screens,114,115 mutagenesis,88 or preparation of combinatorial
libraries for screening112,116–118. Ideally researchers would be able to efficiently explore
the whole design space using readily available genetic constructs and using simple
techniques performed by virtually all life-science labs. In this study, we introduce
poly-transfections (separately mixed transfection mixtures to decrease covariance
in expression) and computational analysis techniques, which combine to drastically
increase the amount of information that can be obtained through transfections.
Our approach - which we term one-pot characterization and optimization - serves
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as a way to determine how a given circuit performs with any combination of circuit
component concentrations, all in a single tube. Circuit behavior for many possible
circuit variants can be derived from a single one-pot dataset and used to make
informed design choices for direct testing in an application of interest. We also
developed DNA assembly schemes and used machine learning to accelerate the build
and learn stages of the DBTL cycle. Our one-pot method, in concert with modern
design tools, will accelerate all stages of genetic circuit development.
4.3 Building a miRNA classifier using traditional
design processes
To provide a point of reference so that one-pot optimization approaches can be
compared to traditional approaches, we provide examples of our initial attempts to
optimize a miRNA classifier. We initially tried to improve upon previous classifier
designs by using better components than those used previously, namely using tran-
scriptional repressors (e.g. TALER14 and BM3R1) with stronger ability to repress
compared to LacI (Fig. 4-1). To test this design, we used a Gateway-Gibson like
cloning approach to make classifiers that were encoded on single plasmids. We chose
to use a single plasmid design in order to reduce the possibility for variance and error
introduced in co-transfections, at the cost of increased cloning time. However, the
performance of the new classifier was lacking, with low dynamic range even across a
wide range of Dox and TALER14 levels (Fig. 4-2)
We then tested many different variants,* most of which are not interesting enough
*notable flow cytometry files at /jgam/Data/flow/2015-02-27HSBFF4;
/jgam/Data/flow/2015-04-15_HSB2_HEK;
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to cover here. The final designs (Fig. 4-3) did show significant improvements in dy-
namic range compared to the initial TALER14-based classifier, with up to 100-fold
differences between HEK293FT and HeLa cells in some cases (Fig. 4-4 and 4-5).
However, it is important to note that the time for designing, planning, testing, and
iterating took approximately half of a grad student’s time over the course of over a
year. And even with that significant dedication of time, a functional design is by
no means guaranteed and with each iteration it is not known which modifications
could yield better designs and which may be dead ends. As a result, whenever a
new genetic circuit is conceived, the highly iterative design-build-test-learn cycle is
slow and cumbersome and the information learned in each of the iterations may not
be very applicable to designing future unrelated circuits. Researchers have recently
noted how a reduction in the number of iterations can have drastic effects on ac-
celerating development times,119 and more fundamental work on infrastructure for
forward engineering of genetic circuits via accurate predictions has been shown.120
Therefore, work on in-depth characterization of parts and accurately modeling their
composition into systems will continue to be an important part of synthetic biology.
The one-pot approaches we present here represent an accelerated way to perform
deep characterization in a single sample and also a method for optimizing whole cir-
cuits at once. Using one-pot optimization, we gathered data for optimizing a miRNA
classifier that performs better than the iterations shown in this section, all in a sin-
gle afternoon session of flow cytometry. As a result, future optimization of genetic
/jgam/Data/flow/2015-04-19_HSB1_HEK;
/jgam/Data/flow/2016-03-08_JG164-JG170;
/jgam/Data/flow/2016-06-05_HS_JG165_199_200;
/jgam/Data/flow/2016-06-19_HS_variants. Plasmid maps correspond to: HSB1; HSB2; JG164;
JG165; JG166; JG199; JG200;JG206; JG207; JG208; JG209.
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circuits may take as little as 2 weeks including cloning steps, compared to the one
year we took using the traditional iterative approach.
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FF4 siRNA
prep Reporter
Repressor
 High sensor design
Tet3g
+Dox
TagBFP
Figure 4-1: Circuit diagram for the initial miRNA high classifier.
Having previously demonstrated the proof of concept for multi-input miRNA-based
classification of cells in Xie et al.35, we sought to improve the design by replacing
the weak LacI repressor with stronger repressors and also using brighter fluorescent
proteins for output (mKate2). In this design, the repressor chosen was TALER14.
We also used a Dox responsive transfection marker (TagBFP) in order to better
visualize changes in Dox concentration rather than just transfection efficiency. In
these experiments we focused on optimizing the miRNA high sensor part of the
circuit as we believed that had the greatest potential for improvement.
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Figure 4-2: Tests of initial miRNA high classifier with TALER14 repres-
sor.
Fluorescence plots of miRNA classifier using TALER14 that senses a single high in-
put (FF4 siRNA codelivered to cells). Blue indicates samples where no input FF4
was delivered and red indicates samples with FF4. We performed a Dox titration, ob-
serving the expected increase in TagBFP fluorescence with increasing Dox. Addition
of Dox also increased expression of the TALER14, reducing expression of mKate2 to
a degree. Though we did observe higher output in the samples with FF4 added, the
dynamic range for this classifier was not high enough for use as a practical classifier.
This lack of dynamic range was observed across all Dox concentrations, suggesting
that little optimization could be obtained by only varying TALER14 expression. We
also looked towards using other easier to use and better performing repressors in the
future.
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BM3R1
miR-21-5p miR-21-5p
tTA
Output
Bi-CMV
TRE
miR-21-5pmiR-21-5p
Gal4-VP16 tagBFP
(Modulate with TMP)
DDd
(+/- BM3R1op)
Figure 4-3: Design of miRNA classifier variants.
Following other previous experiments with miRNA classifiers, we tried a design with
many variations in topology and expression levels. The design used many more
miRNA target sites than previous designs, with targets in the 5’ and 3’ UTRs of
both the BM3R1 repressor and tTA activator, since the Ant/Syn model indicates
that this design should increase dynamic range. We used Gal4-VP16 to activate the
output, and modulated Gal4-VP16 with the presence (or absence) of a degradation
domain (DDd) that can be stabilized by the addition of trimethoprim (TMP). Also,
the expression of Gal4-VP16 may be modulated in certain designs that have a BM3R1
operon (BM3R1op) upstream.
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Figure 4-4: Output from miRNA classifier variants.
Output (mKate2) as a function of TagBFP shows much better dynamic range com-
pared to the previous TALER14 design, especially given the fact that the classifier
is sensing an endogenous miRNA rather than an siRNA in this case. The clas-
sifier senses differences in activity of miR-21-5p, which is high in HeLa cells and
low in HEK293FT cells. Background expression in HEK293FT cells (dotted lines)
vary across the different variants as expected, with the unmodified classifier showing
highest expression and other variants having lower expression, presumably due to
the decrease in Gal4-VP16 expression either from the DDd or BM3R1op. The trend
in expression in HeLa cells (solid lines) is similar however, meaning that the variants
have similar dynamic range and are merely shifting up or down expression in both
cell lines.
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Figure 4-5: Ratios in output from classifier variants.
Comparison of dynamic range as a function of transfection marker shows that most
variants have similar dynamic range. The DDd only and BM3R1op+DDd variants
appeared to have slightly lower dynamic range. Though dynamic range was im-
proved compared to the TALER14 design, we believed further optimizations could
be obtained if expression levels for all components in the classifier could be tuned
properly.
4.4 Results
Biologists frequently use transient co-transfections to introduce exogenous DNA,
RNA, or protein components into cultured cells to modify cellular signaling or behav-
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ior. In many cases, multiple genetic components must be delivered simultaneously.
For instance, simultaneous expression of several transcription factors has been used
to reprogram cell fate,121 and both guide RNA (gRNA) and Cas9 are needed for
targeted nuclease activity.122 Often, the concentrations of each component and their
relative ratios are important for function; for example, specific ratios of reprogram-
ming transcription factors improve reprogramming efficiency by several fold.123,124
However, the ratios for each gene-coding component are often chosen based on intu-
ition, trial and error, or coarse optimization, meaning the operation of the system as
a whole is likely to be suboptimal. For instance, popular plasmids for CRISPR/Cas9
(e.g. pX330125) encode constitutive high expression of both gRNA and Cas9, but
recent results show significant gains in editing efficiency after optimizing the ra-
tio of gRNA to Cas9.126 For even larger and more complex systems, the number
of possible stoichiometries grows exponentially, which drastically reduces the likeli-
hood that subjectively chosen expression levels will yield optimal or even functional
behavior.127 Therefore, optimizing these systems currently involves complex and ex-
pensive pooled methods111,112,128 or time-consuming manual approaches.129 Pooled
experiments in mammalian cells include many steps, each of which requiring signif-
icant expertise, including: design of pooled DNA, assembly into a uniform library,
delivery of the library into cells using virus, and preparation and analysis of high
throughput sequencing experiments.118,130 On the other hand, optimization is more
commonly achieved by manually varying component levels in many different inde-
pendent co-transfection samples, which requires an exponential increase in samples
for each component within the system (∼ 10𝑛−1 co-transfections for 𝑛 components;
Fig. 4-6). Thus co-transfection experiments are often tedious for smaller systems
and infeasible for larger systems such as those being developed in synthetic biology.
Here we introduce a one-pot ‘poly-transfection’ method which enables broad ex-
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ploration of a genetic system’s behavior across a wide range of component stoichiome-
tries and in a single sample. Poly-transfections employ the same reagents and genetic
constructs as co-transfections, but differ in both the protocol and subsequent data
analysis. In this study, we focus on components in the form of DNA plasmids each
encoding a particular gene in the system, though poly-transfections can also be ap-
plied to other types of molecules like RNA or proteins and possibly those that encode
multiple genes. For reference, in a typical co-transfection, plasmids are mixed at a
predetermined ratio before the transfection reagent is added. Unfortunately, this pro-
tocol results in highly correlated delivery of each plasmid and data that covers only
a single stoichiometry per transfected well (Fig. 4-6b,c).131,132 Moreover, inherent
variability in delivery results in expression that varies over several orders of mag-
nitude, making it difficult to make quantitative comparisons unless a constitutively
expressed transfection marker is added for normalization.133 For poly-transfections,
we instead mix each plasmid separately with transfection reagent before addition to
cells, yielding transfection complexes that each have varying amounts of a single plas-
mid species. Transfected cells uptake multiple complexes, resulting in decorrelated
delivery of each component plasmid (Fig. 4-6d,e).131,132 Thus for poly-transfections
the variability in transfection efficiency is actually advantageous and enables poly-
transfections to broadly sample the component ‘concentration space’. In order to
measure how much of each component is delivered to a cell, we include a distinct
transfection markers with each plasmid, such that each fluorescence intensity relates
to the concentration of one component in the system (Fig. 4-6a,b,d). When combined
with single-cell analysis methods such as flow cytometry, each poly-transfected cell
provides an independent measurement of how the system behaves at a specific combi-
nation of component concentrations. Since poly-transfections simplify experimental
planning and execution to a single sample, significant savings in active experiment
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time can be obtained (Fig. 4-6f).
We first determined whether poly-transfections can recapitulate findings from
previous studies and co-transfection experiments. For a dCas9-VPR/gRNA tran-
scriptional activation system, we found that increasing gRNA concentration con-
tributes to graded increases in activation, whereas dCas9-VPR exerts most of its
effects at a relatively low threshold (Fig. 4-6g). These results are consistent with
our co-transfection experiments (Fig. 4-8) and other studies where efficiency of Cas9
editing depended more on gRNA concentration than Cas9 mRNA concentration.126
Therefore activation efforts with dCas9-VPR (and presumably editing applications)
should benefit more from improved delivery of DNA coding for gRNA rather than
Cas9. We also used poly-transfection to analyze input-output relationships for sev-
eral genetic systems, which would enable easier forward engineering of more com-
plex systems like cascades and oscillators in mammalian cells. Genetic systems we
tested include translational repression by L7Ae, transcriptional activation by Tet3G
and Gal4-VP16, and post-transcriptional repression by artificial miRNAs (Fig. 4-
9-4-14). We found good correlation between data from co- and poly-transfections,
demonstrating that poly-transfections provide reliable data (R >0.93 in all cases;
Fig. 4-9-4-14).
Next, we used poly-transfections to rapidly engineer a difficult-to-optimize ge-
netic system for discriminating cancerous from noncancerous cells.35 Cancer cells
often express the biomarker miRNA-21-5p highly;134 thus, we built and optimized
a cell classifier which produces a genetic output only in the presence of miR-21-
5p (i.e. a single-miRNA high classifier). Our classifier is composed of three DNA
components and responds to miR-21-5p in the following way: (i) at high miR-21-5p
activity, the miRNA degrades the transcript encoding the BM3R1 transcriptional
repressor, (ii) degradation of BM3R1 allows transcription from the promoter driving
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mKO2 reporter, and (iii) a Gal4-VP16 transcriptional activator is needed for output
expression (Fig. 4-7a). Constraining this system to accurately produce output only
in miR-21-5p expressing cells requires balancing the ratios of plasmid concentrations
for BM3R1, Gal4-VP16, and reporter.
We optimized transfection-based classification of cells via the miR-21-5p classifier
by using poly-transfection to identify an optimal DNA ratio of the three classifier
components that would specifically distinguish HeLa from HEK293FT cells, which
have high and low miR-21-5p activity respectively. The comprehensive nature of
poly-transfection data allowed us to easily sample various component stoichiometries
in order to better understand how each component contributes to the performance
of the classifier. We evaluated classification accuracy at different component ratios
by subsampling the 3-dimensional poly-transfection data, designating ratiometric
‘trajectories’ through component concentration space (Fig. 4-7b), and including
only cells that were in close proximity to the trajectory (Fig. 4-15). Subsampling
in this manner provided reliable measurements of classification metrics including
specificity, sensitivity, and accuracy (Fig. 4-14). Using an optimization method ,
we identified a well-performing ratio of 10.9 : 1.5 : 1 for Gal4-VP16 : output :
BM3R1 plasmids at which HeLa and HEK293FT cells were distinguished with 91%
specificity, 62% sensitivity, and 77% accuracy (Fig. 4-7c, Fig. 4-14). We verified this
prediction by performing a co-transfection at the corresponding ratio of components
and found that the specificity, sensitivity, and accuracy metrics agreed with the values
computed from the subsampled poly-transfection (99%, 68%, 84% respectively; Fig.
4-7d). Further comparisons between poly- and co-transfections at 27 different DNA
ratios representing titrations of each individual component showed good correlation
for specificity, sensitivity, and accuracy. Analysis showed that high classification
accuracy was possible with Gal4-VP16 expressed at a wide range of high levels, and
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with BM3R1 and output within a narrow band of lower concentrations (Fig. 4-
7e). Overall, these data indicate that subsampled data from single poly-transfection
samples can be used to quickly evaluate system performance, reducing or eliminating
the need to iterate through different physical designs (Fig. 4-14).
Since many future applications of cell-type classifiers will require single-plasmid
designs for packaging into viruses or integration into the genome, we applied our find-
ings to construct optimized single-plasmid versions of the miR-21-5p classifier (Fig.
4-7f). Given that relative DNA copy numbers are fixed in a single-plasmid system, we
instead tuned component expression ratios to more optimized levels identified above
by inserting a repressive upstream open reading frame (uORF) into the 5’UTR of
the mKO2 reporter and truncating the CMV promoter driving BM3R1 (Fig. 4-16, 4-
17).135,136 The miR-21-5p classifier optimized in this way showed higher classification
accuracy in transfections compared to both an unoptimized classifier (high expression
of all components) and a poorly optimized classifier (low Gal4-VP16 expression via
truncated CMV) (Fig. 4-7g). Additionally, when we replaced the fluorescent output
with the apoptosis regulator Bax, the optimized design showed greater ability to se-
lectively induce apoptosis in HeLa cells compared to the other classifier variants (Fig.
4-7g), and demonstrated similar selectivity compared to other more complex miRNA
classifiers.35,137 Note that we optimized the classifier design according to classifica-
tion accuracy, though we could potentially optimize according to other combinations
of specificity and sensitivity (i.e. points on the ROC curve), depending on if the
application is more lenient towards false positives or negatives. This ability to take
a single poly-transfection dataset and optimize based on parameters deemed impor-
tant (even those not initially considered when designing the circuit and experiment)
contributes to greater flexibility of our one-pot approach.
Poly-transfections bridge the gap between simple but low information co-transfections
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and complex high-information pooled approaches (Fig. 4-18). By taking advantage of
innate variations in transfection efficiency, poly-transfections yield high-information
data similar to modern single-cell analysis techniques, while also being substantially
simpler. Specifically, the increased cost and complexity of FlowSeq methods128 and
droplet microfluidics127 makes them unsuitable for small- to medium-scale systems
(2-4 components) commonly used in biology. Furthermore, our poly-transfection
method can be readily extended to newer technologies such as spectral analyzers
and mass cytometers (e.g. CyTOF) that enable even higher dimensional datasets
than are possible with the 5-color flow cytometers used in this study. Likewise, fu-
ture work could further extend the number of components that can be measured
with poly-transfections by using a combination of RNA barcoding and single-cell
sequencing.
Overall our poly-transfection method represents a convenient and powerful one-
pot approach for evaluating concentration-dependent relationships for diverse ex-
perimental systems, from characterization of basic components to optimization of
complex multi-component designs. In addition to Cas9 and classifier systems shown
here, we anticipate that poly-transfections will aid biologists in extracting deeper
information from genomic perturbations, designing reporters with higher signal to
noise ratio, and building tools to more robustly modulate gene expression, among
other applications. Therefore, while poly-transfections are immediately applicable
to fields such as synthetic biology where optimization of complex multi-component
systems is already essential, we envision that the ease of our method will make such
one-pot strategies more feasible to a wide range of fields within biology.
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4.5 Poly-transfection characteristics
We ran preliminary experiments to determine the characteristics of poly-transfections,
namely whether the covariance typically observed in co-transfection could be reduced
in order to obtain cells with more disparate transfection levels of different DNA
molecules. For the purposes of this study, we examined whether poly-transfection
behavior would be suitable for up to five-dimensional circuit characterization, which
would allow for up to 4 circuit parts in addition to one output. We chose to examine
up to five dimensions since the laser/filter settings for most available flow cytome-
ters limits the use of fluorescent proteins to around five, further fluorescent proteins
would result in significant spectral overlap (Fig. 4-23).138 We observed significantly
reduced covariance with poly-transfections compared to co-transfections (Fig. 4-6e-f)
sufficient for at least 4-component circuits to be analyzed with one-pot methods.
We estimated experiment times for co- and poly-transfections to determine how
much time could possibly be saved through one-pot methods. For co-transfections,
estimates of active experiment time (time spent planning, performing experiments,
and analyzing data; incubation periods not included) were calculated based on the
following times: 1hr + 1.25min/sample (planning), 1hr + 1.25min/sample (transfec-
tion), 1 hr + 2min/sample (flow cytometry), 1 hour + 0.5 min/sample (analysis).
With 10𝑛−1 samples for 𝑛 circuit components we obtain 4 + 0.083× 10(𝑛−1) hr. For
poly-transfections the following times were used: 1hr (planning), 1hr (transfection),
1hr + 𝑠(𝑛−4)hr (flow cytometry), 1hr (analysis). Where s is the scale factor for
amount of time needed per dimension for flow cytometry, which is dependent on
transfection efficiency and distribution and sparsity of sampling tolerated. The ideal
poly-transfection will have 𝑠 = 10 similar to co-transfections, while in the worst case
100-fold more cells would need to be collected per dimension. With sparse sampling
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𝑠 < 10 could be possible with the example shown in Figure 4-6d at s=3. We antic-
ipate that recovering information from sparsely sampled data could prove essential
for testing large genetic circuits, though this is an area of research we have reserved
for future work. We used n-4 in the exponent since we empirically found that one
hour of time was required for the 4-part circuit and significantly less for the smaller
circuits. The final equation is then 4 + 𝑠(𝑛−4) hr.
The inherent bias in poly-transfection expression distributions (which are also
present in co-transfections) could hamper efforts to sufficiently and evenly sample
higher order parameter spaces. We have also tested modifications to increase the
efficiency of poly-transfections. We examined whether poly-transfection distribution
could be influenced by the amount of each DNA complex transfected. Indeed in a
two-component circuit, we could shift the location of double-positive cells by reducing
the amount of DNA in one of the complexes and replacing with non-expressing DNA
(Fig. 4-20). This change could allow more efficient exploration of parameter space by
using separate poly-transfections with different distributions that complement lower
density regions that might be present in a single poly-transfection. For example, a 3-
input 1-output system could utilize four poly-transfections, considering that there are
three lower density regions in the 3D input space. Such a compromise would result
in linear increases in the number of required samples per experiment (𝑛 samples
required for 𝑛 dimensions), still a marked improvement compared to the exponential
increase with co-transfections (∼ 10𝑛−1 samples required). Alternatively, we propose
that the dimensionality of the experiment could be reduced by pre-mixing some parts
together before the poly-transfection. This could be helpful when previous small scale
characterizations of sub-circuits have already indicated the ideal ratio for some of
the parts to be used. Thus experiments could be hierarchical; different parts of the
circuit could be tested in parallel with separate poly-transfections to determine ideal
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ratios for some of the parts, then a final poly-transfection with those parts pre-mixed
in order to determine the best relative ratios for the final circuit.
We also tested whether the poly-transfection method was flexible in the types
of transfection reagents that could be used, given that many different reagents and
protocols exist. We saw that in general most transfection reagents give similar distri-
butions covering the available parameter space with some minor variation [that could
perhaps be attributed to variations in transfection efficiency] (Fig. 4-22). We also
tested whether sequential transfection utilizing a mixture of electroporation followed
by chemical transfection. Again we saw that parameter space was explored with this
method, though with more bias towards the electroporated plasmid, likely due to
higher transfection efficiencies achieved by that method (Fig. 4-21).
4.6 Activation by Gal4-VP16
To demonstrate the advantages of one-pot method in characterization of commonly
used genetic parts, we characterized several regulatory modules that act at various
levels of the central dogma. We characterized non-inducible (Gal4-VP16) and in-
ducible (Tet3G, Clontech) transcriptional activation modules, mRNA degradation
modules (synthetic miRNAs) and a translational repression module (L7Ae). Each
module characterization required a single sample (rather than multiple titration
curves), and two transfection complexes.
We began by characterizing the behavior of Gal4-VP16, a transcriptional activa-
tor of gene expression.139 In our system (Fig. 4-27a), Gal4-VP16 is produced constitu-
tively by a CMV promoter. iRFP720 is produced constitutively on the same plasmid
as Gal4-VP16 and serves as a transfection marker indicating the relative concentra-
tion of Gal4-VP16 delivered to a cell. On a separate plasmid, an mKO2 fluorescent
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output is placed under control of a UAS-containing promoter that is activated by
Gal4-VP16. This second plasmid contains a constitutively expressed mNeonGreen
transfection marker, which indicates the concentration of reporter plasmid delivered
to each cell. Input parameter space, the plane defined by Gal4-VP16 (∼iRFP720)
and reporter (∼mNeonGreen), was sufficiently explored in a single poly-transfection
(Fig. 4-27b). Output expression as a function of each tunable parameter can be
given as a 2D heatmap, with colors defined by output fluorescence at each input bin
(Fig. 4-27c). The heatmap indicates that, as would be expected from a well-behaved
activator/promoter pair, output is only expressed when both plasmids are present
at high concentration. In other words, minimal leakiness in output is observed when
reporter concentration is high but Gal4-VP16 concentration is low, a common failure
mode for inducible promoters. We produced corresponding surface and line plots,
where different concentrations of reporter plasmid are indicated by colors (Fig. 4-
27d). Across all reporter bins, we observed a sigmoidal response of output in response
to increases in Gal4-VP16, indicative of typical transcriptional activation. When the
data are instead grouped by Gal4-VP16 amount, the out transfer curve shows a more
linear response to reporter amount but only at high Gal4-VP16 concentration (Fig.
4-27e). These results demonstrate that in our system, when there is sufficient Gal4-
VP16 for activation, output can be further increased by increasing the concentration
of reporter plasmid. We conclude that the concentration of reporter can be used
to ‘set’ the maximal amount of output to that desired in a given application, while
Gal4-VP16 can be used to switch between low and high output levels.
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4.7 Characterization of Tet3G system
Tetracycline-based induction of transcriptional activation/repression by the E. coli
protein TetR and its derivatives has been widely used to tune gene expression both
in output level (by choosing different tetracycline concentrations) and in time. Dox
works by changing the conformation of TetR to abolish (wild-type TetR) or enable
(reversed TetR, or rTetR140) binding to its target DNA operator (TetO). In mam-
malian cells, rTetR can be fused to a trans-activation domain to drive Doxycycline-
induced gene activation from promoters with the TetR-responsive element (TRE), an
array of TetO binding sites upstream of a minimal promoter; this system is referred
to as the reversed tet trans-activator (rtTA). Given rtTA’s use in various biological
studies ranging from initiating cell reprogramming, differentiation, and specific gene
expression, we wanted to test how the amount of rTetR protein and its target pro-
moter affected the observed Dox induction curve. This would help to understand
how changing cellular conditions might propagate to affect the Dox curve, and thus
the ability to predictably control gene expression.
To study rtTA’s activation function and compare the poly- and co-transfection
methods, we performed side-by-side experiments with paired experimental condi-
tions. First, HEK-293FT cells we poly-transfected with two complexes, (1) hEF1a-
driven Tet3G (Clontech) with a hEF1a-driven mNeonGreen reporter and (2) TRE-
driven mKate2 with a hEF1a-driven TagBFP reporter (Fig. 4-10a). In parallel, we
co-transfected various wells of HEK-293FT cells with the same paired plasmids at
various ratios, keeping the same ratio between the reporters and the concomitant
TetR/TRE plasmids. Both poly- and co-transfected samples were analyzed with
flow cytometry.
Data from the co-transfected samples were pooled together to create a similar
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two-dimensional data space comparable to poly-transfections, which we could then
bin in the exact same manner for both methods (Fig. 4-10b). Similar to the Gal4-
VP16 experiment, the 2D grid of bins allows delineation between an increase in the
output plasmid (here marked by TagBFP) and an increase in the Tet3G protein level
(here marked by mNeonGreen). Median mKate2 expression levels in each bin were
calculated and plotted in Fig. 4-10c. The 2D profiles for the poly- and co-transfected
samples were overall very similar, with the most noticeable differences being at lower
TetR/mNeonGreen levels.
We then focused in and compared the effect of increasing Tet3G on the Dox-
induction curves at various selected TagBFP bins (Fig. 4-10d). Overall, the poly-
and co-transfection data agreed very well for all bins except at high-TagBFP and
low-mNeonGreen levels, possibly due to high sensitivity in the system. We found
that relatively little Tet3G is needed to maximize protein expression. However, we
noticed that increasing expression of Tet3G did not monotonically increase promoter
output, but rather caused a decline after reaching a peak output level. We sus-
pect that this can be attributed to self-squelching by the trans-activation domain
in Tet3G141. These results demonstrate the utility of understanding how all com-
ponents to a system contribute to knowledge of function. With the given data, we
can now understand how to maximize gene expression and fold-inducibility from the
rtTA system.
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4.8 Characterization of artificial miRNA for use as
synthetic biology parts
We tested the ability for poly-transfections to simplify the characterization of or-
thogonality between different parts. Here we analyzed a two-part system where
a production of an artificial miRNA sequence142 represses output of corresponding
miRNA sensor - a fluorescent reporter bearing miRNA target sites (Fig. 4-11a).1,35
EYFP served as a marker for relative concentration of artificial miRNA, while EBFP2
served as a marker for the sensor concentration. We determined that input parame-
ter space (EBFP2 vs. EYFP) was sufficiently covered by the poly-transfection (Fig.
4-11b). Plotting sensor output fluorescence (∼mKate2) as a function of miRNA
concentration (∼EYFP) shows that, as expected, output mKate2 is reduced at high
miRNA concentration relative to EBFP2 which contains no target sites (Fig. 4-11c).
A graph of poly-transfection data binned by miRNA concentration then binned by
transfection marker demonstrates the performance of the miR-FF5 sensor at different
miRNA concentrations (Fig. 4-11d). As miRNA concentration is increased, mKate2
fluorescence is decreased further compared to EBFP2 and in a threshold-like manner
as previously observed from similar sensor constructs.44
We then demonstrated that detailed information about miRNA orthogonality
could be obtained from poly-transfection data, at a reduced number of transfections
compared to co-transfections. We conducted poly-transfections using all possible
combinations of eleven different miRNA and sensor sequences, resulting in 11*11=121
separate poly-transfections (Fig. 4-11e). To obtain somewhat similar data using
co-transfections would have required approximately 10*11*11=1210 transfections,
since around 10 co-transfections are required to adequately cover a 2 dimensional
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parameter space (Fig. 4-6d). In this poly-transfection experiment, samples were
prepared in only two 96-well plates, allowing both transfections and flow cytometry
to be conducted in fewer than two hours each with the appropriate high throughput
equipment. Of note is that only 11+11 = 22 lipix-DNA complexes need to be mixed
for poly-transfections, compared to 11× 11 = 121 complexes for co-transfections.
The results from the orthogonality test of artificial miRNAs show that as miRNA
concentration is increased from bin 1 to bin 6, repression of the corresponding sen-
sor is increased with minimal effects on sensors bearing other miRNA target sites.
Specifically miR-FF5 and miR-FF6 showed the greatest degree of repression, indi-
cating that these artificial miRNAs are the best choices when trying to maximize
dynamic range (Fig. 4-11e and Fig. 4-13). There was one example of significant off-
target effects, where miR-SHC007 repressed the sensor for FF6, though on further
examination we found that the FF6 target contained a match for the seed sequence
of miR-SHC007, since both were derived from the same luciferase sequence. We
also compared co-transfection and poly-transfection data by combining all data from
co-transfections into a poly-like dataset and analyzing both datasets in a similar
fashion. For both tested miRNAs miR-FF4 and miR-FF5 the behavior measured
from co-transfections and poly-transfections was similar (Fig. 4-12)
4.9 Characterization of translational repressor L7Ae
We evaluated poly-transfection for its ability to characterize other RNA-level mod-
ules such as translational repression by L7Ae. L7Ae has been used in genetic circuits
to tightly bind to its cognate k-turn RNA motif and block downstream translation.143
We therefore test a two-part system where L7Ae expression represses expression of
a reporter containing 2xkturn encoded in its 5’ UTR. L7Ae was expressed constitu-
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tively along with mKO2 as a marker, while the reporter (2xkturn-mNeonGreen) was
expressed constitutively with tagBFP as marker (Fig. 4-9a). Fig. 4-9b shows output
mNeonGreen fluorescence of cells within this two-dimensional parameter space and
the corresponding surface plot is depicted in Fig. 4-9c. As expected, we see that
fluorescence increases in response to increasing amounts of reporter but decreases
in response to increasing amount of L7Ae. Also, when compared to a concatenated
set of 11 co-transfected samples that explored the same parameter space, the poly-
transfection data were similar.
4.10 Building up to a cell-type classifier responding
to miR-21-5p
We scaled up our efforts towards characterizing miRNA high sensors which contain
either three or four tunable parameters and one output. Our high sensors are based
on previous designs, with inclusion of a stronger transcriptional repressor and miRNA
target sites in both the 5’ and 3’ UTRs.35 In the circuit design, an endogenous miRNA
represses a repressor - in this case BM3R1 - which represses the output, such that
output is produced when miRNA activity is high. We also included a Gal4-VP16
activation of output in order to more easily tune circuit behavior by modulating
Gal4-VP16 concentration. This is in contrast to a miRNA low sensor where out-
put is produced when miRNA activity is low (Fig. 4-11). We gradually built up
toward a miRNA high sensor starting from the Gal4-VP16 module (Fig. 4-27, 4-
25a-b) and adding the BM3R1 transcriptional repressor (Fig. 4-25c-d) and miRNA
target sites (Fig. 4-25e-g). We tested designs in two cell types: HEK293FT which
exhibits low activity of miR-21-5p, and HeLa which exhibits high activity. Thus our
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immediate goal was to identify areas in parameter space where output was minimal
in HEK293FT cells and high in HeLa cells. Starting with the Gal4-VP16 activation
of the output, output fluorescence as a function of the two input parameters was
high when both the reporter and Gal4-VP16 concentration are high (Fig. 4-25b).
This behavior was observed for both HEK293FT and HeLa cells, as shown by a low
HeLa/HEK293FT ratio in output across all of parameter space. Addition of BM3R1
to transcriptionally repress the output added another dimension to the parameter
space, such that output was only expressed when reporter was high, Gal4-VP16 was
high, and BM3R1 was low (Fig. 4-25d). Again we observed that output was similar
in HEK293FT and HeLa cells. Finally, addition of miR-21-5p target sites to BM3R1
allowed for cell-type specific expression (Fig. 4-25e). HEK293FT cells exhibit neg-
ligible miR-21-5p activity so the output behavior in those cells was similar to the
previous case lacking target sites (Fig. 4-25d,f) On the other hand since miR-21-5p
has high activity in HeLa cells, the region of parameter space where HeLa expressed
high output was expanded, resulting in a band of parameter space where output
was high in HeLa but not HEK293FT cells (Fig. 4-25f). Furthermore, calculation
of specificity, sensitivity, and accuracy showed a similar result, where specificity was
high where HEK293FT output was low, sensitivity was high where HeLa output was
high, and accuracy was high in a band of parameter space where both were true (Fig.
4-25g). Therefore, high sensor designs should be tuned such that expression of each
of the inputs is located around the band where accuracy is highest. We also tested
a 4-component design where BM3R1 was activated by the transcriptional activator
tTA, though minimal benefit in performance was observed for that variant so further
testing was performed in the simpler 3-plasmid circuit (Fig. 4-26-4-28).
For the 3-component design, optimization of expression ratios for all compo-
nents was initially performed using the Nelder-Mead simplex algorithm (fminsearch
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in MATLAB) with subsampling the poly-transfection and calculating classification
accuracy, resulting in a ratio of 435ng: 227ng : 45ng for Gal4-VP16 : output :
BM3R1 and an accuracy of 72%. Then we manually tuned the DNA amounts to
find a more robust region of parameter space (435ng : 60ng : 40ng) with better clas-
sification accuracy of 77%. With a more advanced optimization strategy, it is likely
that robust classification could be optimized without manual intervention. Such
advances will likely be required in the future with larger more complex systems.
4.11 Additional analysis
We anticipate several challenges in applying poly-transfections to increasingly larger
genetic circuits. First, the transfection biases (which are inherent to all transfec-
tions) result in data that is not uniformly sampled across the parameter space. This
bias towards singly- and doubly-transfected cells can be corrected for by subsam-
pling the data to normalize the transfection spread (Fig. 4-24) Second, with greater
dimensionality, datasets become more challenging to analyze and interpret into a set
of design rules. Consequently, we anticipate that techniques like machine learning
will play a role in simplifying results into sets of design rules that are intelligible
to designers. We tested the ability for random forest regression to determine the
most important parameters in the 4-component miRNA high sensor circuit. We
chose random forests due to their simplicity and ability to generate feature impor-
tances. Our analysis indicated that Gal4-VP16 was the most important parameter
for obtaining functioning high sensors, followed by the reporter and ratios between
repressing (tTA, BM3R1) and activating (Gal4-VP16, reporter) circuit components
(Fig. 4-29). Third, the broad excitation and emission spectra of fluorescent pro-
teins limit the number of components that can be simultaneously measured to the
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number of lasers in current flow cytometers. One potential solution is to instead
use spectral analyzers, which enable better deconvolution of overlapping spectra by
measuring at many wavelengths simultaneously. Additionally, mass cytometry (e.g.
CyTOF) paired with epitope tagging of circuit components could offer another ap-
proach, though staining will introduce further varability to the measurements. A
final limitation is given by the number of cells that can be measured per unit time.
Current cytometers can measure a few thousand events per second, but as the dimen-
sionality of an experiment increases, the number of events measured must similarly
increase to maintain the same level of coverage (Fig. 4-6e) A combination of un-
dersampling (and subsequent data reconstruction) and advances in flow cytometry
instrumentation may be necessary to keep pace with large circuit testing.
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Figure 4-6: Comparison of co-transfection and poly-transfection methods.
(a) Diagram of genetic system with three DNA plasmid components (Comp A-C).
This example corresponds to a system for miRNA-based cell classification, where
Comp A, B, and C are BM3R1 with miR-21-5p target sites, mKO2, and Gal4-VP16
respectively (Fig. 4-7). In a typical co-transfection, constitutive expression of only
a single transfection marker fluorescent protein (FP) is needed, though here we in-
clude three (FP A-C) so that coverage of ‘concentration space’ can be visualized
for both co- and poly- transfections. (b) Co-transfection (co-TX) workflow. Each
DNA component is premixed at defined ratios before transfection reagent is added,
forming complexes containing DNA and transfection reagent (gray circles). Since
DNA is premixed, all cells within a well are transfected with a fixed ratio of each
component. While the number of total plasmids delivered to each cell varies, the
ratio of each remains similar. Therefore only a single ratio of concentration space
is explored per well, as indicated by the scatter plot in 3-dimensional concentra-
tion space. (c) Number of co-transfection samples required to sample concentration
space. With a system containing two-components (e.g. L7Ae repression, Fig. 4-9),
a scatter plot of 2-component co-TX samples with DNA premixed at varying ratios
indicates that ∼ 10𝑛−1 samples are required for a circuit containing 𝑛 parts. Different
colors indicate samples with different DNA ratios. (d) Poly-transfection (poly-TX)
workflow. Each component is mixed with transfection reagent separately to form
distinct transfection complexes. Transfected cells take up multiple complexes and
express varying amounts of each component, filling concentration space in a single
sample as shown in the 3D scatter plot. (e) Coverage of 2-dimensional concentra-
tion space with single poly-transfection sample. (f) Estimates of active researcher
experiment time needed for co- and poly-transfections. Co-transfections require a
fixed setup time plus hands-on/analysis time for each sample. Since the number
of samples increases exponentially with the number of components within a genetic
system, experimental time also increases exponentially. As poly-transfections require
only one sample, experiment time depends mostly the number of cells to be collected,
resulting in more efficient use of time. With greater than four circuit components,
experiment time may scale depending on transfection efficiency and tolerance for
undersampling; examples are indicated by orange lines and the range is indicated
by yellow shading. Feasible and infeasible experiment times are indicated by white
and gray backgrounds respectively. Equations for estimated experiment time can be
found in section 4.5. (g) Characterization of transcriptional activation of a fluores-
cent reporter by dCas9-VPR. Contributions to activation by dCas9-VPR and gRNA
can be measured simultaneously with our one-pot method. Shown are the circuit
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diagram, subsampled scatter, and a surface plots of output as a function of gRNA
and dCas9-VPR at intermediate TagBFP transfection marker levels (103 to 104 AU).
Surface plots indicate the medians of mNeonGreen within each 2D bin and data at
all TagBFP levels can be found in Fig. 4-30.
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Figure 4-7: Rapid optimization of a miRNA classifier using poly-
transfection.
(a) miRNA classifier to be optimized. In cell lines where miR-21-5p activity is high
(e.g. HeLa), BM3R1 is repressed by the miRNA, derepressing output mKO2 in the
presence of Gal4-VP16. (b) Poly-transfection (poly-TX), co-transfection (co-TX),
and subsampled poly-TX data in three component dimensions. Poly-TX data shows
sufficient coverage in three input dimensions such that it can be subsampled according
to a ratio trajectory (blue) to yield data similar to co-TX. For poly-transfection, at
least 1.5 million cells were assayed. (c) Classification in HEK293FT and HeLa
cells based on the subsampled poly-TX. Scatter diagram of mKO2 output is plotted
as a function of reporter marker fluorescence (mNeonGreen). Vertical dotted lines
designate the threshold for cells designated as transfected (mNeonGreen = 5 × 102
AU) and horizontal lines designate the threshold for determining if cells express
high or low output (mKO2 = 102 AU). Poly-TX data was subsampled according
to a trajectory corresponding to Gal4-VP16 = 435 ng of DNA, reporter = 60 ng,
and BM3R1 = 40 ng. For HEK293FT cells (red), output remained low in most
cells across all reporter levels, while in HeLa cells (purple) a majority of transfected
cells expressed high output (specificity = 91%, sensitivity = 62%, accuracy = 77%).
(d) Cell classification in a co-TX experiment at same component ratio as in (c).
Similar to the subsampled poly-TX, output was low in HEK293FT cells and high in
HeLa cells (specificity = 99%, sensitivity = 68%, accuracy = 84%). (e) Classification
accuracy as a function of component amounts. For either co-TX or subsampled poly-
TX data, accuracy showed similar dependency on BM3R1, reporter, and Gal4-VP16
amounts. DNA amounts correspond to those in (c) with one of the components varied
at a time. For co-transfections, the 27 different ratios used are listed in Table 4.2
(f) Circuit diagram for single-plasmid miRNA high sensors. Tunable parts include
either upstream open reading frames (uORFs) or CMV truncations (CMVd), both of
which tune down expression to a defined degree (Figs. 4-16, 4-17).135,136 Also given
is the table of CMV truncations and uORFs used in single-plasmid constructs. The
optimized circuit encodes high expression of Gal4-VP16 and reduced levels of output
and BM3R1, the unoptimized circuit encodes high expression of all three, while the
poorly optimized circuit encodes low expression of Gal4-VP16 and high expression
of output and BM3R1. (g) Performance of an optimized single-plasmid high sensor
compared to unoptimized and poorly optimized variants. Scatter plots of output
(mKO2) as a function of transfection marker (mNeonGreen) in the poorly optimized
high sensor (left) show low output in both HEK293FT and HeLa cells, resulting
in high specificity (100%) but inferior sensitivity (2%) and classification accuracy
(51%). The unoptimized high sensor (middle) shows low output in HEK293FT
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(specificity = 99%), but only high output in a fraction of HeLa cells (sensitivity
= 45%), and an overall lowered ability to classify cells (accuracy = 72%). For the
optimized high sensor (right), output remained low in most transfected HEK293FT
cells (specificity = 91%) and high in most transfected HeLa cells (sensitivity = 90%),
resulting in a generally high classification accuracy (accuracy = 90%). Results from
the optimized classifier with Bax as output show much higher degree of killing in
on-target HeLa cells (black) with low killing in off-target HEK293FT cells (white).
Apoptosis percentages are relative to positive controls with constitutively expressed
Bax. Error bars for bar charts indicate standard deviations for technical triplicates.
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Figure 4-8: Co-transfection experiment for dCas9-VPR transcriptional
activation.
(a) dCas9-VPR activation system in co-transfection format. Similarly to the poly-
transfection experiment (Fig. 4-6f), dCas9-VPR and gRNA are constitutively ex-
pressed and activate a TRE promoter which is targeted by the gRNA. Since all com-
ponents are premixed before making transfection complexes, only a single transfec-
tion marker is needed (TagBFP). We transfected HEK293FT cells in 24-well format
with 60 ng of the output plasmid, 60 ng of the transfection marker CMV-TagBFP,
and a total of 210 ng payload split between dCas9VPR and gRNA plasmids at vari-
ous ratios. (b) We calculated the fraction of transfected cells expressing the output
above a threshold (100 AU) for each ratio of payload. The samples in which 1-10 fold
more gRNA plasmid was delivered relative to dCas9-VPR showed higher frequency
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of activation. This result is in agreement with the poly-transfection experiment (Fig.
4-6f). Two samples where gRNA DNA amount was below (c) or above (d) dCas9-
VPR are highlighted. (c) Scatter plot showing amount of output (mNeonGreen) and
transfection marker (TagBFP) along with the thresholds for determining whether a
cell was transfected (TagBFP = 500 AU) or expressing output (mNeonGreen = 100
AU). For this sample, gRNA DNA was ∼3-fold lower than that for dCas9-VPR. (d)
Similar scatter plot to (c) but where gRNA dNA was ∼3-fold higher than dCas9-
VPR. Note that in this co-transfection protocol, we used DNA amounts based on
previous studies102. However, our corresponding poly-transfection experiment has
indicated that greater activation can be achieved at altered amounts (Fig. 4-6f)
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Figure 4-9: One-pot characterization of L7Ae translational repression.
(a) Circuit diagram for L7Ae repression. The first plasmid expresses L7Ae and
mKO2 constitutively. The second plasmid expresses tagBFP and the mNeonGreen
output reporter that contains two k-turn motifs (2xKT) in its 5’ UTR and is repressed
by L7Ae. (b) 3D scatter plot for raw poly-transfection data. mNeonGreen fluores-
cence is is plotted and colored for the the two-dimensional parameter space define
by reporter amount (tagBFP fluorescence) and L7Ae amount (mKO2 fluorescence).
(c) Surface plot of the poly-transfection data. Data was binned on the fluorescence
of the two input dimensions (tagBFP and mKO2) and points show median mNeon-
Green in each bin. Transfer curve lines are colored corresponding to reporter bin.
(d) Comparison of poly-transfection and co-transfection transfer curves. The data
from 11 co-transfection samples for different ratios of L7Ae-containing plasmid and
reporter-containing plasmid were concatenated, binned, and as in (c). Transfer curve
lines are colored corresponding to reporter bin. Both poly-transfection data (solid)
and co-transfection data (dashed) show similar behavior.
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Figure 4-10: One-pot characterization of Doxycycline-induced Tet3G ac-
tivation.
(a) Circuit diagram for Tet3G activation. The first transfection complex contains
constitutively expressed Tet3G and mNeonGreen. The second complex contains a
constitutive TagBFP reporter and a Dox-induced, Tet3G-driven mKate2 output. (b)
Binning scheme for comparing poly- and co-transfections. Poly- and co-transfected
data were divided into evenly-spaced bins determined by the fluorescence level of
mNeonGreen (X-axis) and TagBFP (Y-axis), which report the amount of Tet3G
and the output promoter, respectively. For comparability, co-transfection data were
pooled into one collective sample prior to binning. Bin colors were randomly assigned
for visualization purposes. (c) Median mKate2 fluorescence in each bin at each level
of Dox induction for both the poly-transfection and pooled co-transfection data. (d)
Direct comparison of Dox-induction curves at different Tet3G and output levels.
Each panel shows the Dox-induction curve for one slice of data corresponding with
the indicated TagBFP bin. Each line corresponds with one mNeonGreen bin. Dashed
lines represent co-transfection data and solid lines represent poly-transfection data.
The two methods show very similar behavior, except at very high output plasmid
and low Tet3G levels.
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Figure 4-11: One-pot characterization of artificial miRNA activity and
orthogonality.
(a) Genetic circuit for testing artificial miRNA behavior. The circuit consists of two
plasmids where the first expresses a synthetic miRNA based on a miR-155 expression
platform and also an EYFP marker serving as an indicator of miRNA concentration.
The second plasmid encodes a miRNA low sensor where the mKate2 fluorescent pro-
tein contains miRNA target sites in the 3’ UTR which mediate repression of mKate2
in the presence of the complementary miRNA. An EBFP2 transfection marker indi-
cates how much of this sensor plasmid is delivered to each cell. (b) Scatter plot of
poly-transfection input parameter space for miR-FF5. A plot of miRNA concentra-
tion (∼EYFP) and sensor concentration (∼EBFP2) shows that most of parameter
space is covered by the poly-transfection. Data are colored according to EYFP fluo-
rescence, with yellow to red marking the lowest to highest EYFP bins respectively.
(c) Scatter plot of output as a function of miR-FF5 concentration. In contrast to
EBFP2, mKate2 is decreased when miR-FF5 concentration (∼EYFP) is increased,
demonstrating that miR-FF5 is able to repress the FF5 sensor. (d) Sensor perfor-
mance at different miR-FF5 concentrations. Since sensors for endogenous miRNAs
are often plotted with output as a function of transfection marker, we binned data
in each of the EYFP bins further using EBFP2 and calculated the mKate2 medians
(circles). Lines indicate fits to a miRNA repression model.44 As miRNA concentra-
tion was increased, its ability to repress the sensor was increased as indicated by
further decreases in mKate relative to EBFP2. (e) Orthogonality of artificial miR-
NAs and sensors. We generated orthogonality matrices for each EYFP bin where
rows indicate which target sites were present on the sensor and columns indicate
the artificial miRNA introduced. Colors indicate the miRNA activity as fit using a
miRNA repression model in order to compress the EBFP2 and mKate2 dimensions
into a single measure for simplified visualization. Squares corresponding to the miR-
FF5 data displayed in (d) are outlined with the appropriate EYFP bin color. Almost
all miRNA/sensor pairs are highly orthogonal, as illustrated by miRNa activity along
the diagonal at high miRNA concentration (bin 6). 11*11=121 poly-transfections
were needed to generate the five-dimensional data shown here.
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Figure 4-12: Comparison of co- and poly-transfections for artificial
miRNA experiment.
For FF4 (left) and FF5 (right) we used separate co-transfections (top) or a poly-
transfection (middle) to obtain cells spanning the two-dimensional input parameter
space. After concatenating data together from the separate co-transfections we an-
alyzed data by binning along EYFP then EBFP to plot miRNA activity as amount
of transfected miRNA increased (bottom). Both co-transfections (solid lines) and
poly-transfections (dashed lines) exhibited similar sensor behavior in response to
miRNA.
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Figure 4-13: miRNA activity for each artificial miRNA tested.
Though each sensor showed a repression when the corresponding miRNA was added,
the degree of repression and thus the activity of each miRNA varied. Curves were
fit using a miRNA repression model similar to those previously published44 and fit
parameters were used as indicators for miRNA activity shown in Fig. 4-11. The
FF miRNA showed the highest activity in general, followed by the SHC miRNAs
derived from Sigma Aldrich sequences, and then the LZ and MT miRNAs. These
results indicate that poly-transfections can serve as part of a simplified strategy to
characterize miRNA and shRNA strengths.
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Figure 4-14: Additional information for the miR-21-5p classifier.
(a) Receiver operating characteristic (ROC) curves for discrimination of HeLa and
HEK293FT cells with the optimize. Comparison of ROC curves for either a co-
transfection or subsampled poly-transfection show similar behavior at DNA amounts
of 40ng:60ng:435ng for BM3R1:reporter:Gal4-VP16. Higher accuracy and AUC
were obtained with the co-transfection, perhaps due to increased noise with poly-
transfections. AUC was 94.7% and 84.3% for co-transfection and subsampled poly-
transfection respectively. (b) Correlation between subsampled poly-transfection and
co-transfections. Sensitivity, specificity, and accuracy data corresponding to Figure
4-7e were plotted and correlation coefficient measured. For each metric, the sub-
sampled poly-transfections correlated well with the actual measurements from co-
transfection, indicating the potential for poly-transfections to circuit/system design,
in this case for a miR-21-5p classifier. (c) ROC curves for variants of the miR-21-5p
classifier. ROC curves show progressively increasing accuracy and AUC as variants
transition from poorly optimized, to unoptimized, to optimized. AUC was 62.4%,
86.0%, and 95.8% respectively.
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Figure 4-15: Demonstration of subsampling for poly-transfections.
Since often the genetic circuits (or systems) used for therapeutic or other appli-
cations will be co-expressed at some ratio, it may be advantageous to subsample
poly-transfection in a way that mimics expression at that ratio, giving a valuable
estimate of how that genetic circuit will perform. In order to subsample, we defined
‘trajectories’ that correspond to a specific ratio of DNA as indicated in red (which can
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also be defined by DNA amounts). Poly-transfection data ‘near’ the trajectory are
included for plotting in blue. Whether a given data point is included is determined
by the distance of that point from a point in the trajectory. In our subsampling, we
included the first 312 cells within 0.1 distance units of the trajectory point, 161 cells
within 0.2 distance, 98 cells within 0.3 distance, 50 cells within 0.4 distance, and 18
cells within 0.5 distance. Distance was in logicle transformed space and the sampling
distribution was based on a log-normal distribution within a three-dimensional pa-
rameter space. The genetic system shown here is for the miRNA high sensor shown
in Fig. 4-7. We show only the data for two of the input parameters for simplicity,
though the subsampling was performed in the full 3D parameter space. After sub-
sampling, output can be plotted as a function of any of the input components, in
this case the amount of reporter plasmid. Two examples in HeLa cells with different
ratios of components are shown. Note that the example with high Gal4-VP16 showed
higher output in HeLa cells as we indicated previously, while the example with low
Gal4-VP16 showed minimal ability to provide a positive output.
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Figure 4-16: Tuning gene expression using upstream open reading frames
(uORFs).
We tested whether uORFs could be used to tune gene expression where the CMV
truncations are not suitable, for instance when using an inducible or tissue-specific
promoter. In our test constructs, mNeonGreen was placed under control of a CMV
promoter with uORFs upstream in between promoter and gene, while TagBFP
was used as a transfection marker. Thus effects from the uORF should knock-
down mNeonGreen expression but not TagBFP. We observed this behavior in both
HEK293FT and HeLa and to an increasing degree as more uORFs were added.
Analysis was conducted similarly to the CMV truncations, with binned data fit to
a ratiometric model to determine the degree of knockdown. Knockdown was con-
sistent across cell lines with R-squared values above 0.99 for both linear and log
plots. Knockdown values averaged across cell lines are shown, with up to 388-fold
knockdown possible with the 12x uORF variant.
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Figure 4-17: Tuning gene expression using promoter truncations.
We tested different truncations of the CMV promoter to determine the ability to
tune down gene expression. We tested several previously characterized truncations
along with new ones. In the test plasmids, mNeonGreen is driven by the CMV
truncation of interest while a TagBFP driven by full CMV serves as a transfection
marker. In both HEK293FT and HeLa cells, as CMV is truncated further there is a
marked decrease in mNeonGreen compared to the TagBFP reference. Binned data
(circles) were fitted (lines) using a model where mNeonGreen is simply a fraction of
TagBFP level. The fit mNeonGreen/TagBFP expression ratios (and log ratios) were
then plotted for HEK293FT vs. HeLa and we observed comparable knockdown of
mNeonGreen across cell lines. Values for knockdown (averaged over both cell lines)
of our chosen set spanning a range of values is shown in the inset, with up to 143-fold
knockdown with CMVd3. R-squared values for knockdowns when compared across
cell lines were high at 0.966 and 0.988 for linear and log ratios respectively. These
results indicate that CMV truncations can be used to tune gene expression to a large
and controllable degree in the two cell lines tested.
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Figure 4-18: Qualitative comparison of methods to characterize and op-
timize genetic circuits and systems.
In general, the higher information content experiments require more experimental
complexity (which is roughly correlated with cost, time or chance for error). Co-
transfections are relatively simple to perform but manual pipetting steps limit the
number of samples (and thus information) per assay. Automated transfection and
measurements may increase the number of samples that can be acquired by 1-2 orders
of magnitude, resulting in a small increase in experimental complexity and informa-
tion content. Pooled library approaches require many complex steps but yield much
more information (e.g. around 5 × 104 combinations for CombiGEM118). Typical
steps include generating a uniform library of variants - either through combinato-
rial DNA assembly or mutagenesis strategies, delivery and integration of DNA at
a single copy per cell (e.g. with low MOI lentivirus or landing pads), flow sorting
of cells with different output levels into groups, then conducting high throughput
sequencing on each sorted group to determine which constructs expressed which out-
put levels. Poly-transfections can yield information with similar information content
to smaller pooled library experiments. For instance, with a 4-component system
using 15 expression level bins per dimensions, the parameter space is approximately
5 × 104 potential combinations. Additionally, since the poly-transfection requires
only a single well of cells, an experiment is only as complex to perform as a manual
transfection.
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Figure 4-19: Simplified assembly strategy for one-pot-ready plasmids.
We have constructed a set of backbone plasmids containing constitutive expression
of one of five fluorescent proteins (Sirius, TagBFP, mNeonGreen, mKO2, iRFP720)
along with restriction sites and colorimetric selection for BsaI-mediated Golden Gate
assembly. In a single Golden Gate step, plasmid level 0 (pL0) plasmids encoding
insulator, promoter, 5’ UTR, gene, 3’ UTR, and poly-A sequences can be assem-
bled into the backbone and white colonies can be selected for against red-expressing
background. Plasmids assembled in this way are immediately ready for use in poly-
transfections since they encode simultaneous expression of a circuit part (Gal4-VP16
in the illustrated example) and a fluorescent transfection marker (iRFP720 in the ex-
ample). The backbone plasmids will be deposited into Addgene for to aid researchers
in their one-pot characterization or optimization experiments.
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Figure 4-20: Poly-transfection distributions can be changed by titrating
DNA.
(a) Poly-transfection with equal amounts of TagBFP- and mKO2-expressing plas-
mids. This poly-transfection used 250 ng of each plasmid, resulting in a high pro-
portion of double-positive cells (points colored by density, yellow = greater density)
expressing medium-high levels of both TagBFP and mKO2. Single-positive and un-
transfected cells are colored in gray. (b) Poly-transfections with 5-fold decreased
TagBFP plasmid. For the TagBFP plasmid-lipid complexes, 50 ng of TagBFP plas-
mid and 200 ng of non-expressing dummy vector were premixed and transfection
reagent added as before. In this case, double-positive cells express low-medium lev-
els of TagBFP but still medium-high levels of mKO2. Thus the cells in the lower
TagBFP polytransfection (and in an additional lower mKO2 polytransfection) could
be used to more efficiently sample the parameter space between doubly positive and
singly-positive populations, compared to the poly-transfection in (a) alone.
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Figure 4-21: Expression distribution from sequential electroporation and
lipid transfection.
In the following experiment, an EYFP containing plasmid was transfected to de-
termine the effect of miRNA target sites on a separate miRNA sensor with EBFP2
and mKate2 fluorescent proteins. The EYFP plasmid was first electroporated into
HEK293FT cells, incubated for 24 hours, then the EBFP2 and mKate2-containing
plasmid was transfected with lipofectamine 3000. Similar broad expression distribu-
tions were obtained with the sequential electroporation/lipid transfection compared
with the lipid-only method. It is possible that other methods of transfection can be
combined to yield poly-transfection data, though we focused on lipid-only methods
for simplicity. Note that some cells are off-scale due to compensation to correct for
mKate2 bleedthrough into the other channels.
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Figure 4-22: Poly-TX with different cationic transfection reagents.
(a) HEK-293FT cells poly-transfected with hEF1a_TagBFP (x-axis/columns) and
hEF1a_tdTomato (y-axis/rows) each complexed with one of five cationic transfection
reagents (Viafect, Attractene, Lipofectamine 3000, FuGENE6, PEI MAX). 4000 cells
shown in each plot. (b) % cells positive for TagBFP or tdTomato in each sample
(single- or double-positive). (c) % cells positive for both TagBFP and tdTomato in
each sample (double-positive). (d) Correlation between log10-transformed TagBFP
and tdTomato values in the double-positive population of each sample.
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Figure 4-23: Screening of fluorescent proteins to determine compatible
sets.
We tested a panel of 22 different fluorescent proteins to determine how many could
be measured without significant bleedthrough in signal between channels. Fluores-
cent scores were calculated for each FP and measured with each channel using the
following equation: score = log10(99th percentile channel fluorescence from sample)-
log10(channel background from untransfected). Fluorescent proteins were chosen
for emission across a range of spectral space and for excitation with the 5-laser cy-
tometer we used for the study. We also tested several high stokes shift proteins
(LSS-mOrange, mBeRFP, mT-Sapphire) to determine whether two fluorescent pro-
teins could be measured from the same laser, though those still resulted in signifi-
cant bleedthrough to other channels. We observed several incompatibilities of note:
mKate2 and mRuby2 have high bleedthrough into many channels, yellow fluorescent
proteins (EYFP and mVenus) show high signal in the BUV 396 channel used to
measure Sirius so green FPs are more desirable when both are to be measured, and
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all red fluorescent proteins we measured (notably tdTomato, mScarlet, TagRFP-T,
mApple1) showed stochastic signal in the Pacific Blue channel which meant com-
pensation could not be used to correct for bleedthrough - instead orange fluorescent
proteins (mKO2 measured in the PE channel) appear to be an alternative. We deter-
mined that the set comprised of Sirius, TagBFP, mNeonGreen, mKO2, and iRFP720
(measured in BUV396, Pacific Blue, FITC, PE, and Alexa Fluor 700 channels re-
spectively) appeared to show the most orthogonal signals and bleedthrough that
could be compensated for. When designing experiments with fewer than five fluores-
cent proteins, it may be useful to note the lower brightness of Sirius and moderate
bleedthrough of mKO2 into mNeonGreen.
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Figure 4-24: Normalization of poly-transfection data to reduce effects of
transfection distribution.
(a) L7Ae repression circuit. Note that mKO2 and TagBFP are the input com-
ponents (i.e. independent variables). Ideally data would sample across these two
dimensions uniformly (b) Raw poly-transfection distribution. As previously noted,
poly-transfections show a bias towards null-, singly-, and doubly-transfected cells,
with fewer cells falling in between these regions. The first 14,700 data points from
a total of >600,000 events are plotted here. (c) Normalized poly-transfection data.
After binning with 7 bin edges across each dimension (49 total bins), 300 cells in each
bin were randomly selected to be included in the normalized data. This resulted in a
total of 14,700 data points, which is the same as in (b). The normalized scatter plot
shows significantly less bias, though a slight bias remains in the singly-transfected
bin. Bias could be further reduced by including more bin edges, or using other ap-
proaches to subsample (e.g. tessellation-based methods). More uniform sampling
will likely help analysis of more sensitive circuits or those that cannot be analyzed
by taking the median/geometric mean of binned output fluorescence (which already
corrects for transfection biases to a degree).
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Figure 4-25: Rapid characterization of a miRNA classifier and its sub-
components.
(a) Circuit for Gal4-VP16 activation. The Gal4-VP16 activation circuit previously
shown in Fig. 4-27 comprises a portion of the miR-21-5p classifier. For all circuit
diagrams, the indicated CMV-fluorescent protein transfection markers were encoded
on the same plasmid as the circuit parts but displayed separately to simplify the
diagrams. (b) Heatmaps of activation by Gal4-VP16 in HEK293FT and HeLa cells.
Heatmaps show that output is restricted to the corner where Gal4-VP16 and reporter
are high. Taking the ratio of output in HeLa to HEK293FT shows minimal difference
in output between the two cell lines. (c) Addition of BM3R1 repression to the circuit.
BM3R1 is added to the circuit with a TagBFP transfection marker, such that mKO2
output is repressed when BM3R1 is expressed. (d) Heatmaps of output for BM3R1
and Gal4-VP16 circuit. In both HEK293FT and HeLa cells, output is restricted to
the corner in parameter space where Gal4-VP16 and reporter are high but BM3R1
remains low. The minimal difference in HeLa/HEK293FT ratio shows that behavior
of the circuit is similar in both cell types. Gray indicates that no cells were collected
within a given bin. (e) A miRNA classifier circuit to distinguish HEK293FT and
HeLa cells. With the addition of miR-21-5p target sites in both UTRs of BM3R1, a
miRNA classifier is constructed. In HeLa cells, miR-21-5p activity is high, repressing
BM3R1 and allowing mKO2 output to be expressed. Whereas in HEK293FT cells,
miR-21-5p activity is low, such that BM3R1 remains high and represses the output.
(f) Heatmaps for the complete miRNA classifier. In HEK293FT cells, behavior is
similar to the case without target sites (d) since miR-21-5p activity is low,resulting
in minimal effects from addition of miRNA target sites to BM3R1. In contrast,
HeLa cells show output in an expanded region of parameter space, since endogenous
miR-21-5p is able to knock down BM3R1 to some degree. Taking the ratio of HeLa
to HEK293FT shows a band of parameter space where output is high in HeLa but
low in HEK293FT. (g) Specificity, sensitivity and accuracy for the miRNA classifier.
Sensitivity is calculated as the fraction of HEK293FT cells correctly determined to
be low in output (mKO2 > 102 AU), sensitivity is calculated as the fraction of HeLa
cells correctly determined to be high in output (mKO2 < 102 AU), while accuracy is
calculated as the fraction of all correctly classified cells. Again a band in parameter
space exhibits the optimal classification accuracy.
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Figure 4-26: Data for 4-component miRNA classifier.
(a) In the 4-component miRNA classifier, BM3R1 is activated by tTA rather than
transcribed from a constitutive promoter. Both tTA and BM3R1 contain miRNA
target sites to give the miRNA the potential to regulate multiple circuit components
and possibly enhance classification. (b) In these heatmaps, each dot represents one
bin or region of parameter space. In HEK293FT cells, output remained generally
low across parameter space, though there was some expression (as also seen for the
3-component classifier in Fig. 4-25) at high Gal4-VP16 and marker when BM3R1
and tTA were low (c) For HeLa cells output was high with Gal4-VP16 and marker
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and low-medium levels of tTA and BM3R1. (d)One area of parameter space shows
output in HeLa compared to HEK293FT as indicated by high HeLa/HEK293FT flu-
orescence ratio. (e) Specificity, or the fraction of HEK293FT cells correctly classified
as negative in output (threshold = 100 AU), indicated most parameter space regions
showed minimal HEK293FT output, with the exception of again high Gal4-VP16
and marker with low BM3R1 and tTA. (g) Sensitivity, or the fraction of HeLa cells
correctly classified as positive in output, showed the inverse relationship compared to
specificity. (f) Similarly to the 3-component classifier, a heatmap of accuracy shows
a region in parameter space where high specificity and sensitivity overlap.
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Figure 4-27: One-pot characterization of Gal4-VP16 activation.
(a) Circuit diagram for Gal4-VP16 activation. The first plasmid contains both con-
stitutive expression of Gal4-VP16 and iRFP720. iRFP720 fluorescence serves as an
indicator for the amount of DNA encoding Gal4-VP16 transfected into any given
cell. The second plasmid contains an mKO2 fluorescent output that is activated by
Gal4-VP16 and an mNeonGreen transfection marker that serves as a reporter for
how much output plasmid was delivered to each cell. (b) 3D scatter plot for raw
data obtained by poly-transfection. The two input parameters - Gal4-VP16 and
reporter concentrations - are plotted on the x and y axes, while the output is plot-
ted on the z-axis. Units for each axis are given by fluorescence units (AU) for the
associated fluorescent proteins indicated in parentheses. Each point represents one
cell colored according to output fluorescence using the same colorbar as in (c). Poly-
transfected cells span the entire input parameter space, as demonstrated by coverage
across Gal4-VP16 and reporter dimensions. (c) Heatmap of Gal4-VP16 activation.
Data were binned by subdividing the data according to the two input dimensions
and median output fluorescence for each bin was calculated. Medians are shown as
different colors according to the indicated colorbar. (d) Surface plot and transfer
curves where Gal4-VP16 is varied while reporter is held constant. Surface plots for
the binned data provide a different way to illustrate the combined effects of either
Gal4-VP16 and reporter on the output fluorescence. Colored lines represent trans-
fer curves where reporter concentration is held constant (blue = low, green = high
concentration) while Gal4-VP16 is increased. As Gal4-VP16 increases, output rises
in a threshold-like manner, a behavior maintained across all reporter transfection
levels. (e) Surface plot and transfer curves where Gal4-VP16 is held constant while
reporter is varied. Colors represent transfer curves where Gal4-VP16 is constant
(teal = low, pink = high concentration) while reporter is increased. As the reporter
increases, output rises in a linear manner, showing that maximal output is limited
by how much output plasmid is delivered via the transfection.
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Figure 4-28: ROC-like curves to compare 3- and 4-component miRNA
classifiers.
We derived ROC-like curves from the data for both 3-component (Fig. 4-25) and
4-component (Fig. 4-26) miRNA classifiers by taking the sensitivity and specificity
within each bin and plotting the resulting scatter plot. Lines were fit according to a
bi-normal model and area under the curve (AUC) was calculated. Points are colored
according to accuracy in each bin. The AUC can give a general measure of how well
each circuit design performs relative to the other, since all areas of parameter space
are used to calculate the ROC curve. In this case the AUC values for 3- and 4-
component classifiers were similar, indicating minimal performance gain by addition
of tTA activation. Thus we chose to focus on the 3-component classifier since it
would be easier to tune due to the reduced numbers of components.
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Figure 4-29: Analysis of 4-component classifier with machine learning.
We utilized random forest regression to analyzed the binned accuracy data for the
4-component miR-21-5p classifier in order to derive design rules insight into the
circuit. The following example serves as a proof of concept for analyzing even higher
dimensional data that could be obtained via poly-transfections in the future. We
chose random forest regression due to the ease of implementation while still retaining
the ability to regress more complicated datasets. (a) The effect of minimum leaf
size (MinLeafSize) on the size of decision trees comprising the random forest. As
MinLeafSize was decreased, trees contained more branches and likely higher risk of
overfitting. (b) Optimization of MinLeafSize and number of trees in the random
forest. Plotting out of bag error as a function of number of trees and MinLeafSize
shows that around 80 trees are sufficient to obtain minimal error. We chose to
use MinLeafSize of 100 to reduce the likelihood of overfitting while still maintaining
relatively low error. (c) Parameter importance for amounts of each circuit component
and also the ratios of each. We chose to include ratios (i.e. diagonal splits in
parameter space, rather than only vertical or horizontal) since often behavior of
a circuit can be accounted for by ratiometric measures. Marker and Gal4-VP16
amounts appear most important for circuit function, followed by the ratios of tTA or
BM3R1 (the repressing side of the circuit) to Gal4-VP16 or marker (the activating
side of the circuit). This suggests that contributions for repressing and activating
components should be balanced for optimal miRNA sensing. (d) Partial dependence
plots for amounts of circuit components show that a prerequisite amount of marker
(∼ 102 AU) and Gal4-VP16 (∼ 103 AU) are necessary for classification accuracy.
This is apparent when looking at the binned accuracy data, as accuracy is only high
when both of these conditions are met (Fig. 4-26). (e) Partial dependence plots for
the ratios of circuit components shows that generally better classification is obtained
when components are present at similar ratios. In general, repressing components
(tTA, BM3R1) should be equal or less than activating components (marker, Gal4-
VP16). Also important was the marker/Gal4-VP16 ratio which should be similar.
As both one-pot methods and machine learning are further developed in the future
we expect even greater insight into circuit design rules to be possible, in addition to
facilitation of larger, more complex and sophisticated circuits.
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Figure 4-30: Heatmap for binned VPR activation data across the full
input parameter space.
Plotted is the fluorescent output as a function of the three different circuit compo-
nents (dCas9-VPR, gRNA, and output plasmid). Output fluorescent is colored ac-
cording to the indicated scale bar (AU). Note as previously indicated (Fig. 4-6h) that
there is a graded response of output with increasing gRNA, but more threshold-like
behavior with dCas9-VPR. Addition of reporter plasmid results in graded increase
in output expression, though interestingly there appears to be a slight decrease at
very high concentrations. As a result, the optimal region for activation occurs at
high dCas9-VPR and gRNA concentration and medium-high reporter plasmid con-
centration.
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Recommended Values
2-complex 3-complex 4-complex n-complex
Day 0 Grow appropriate Cells per sample = > 4e4 > 2e5 >2e6number of cells
Day 1 Create lipid-DNA DNA = 30 ng 200 ng 1500 ng
complexes P3000 = 0.1 uL 0.33 uL 2.5 uL
Lipo3000 = 0.1 uL 0.33 uL 2.5 uL
Opti-MEM = 10 uL 16.5 uL 125 uL
(each per complex)
Trypsinize and Cells per sample = > 4e4 > 2e5 >2e6
plate cells Media per sample = 100 uL 0.5 mL 2x 2mL = 4mL
Plate format 96-well 24-well 2 wells in 6-well
Add lipid-DNA DNA total = 2x30 = 60 ng 3x200 = 600 ng 4x1500 = 6 ug
complexes to cells Volume total = 2x10 = 20 uL 3x17.2 = 52 uL 4x130 = 520 uL
Incubate cells Time = 48 hours 48 hours 48 hours 48 hours
Day 3 Analyze cells Cells per sample = As many as >4e5 >2e6sampler allows
(ideally 8e4)
2,000 x 10n-1
30 x (2/n) x 10n-1
0.05 x (2/n) x 10n-1
0.05 x (2/n) x 10n-1
2.5 x (2/n) x 10n-1
2,000 x 10n-1
varies
varies
30 x 2 x 10n-1
2.6 x 2 x 10n-1
~2,000 x 10n-1
Step Parameter
Table 4.1: Quick start guide for poly-transfections.
Overview of poly-transfection method and recommended volumes and amounts for
preparing and transfecting cells. Different values are given depending on the
number of complexes needed for the genetic circuit. Values shown here are for
HEK293FT cells; note that optimal values may change depending on transfection
efficiency, cell size etc. Further details may be found on Protocol Exchange #6667.
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Sample BM3R1 Output Gal4-VP16
(ng) (ng) (ng)
1 5 60 435
2 10 60 435
3 20 60 435
4 40 60 435
5 60 60 435
6 80 60 435
7 100 60 435
8 150 60 435
9 200 60 435
10 5 5 435
11 5 10 435
12 5 20 435
13 5 40 435
14 5 60 435
15 5 80 435
16 5 100 435
17 5 150 435
18 5 200 435
19 5 60 10
20 5 60 25
21 5 60 50
22 5 60 100
23 5 60 200
24 5 60 300
25 5 60 400
26 5 60 435
27 5 60 480
Table 4.2: DNA amounts for co-transfection testing of miR-21-5p classifier
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4.11.1 Complete workflow for one-pot optimization experi-
ments
Step 1. Determine the components of the circuit to be tested
One should plan in advance what the circuit(s) to be tested will contain. For example
throughout this protocol we will plan an experiment to characterize the ability of
Gal4VP16 to activate a new design for a Gal4VP16 activatable promoter. Our circuit
components include:
1. constitutive expression of Gal4VP16
∙ Insulator = CTCF binding motif
∙ Promoter = CMV
∙ 5’ UTR = inert sequence
∙ Gene = Gal4VP16
∙ 3’ UTR = inert sequence
∙ Terminator = SV40 poly A
2. fluorescent protein output from a Gal4VP16 activatable promoter.
∙ Insulator = CTCF binding motif
∙ Promoter = Gal4VP16 activatable promoter
∙ 5’ UTR = inert sequence
∙ Gene = Fluorescent protein (later determined to be mKO2)
∙ 3’ UTR = inert sequence
∙ Terminator = SV40 poly A
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Step 2. Determine which fluorescent proteins to use in the experiment
One will need to determine the set of fluorescent proteins to be used, which may
depend on what equipment is available to make fluorescent measurements. For the
flow cytometer we used (BD Fortessa with 355nm laser + 379/28nm filter, 405 +
450/50, 488 + 530/30, 561 + 582/15, 640 + 710/50) the following sets of fluorescent
proteins were demonstrated to work well:
∙ Two-color experiments = TagBFP + mNeonGreen or mKO2
∙ Three-color experiments = TagBFP + mNeonGreen + (mKO2 or iRFP670 or
iRFP720)
∙ Four-color experiments = TagBFP + mNeonGreen + mKO2 + iRFP720
∙ Five-color experiments = Sirius + TagBFP +mNeonGreen + mKO2 + iRFP720
Use of additional colors is possible, especially with spectral analyzers. Though
one will need to make sure that bleedthrough of signal from one fluorescent protein
to another is minimal (after compensation if necessary).
For our example, we will use TagBFP as a transfection marker for Gal4VP16
expression, mKO2 as the output signal, and mNeonGreen as the transfection marker
for the output plasmid. This design results in the following transfection marker
components to be assembled:
3. constitutive expression of TagBFP
∙ Insulator = CTCF binding motif
∙ Promoter = CMV
∙ 5’ UTR = inert sequence
∙ Gene = TagBFP
∙ 3’ UTR = inert sequence
∙ Terminator = SV40 poly A
4. constitutive expression of mNeonGreen
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∙ Insulator = CTCF binding motif
∙ Promoter = CMV
∙ 5’ UTR = inert sequence
∙ Gene = mNeonGreen
∙ 3’ UTR = inert sequence
∙ Terminator = SV40 poly A
Note that not all fluorescent proteins may be suitable for multi-color cytometry.
We found that almost all red fluorescent proteins had significant signal in the 450/50
channel with a strange stochastic behavior. We believe this is due to a blue inter-
mediate during folding of the red fluorescent proteins. For this reason, we chose to
use an orange fluorescent protein (mKO2) instead which has some spillover into the
530/30 channel but has predictable behavior which can be accounted for with com-
pensation. We also observed that yellow fluorescent proteins spill into the 379/28
channel so we used green fluorescent proteins instead. Finally, some red fluorescent
proteins have signal in the 710/50 channel, limiting the choice of red/orange FP.
Step 3. Clone needed plasmid level 0 (pL0) constructs
One should clone the needed parts (eg. promoters, coding sequences, etc) into pL0
plasmids with the appropriate Golden Gate assembly overhangs - or obtain existing
pL0’s from other researchers. pL0 plasmids generally have spectinomycin resistance
and the backbones have LacZ which is displaced after assembly for blue/white screen-
ing. pL0 overhangs are as follows and are generated by the BbsI restriction enzyme
for cloning into the pL0 backbone:
∙ pL0-I (insulator) = [GGAG] - [TACT]
∙ pL0-P (promoter) = [TACT] - [CAGA]
∙ pL0-5 (5’ UTR) = [CAGA] - [AGGT]
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∙ pL0-G (gene/coding sequence) = [AGGT] - [GCTT]
∙ pL0-3 (3’ UTR) = [GCTT] - [CAAC]
∙ pL0-T (terminator/pA) = [CAAC] - [CGCT]
For example, a pL0-P with CMV can be obtained by generating the double-
stranded DNA fragment below by PCR or synthesis and cloned into the pL0-P back-
bone vector with BbsI Golden Gate (bolded sequences correspond to BbsI recognition
site and underlined sequences correspond to BbsI cut site):
NNNGAAGACNNTACT - CMV sequence - CAGANNGTCTTCNNN
In general, Golden Gate reactions consist of the following:
∙ 40 fmol of each DNA part
∙ Water to a total reaction volume of 10 uL
∙ 1 uL of T4 ligase buffer (Promega)
∙ 0.4 uL of Type IIs restriction enzyme (NEB)
∙ 0.2 uL of T4 ligase HC (Promega)
Golden Gate thermocycling consists of the following:
1. 37C for 5min
2. 50 cycles of 37C for 2min, 16C for 5min
3. 50C for 5min
4. 80C for 10min
5. Hold at 4C
Golden Gate reactions can be transformed into chemically competent cells at
relatively high efficiency.
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Step 4. Clone plasmid level 1 (pL1) constructs containing transcription
units
Using the pL0 constructs, one should assemble transcription units (TUs) into pL1
backbones. These should contain one each of pL0’s designated as I, P, 5, G, 3, and T.
In most cases, circuit components should be assembled into the pL1-S1S2 backbone
while fluorescent protein transfection markers should be assembled into the pL1-S2S3
backbone. Assembly of pL1 plasmids is conducted using BsaImediated Golden Gate
assembly.
For our example, we will assemble:
1. pL1-S1S2 with TU for constitutive Gal4VP16
2. pL1-S1S2 with Gal4VP16 activatable promoter and mKO2 output
3. pL1-S2S3 with constitutive expression of TagBFP
4. pL1-S2S3 with constitutive expression of mNeonGreen
Step 5. Clone plasmid level 2 (pL2 constructs) that contain one circuit
TU and one transfection marker TU
Using Gibson assembly, one should assemble together pairs of constructs with one
circuit TU and one transfection marker TU. In most assemblies the pL2-S3S1 back-
bone may be used, but other Gibson backbones with Weiss lab overlapping sequences
can also be used. Each plasmid should be digested with I-SceI restriction enzyme,
PCR purified or gel extracted, and the linear fragments used for a Gibson reac-
tion. We obtained reaction mix from SGI as the Gibson Ultra Kit and followed the
manufacturer’s protocol for assembly. We electroporated assembly products electro-
competent cells (NEB 10-beta cells) as we generally found larger constructs harder
to transform with chemically competent cells.
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We have also deposited pL2 backbones already containing constitutive expression
of different fluorescent proteins, such that only a single Golden Gate step is required
to assemble functional pL2 vectors (Addgene vectors #109150-109154).
In our example, pL1-S1S2 with constitutive Gal4VP16 (#1) should be assem-
bled with pL1-S2S3 with TagBFP (#3) and pL2-S3S1 to generate construct A.
And also pL1-S1S2 with activatable promoter and mKO2 (#2) should be assem-
bled with pL1-S2S3 with mNeonGreen (#4) and pL2-S3S1 to generate construct
B. This should generate two final plasmids for poly-transfection. Both constructs
should be midiprepped to obtain transfection quality DNA with reduced endotoxin
concentrations.
Alternatively, it is possible to conduct poly-transfections using pL1’s instead of
pL2’s. In this case, equimolar concentrations of pL1’s should be mixed together
in each lipid complexes, such that mixtures contain the same constructs as those
assembled into pL2’s listed here.
Step 6. Grow and maintain cells of interest
Cells of interested should be obtained from a reliable source, thawed into the appro-
priate growth medium, and verified to be free of mycoplasma or other contaminants.
Cells should be regularly split into new flasks/dishes when appropriate confluence
is reached (use the appropriate maintence conditions provided for the cells) using
trypsin or other dissociation medium. For our study, we grew HEK293FT cells
(Thermo Fisher) and HeLa cells (ATCC) in DMEM DMEM with 4.5 g/L glucose,
L-glutamine, and sodium pyruvate (Cellgro) and supplemented with 10% FBS (Cell-
gro) and at 37C / 5% CO2 . Before transfection, one should calculate approximately
how many cells will be required for the experiment and determine if the necessary
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number of cells have grown. We use 200,000 HEK293FT cells per well or 150,000
HeLa cells per well in a 24-well plate and then scale that number according to plate
surface area.
Step 7. Prepare transfection mixtures
Transfection mixtures can be separately prepared according to the manufacturer’s
protocol, then simultaneously added to cells. We have mostly used lipofectamine
3000 for transfection, but have shown that poly-transfections work with a variety of
transfection agents.
In our protocol, we diluted 900 ng of each input plasmid with 75 uL of Opti-
MEM (Thermo Fisher), mixed in 1.5 uL of P3000 reagent, then mixed in 1.5 uL of
Lipofectamine 3000 reagent. Each complex was mixed separately and incubated for
30 min before being added to cells plated in a 6-well format. Note that in a 24-well
format, these volumes correspond to 150 ng of DNA in 12.5 uL of OptiMEM, 0.25 uL
of P3000, and 0.25 uL of lipofectamine per complex. If using transfection markers on
a separate plasmid from the circuit component, one can use equimolar concentrations
of each to a total of 150 ng of DNA (24-well format) or 900 ng (6-well) then add the
corresponding amount of Opti-MEM and lipofectamine reagents.
Step 8. Add transfection mixtures to cells
Add the desired complexes to cells. In our example, separate complexes prepared
for constructs A and B would be applied to cells at the same time and cells would
be allowed to grow in order to express the circuit components as well as fluorescent
proteins. In our experiments we waited 48 hours between transfection and flow
cytometry.
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Step 9. Prepare cells for flow cytometry
Cells should be suspended into PBS or FACS buffer using methods appropriate for
the cell lines tested. For our adherent cells, we trypsinized cells (0.2 mL in 24-well),
resuspended them in growth media (0.5 mL in 24-well), spun then down at 100 x g,
aspirated the media and resuspended in PBS (0.5 mL for 24-well).
Step 10. Prepare flow cytometer and run calibrations
The flow cytometer should be operated according to the manufactuer’s protocols.
Single color controls should be run and PMT voltages set to obtain best dynamic
range without saturation of highly expressing cells. We highly recommend running
multi-peak fluorescent calibration beads (we have used Spherotech URCP-100-2H
or RCP-30-5A) to make sure that the cytometer is running correctly and to enable
more quantitative and reliable measurements that are reproducible across different
cytometers.
Step 11. Run samples through the flow cytometer
After running controls through the cytometer, samples should be run, making sure
that a wide range of fluorescent color space is covered when fluorescent channels
are plotted against each other. As many cells as necessary should be collected such
that an adequate number of events are recorded across the fluorescent color space.
Generally we used all cells from a well in a 24-well plate for 2- complex experiments,
a 6-well plate for 3-complex experiments, and 2 pooled wells from a 6-well plate for
4-complex experiments.
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Step 12. Export data and finish cytometer session
Data should be exported as fcs files and the cytometer cleaned and shut down.
Step 13. Set up existing analysis pipelines
We have developed code to quickly bin data along multiple dimensions using MAT-
LAB. The code can be found at GitHub under https://github.com/jonesr18/
MATLAB_Flow_Analysis Additonal code may also be needed for downstream anal-
ysis in order to read in fcs files (Laszlo Balkay: https://www.mathworks.com/
matlabcentral/fileexchange/9608-fca-readfcs), and logicle transform (Rachel
Finck: https://www.mathworks.com/matlabcentral/fileexchange/
45022-logicle-transformation).
Step 14. Process data using the FlowData method
Use a MATLAB script to call the FlowData method for binning. See the attached
zip file for an example m-file and fcs files.
Step 15. Further analyze binned data to generate characterization or
conclusions
If custom analysis needs to be conducted, binned or raw data can be analyzed and
visualized in Matlab.
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Chapter 5
Conclusions and future directions
In this work we have described several advances in applying engineering principles
towards the design and implementation of new genetic circuits, as well as key tech-
nologies for facilitating the engineering cycle itself. Our work towards generating
fundamental design rules and predictive models for miRNA repression should en-
hance the construction of more complex miRNA sensors and classifiers in the fu-
ture. Our advances to the design-build-test-learn (DBTL) cycle will also translate
more generally to other projects in synthetic biology. The main contributions to
the DBTL cycle include: the formulation of the Ant/Syn model (design), faster and
easier DNA assembly techniques - namely microfluidics and DNA assembly plasmids
like the multi-assembly vector and low sensor backbones (build), poly-transfection
(test), and quantitative analysis along with machine learning to parse diverse datasets
(learn). While we have made several advances in these areas, key limitations and
future work remain for each.
Design: The Ant/Syn model we describe explains some of the combinatorial ef-
fects that occur when multiple miRNAs regulate a synthetic reporter. However, the
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Ant/Syn model is only one step towards a more ideal model which would be able to
predict miRNA repression effects of any sequence of DNA - including endogenous or
even random sequences. As such, future models will need to be improved in several
key ways. First, the mechanisms for Ant/Syn and other interactions must be ascer-
tained so that models may be updated accordingly. Such studies will also enhance
the general understanding of cell signaling and could have impacts in areas where
miRNAs are disregulated (e.g. cancer). Second, researchers should investigate pos-
sible explanations for the poor correlation between miRNA expression and miRNA
activity. If such effects could be adequately explained such that miRNA activity
could be accurately inferred from miRNA expression data, miRNA repression mod-
els could take advantage of the vast quantity of small RNA abundance data that is
available. As it is now, abundance data is only modestly useful and primarily used
to make educated guesses as to which miRNAs might be useful to sense, followed
by experimental determination of miRNA activity.11 We expect that significant and
collaborative work will be required to build a ‘miRNA activity dictionary’ that can
relate these two quantities in a wide range of useful cell types. Finally, prediction of
miRNA target sites and their relative strengths will need to be more reliable. Cur-
rent miRNA target site predictions generate many false positives,144 meaning that
the are of little use for predicting the strength of miRNA repression for endogenous
transcripts for instance.
Build: We have made several advances in our DNA assembly platform to speed up
construction of genetic circuits. Our lab has previously adapted and expanded the
previous modular cloning (MoClo145) system to include mammalian parts.54 More
recently we have used a Golden Gate-Gibson system* to assemble even larger cir-
*work pioneered by Dr. Jin Huh in the Weiss lab
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cuits, where transcription units (TU) are assembled via Golden Gate as in MoClo,
but multi-TU plasmids are assembled using a Gibson step146 similar to the another
previous assembly strategy.53 For miRNA sensing circuits we built a common back-
bone, termed the miRNA low sensor backbone (LSB), that includes four repeats of
sequence validated target sites. LSB plasmids can be used directly for transfection
experiments, providing a red fluorescent signal from mKate2 that is regulated by
the miRNA target sites, and a constitutive blue signal from EBFP2 for reference.
Sensors can also be integrated into the genome using BxB1 recombinase.54 Moreover
these backbones can serve as PCR templates for amplification of miRNA targets for
assembly into other miRNA sensors - including multi-input ones - since the overhangs
can be easily changed during the PCR step. The low sensor backbone is also one of
several designs based on a multi-assembly vector, where TUs can be assembled by a
Gateway step to insert the promoter and gene, the 3’ UTR is added with a Golden
Gate step, and then multiple TUs can be assembled together using Gibson. We
anticipate that the flexibility of the Golden Gate-Gibson assembly will make it an
invaluable tool for assembling larger and more complex circuits in mammalian syn-
thetic biology, with up to 7 TUs assembled into a single plasmid. These and future
developments should aid the development of larger systems, for instance metabolic
engineering in mammalian cells, once other barriers to their design are overcome.
Future advances in DNA assembly might utilize ligase cycling reaction (LCR)56 in-
stead of Gibson assembly, which may offer even more efficient assembly of many
different TUs in a single step. One long term challenge is how to assemble constructs
together without having to worry about the presence of Type IIS recognition sites
within the assembled sequences. At this time, such sites are often mutated to avoid
unwanted cleavage, but these mutations in many types of sequences (e.g. promoters,
poly-A signals, enhancers, insulators) may affect their function. However, leaving in
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the Type IIS recognition sites can severely hamper assembly efficiency, especially if
there are several such sites. Other future improvements in DNA assembly could in-
volve miniaturization of assembly reactions to reduce cost and increase throughput.
In collaboration with Lincoln Laboratory we have explored the use of microfluidics
to streamline DNA assembly.147 We anticipate these and other microfluidic meth-
ods (e.g. droplet microfluidics148) will greatly accelerate the build portion of the
design-build-test-learn cycle.
Implementation and design of miRNA sensors/classifiers also have room for im-
provement. Most miRNAs have small (∼2-fold) effects on transcripts they regu-
late,71,149 which can often limit the dynamic range possible with sensors. Circuits
that have ultrasensitive behavior - steep input-output curves - could potentially be
used to amplify small changes in input miRNA signal to larger changes in output.
However, work in implementing ultrasensitivity in mammalian systems is an ongoing
effort. We have also encountered technical limitations when making miRNA activity
measurements. In our work, we primarily use transfections to deliver miRNA sensors
to cells due largely to the simplicity of the method. However, this limits our data to
those cell lines which can be easily transfected - namely cell lines. While other plat-
forms like AAV could possibly offer better and more uniform transduction of cells,43
several cell lines and cell types are still lowly transduced with such methods.150 We
believe cell-free methods could prove a useful alternative for measuring miRNA ac-
tivity. In such experiments, miRNA sensors could be added to cell lysate and output
could be measured as bulk fluorescence or luminscence. Since DNA would not need
to be delivered past the cell wall, presumably any cell type could be measured, in-
cluding primary cells, assuming enough cells can be extracted. Possibly the reactions
could be scaled down using microfluidics in order to make measurements in rarer cell
types possible.
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Test: We have developed the poly-transfection method in order to obtain signif-
icantly more information per transfected sample. Since the formation of indepen-
dent transfection complexes requires minimal modification of traditional transfec-
tion procedures, we imagine that most labs could easily adopt poly-transfections.
There are some remaining research questions that will need to be answered for poly-
transfections to be used to their full potential. Poly-transfection and co-transfections
yield largely similar data, though in some systems the outputs are up to ∼2-fold dif-
ferent. This discrepancy has minimal effect when characterizing parts for building
medium-scale systems (∼4 components), though the cumulative discrepancy could
be significant if using separate characterization data to predict function of larger
systems. It should be noted however that a poly-transfection of the larger system
itself should not be affected. There are limitations on how large a system can be
tested with poly-transfection. Namely the number of cells required to sample pa-
rameter space for a poly-transfection at a given coverage still grows exponentially
with the number of components. Thus poly-transfections drastically simplify and
speed up testing for small- and medium-size systems but their applicability to large
systems remains to be seen. First of all, the number of distinguishable fluorescent
proteins with the flow cytometers we used was around five. Spectral analyzers have
the potentially to immediately increase the number fluorescent proteins that can be
measured, since they could allow better deconvolution of fluorescent proteins with
overlapping emission spectra. In the future, mass cytometers could further increase
the number of possible signals, since using heavy metal ions as readout currently
enables readout from 23 signals. Though a significant amount of optimization and
testing would be required to link transcriptional output to a metal ion signal. An-
other technology that could further extend the number of components that can be
measured with poly-transfections may be a combination of RNA barcodes expressed
232
from each component and single-cell sequencing. A much simpler approach would be
to sample the parameter space at lower (perhaps sparse) coverage and use algorithms
to impute or smooth the data. Again significant optimization would be required to
determine what degree of coverage is necessary for what kinds of genetic circuits.
Learn: Throughout this thesis, we have used custom MATLAB scripts* to con-
duct more quantitative analysis of flow cytometry than possible with commercial
software such as FlowJo. Previously, researchers would gate cells and measure mean,
median, or geometric means of the output, under the assumption that delivery of
DNA was equally efficient in all samples. However, this method neglects the trans-
fection distribution present which ranges across several orders of magnitude within a
single sample. Moreover, any variation in transfection efficiency across samples could
have drastic effects on measured output. For instance, if comparing two transcrip-
tonal activators and one activates 2-fold higher but transfects <0.5-fold as efficiently
(due to plasmid size or preparation quality), it would be deemed a worse activator.
Instead, building upon previous work,133 we use binning for one or several transfec-
tion markers to account for transfection efficiency within the sample. We have used
binned data to fit biochemical models - as in the miRNA repression model - and
used binning across multiple transfection markers to characterize genetic circuits us-
ing poly-transfection. We also demonstrated proof of concept work for using machine
learning to determine design rules for a genetic circuit, from binned poly-transfection
data. Significant future work will be required to make this analysis easy to use. Re-
cent work in our lab has been oriented towards building a similar analysis platform
in Python with an intuitive graphical user interface†. These examples illustrate the
*work spearheaded by Breanna DiAndreth and Ross Jones within the Weiss lab
†Work by Dr. Brian Teague in the Weiss lab; CytoFlow: http://bpteague.github.io/
cytoflow/
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growing need to quantitatively understand genetic circuits and systems in order to
make more reliable predictions. We anticipate that a key part of that understanding
will be analysis based on the techniques we have shown here.
Our work presented here has advanced several applied and foundational areas
of synthetic biology. The library of miRNA sensors and Ant/Syn model will aid
the design of future miRNA classifiers and even RNAi knockdown efforts, and poly-
transfections and quantitative analysis will promote the characterization of modules
and systems in mammalian cells. These developments not only facilitate exciting
applications in mammalian synthetic biology, but also serve as a foundation for
biologists to probe and model endogenous cellular signaling in new ways.
234
References
11. Mullokandov, G. et al. High-throughput assessment of microRNA activity and
function using microRNA sensor and decoy libraries. Nat Methods 9, 840–846
(2012).
43. Tian, W. et al. High-Throughput Functional MicroRNAs Profiling by Recom-
binant AAV-Based MicroRNA Sensor Arrays. PLoS ONE 7, 1–10 (2012).
53. Guye, P., Li, Y., Wroblewska, L., Duportet, X. & Weiss, R. Rapid, modular
and reliable construction of complex mammalian gene circuits. Nucleic Acids
Research 41 (2013).
54. Duportet, X. et al. A platform for rapid prototyping of synthetic gene networks
in mammalian cells. Nucleic Acids Research 42, 13440–13451 (2014).
56. Kok, S. D. et al. Rapid and reliable DNA assembly via ligase cycling reaction.
ACS Synthetic Biology 3, 97–106 (2014).
71. Selbach, M. et al. Widespread changes in protein synthesis induced by mi-
croRNAs. Nature 455, 58–63 (2008).
133. Davidsohn, N. et al. Accurate Predictions of Genetic Circuit Behavior from
Part Characterization and Modular Composition. ACS Synthetic Biology 4,
673–681 (2015).
144. Pinzon, N. et al. MicroRNA target prediction programs predict many false
positives. Genome Research 27, 234–245 (2017).
145. Weber, E., Engler, C., Gruetzner, R., Werner, S. & Marillonnet, S. A modular
cloning system for standardized assembly of multigene constructs. PLoS ONE
6 (2011).
146. Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several
hundred kilobases. Nature Methods 6, 343–5 (2009).
147. Kong, D. S. et al. Open-source, community-driven microfluidics with Metaflu-
idics. Nature Biotechnology 35, 523–529 (2017).
148. Shih, S. C. C. et al. A Versatile Microfluidic Device for Automating Synthetic
Biology. ACS Synthetic Biology 4, 1151–1164 (2015).
235
149. Baek, D. et al. The impact of microRNAs on protein output. Nature 455,
64–71 (2008).
150. Ellis, B. L. et al. A survey of ex vivo/in vitro transduction efficiency of mam-
malian primary cells and cell lines with Nine natural adeno-associated virus
(AAV1-9) and one engineered adeno-associated virus serotype. Virology Jour-
nal 10, 1 (2013).
236
Chapter 6
Appendix
6.1 Methods for DNA assembly with microfluidics
6.1.1 Genetic circuit assembly
For each genetic circuit assembly, pairs of assembly reactions were performed both at
conventional volume scales (2 to 10 uL depending upon the biochemistry) and in the
microfluidic device (300 to 650 nL scale). The reactions performed in conventional
volume formats (200 uL PCR tubes) are hereafter referred to as “tube” reactions.
Assembled genetic circuits were then transformed into E. coli for clonal selection,
validated by restriction digestion, and finally tested in live cells to verify functional-
ity. Ligation Assembly Protocol Ligation assembly was utilized to construct a 5,362
bp genetic circuit featuring a GFP reporter expressed from a constitutive pTet pro-
moter. The circuit was assembled from two BioBricks30– a constitutive GFP insert
(BBa_I13522) and high copy plasmid backbone (I140322). These BioBricks were
previously digested with EcoRI and PstI to generate linear fragments for ligation as-
sembly. The I13522 GFP insert and I14032 backbone fragments were gel extracted,
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yielding a concentration of 26.8 ng / ml and 47.1 ng /ml, respectively. Tube reactions
were performed at a 2 uL scale. 0.5 uL of T4 DNA Ligase, 0.5 uL of Ligase buffer,
0.5 uL of GFP insert and 0.5 uL of backbone were mixed and incubated at 25 ∘C for
30 min.
6.1.2 Ligation assembly protocol
Ligation assembly was utilized to construct a 5,362 bp genetic circuit featuring a
GFP reporter expressed from a constitutive pTet promoter. The circuit was assem-
bled from two BioBricks30– a constitutive GFP insert (BBa_I13522) and high copy
plasmid backbone (I140322). These BioBricks were previously digested with EcoRI
and PstI to generate linear fragments for ligation assembly.
The I13522 GFP insert and I14032 backbone fragments were gel extracted,
yielding a concentration of 26.8 ng / ml and 47.1 ng /ml, respectively. Tube reactions
were performed at a 2 uL scale. 0.5 uL of T4 DNA Ligase, 0.5 uL of Ligase buffer,
0.5 uL of GFP insert and 0.5 uL of backbone were mixed and incubated at 25 ∘C for
30 min.
Antibiotic selection was performed by transforming 1 uL of each tube reaction
into 50 uL of chemically competent, high efficiency DH5alpha E. coli one-shot cells
(Invitrogen), followed by incubating on ice for 30 min. The cells were then heat
shocked at 42 ∘C in a water bath for 45 s and then returned to ice for 2 min. 300
uL of SOC was then added, followed by shaking incubation at 225 rpm and 37 ∘C.
Finally, 1 uL of the 350 uL SOC mixture was plated onto LB with ampicillin (100
ug / mL) after 1 hour of shaking. The 1 uL aliquot was then mixed with 50 uL of
SOC on the plate to allow even spreading of the mixture. Plates were inverted and
incubated at 37 ∘C overnight and then colonies were counted. Assembled constructs
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were then verified by restriction digestion with enzymes PstI and EcoRI resulting in
4kb bp and 949 bp fragments, respectively.
6.1.3 Ligation-assembled GFP expression circuit biological val-
idation
The assembled plasmids were biologically validated for constitutive GFP fluorescence
in E. coli. 1 uL of each DNA miniprep was transformed into 10G cells (Lucigen) by
heat shock and plated onto plates containing 50 ug / mL kanamycin. Single colonies
were picked and grown in 2 mL cultures of kanamycin-containing LB overnight.
Overnight cultures were diluted to OD600=2e-6 and grown for 6 hours to an OD600
of 0.01. GFP fluorescence was analyzed by flow cytometry with an LSRFortessa cell
analyzer (BD Biosciences) and FlowJo software (Tree Star).
6.1.4 Gateway assembly protocol
Gateway assembly was utilized to construct a 3,479 bp that constitutively expresses
EGFP. 1 plasmid part and 1 entry vector were assembled to form the final con-
struct in a 10 uL bench top reaction. Entry vector plasmid stock pDonr221 was
obtained from Life Technologies (part 12536017). Linear insert cGFP was amplified
by PCR with Phusion Master Mix from New England Biolabs (part M0531L), using
primers attB1 (GGGGACCACTTTGTACAAGAAAGCTGGG) and attB2 (CCC-
CACAAGTTTGTACAAAAAAGCAGG) and a source plasmid (pEGFP, BD Bio-
sciences). PCR product was analyzed via electrophoresis through a 1% agarose-TAE
gel. The PCR fragment was excised from the gel and purified using Qiagen Gel Ex-
traction Kit (part 28706) following the manufacturer’s protocol. The concentration
of the purified fragment was determined by NanoDrop spectroscopy.
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A Gateway BP assembly master mix sufficient for ten 10 uL reactions was made
by adding 10 uL of pDonr221 (150 ng / uL stock), 10 uL of cGFP PCR fragment
(150 ng / uL stock), and 60 uL TE. For bench top reactions, 8 uL of the DNA master
mix was added to 2 uL of BP recombinase (Life Technologies), mixed by pipette and
incubated for 16 hours at 25 ∘C on a PCR machine followed by incubation at 4 C
upon completion of the reaction. Reactions (bench top and microfluidic) were then
treated with 1 uL of Proteinase K for 10 minutes at 37 ∘C.
Antibiotic selection was performed by transforming 1 uL of each bench top reac-
tion into 50 uL of chemically competent, high efficiency Mach T1 E. coli one shot
cells (Life Technologies, C862003). Transformation involved incubation on ice for 30
min, followed by heat shock at 42 C in a water bath for 45 s and then returning to
ice for 2 min. 300 uL of SOC was then added to the mixture, followed by shaking
incubation at 225 rpm and 37 ∘C. A 10 uL aliquot of the 350 uL SOC mixture was
plated onto LB and Kanamycin (30 ug / mL) after 1 hour in the shaker. Plates were
inverted and incubated at 37 ∘C overnight and then colonies were counted.
Assembled constructs were then verified by growing colonies in LB and Kanamycin
(30 ug / mL) overnight at 37 ∘C, purifying plasmid DNA (Qiagen spin 250 miniprep),
and performing restriction digestion with enzymes AflII and EcoRV, resulting in 2,317
bp and 1,162 bp fragments.
6.1.5 Gateway-assembled GFP expression circuit biological
validation
The assembled BP plasmids were biologically validated for constitutive GFP fluo-
rescence in E. coli. 1 uL of each DNA miniprep was transformed into 10G cells
(Lucigen) by heat shock and plated onto plates containing 50 ug / mL kanamycin.
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Single colonies were picked and grown in 2 mL cultures of kanamycin-containing LB
overnight. Control 10G cells (Lucigen) were grown in LB overnight. Overnight cul-
tures were diluted 1000:1 and grown for 3 hours to an OD600 of 0.01-0.04 (0.06-0.08
for control cultures, which grew faster without a plasmid). Cultures and control
cultures were then diluted 100:1 in 1X PBS and GFP fluorescence was analyzed by
flow cytometry with an LSRFortessa cell analyzer (BD Biosciences). For each sample
and control, 100,000 events (after gating by forward and side scatter) were processed
with FACSDiva software (BD Biosciences) to determine mean fluorescence. FITC-A
laser power was set to 420V.
6.1.6 Gibson assembly protocol
Gibson assembly was utilized to construct a 4708 bp experimental genetic circuit for
cell density dependent gene expression. Four linear fragments (1070 bp, 1130 bp,
1132 bp and 1614 bp, respectively) were utilized for each 5 uL Gibson tube assem-
bly reaction. The fragments were generated by polymerase chain reaction (PCR),
gelpurified (Qiagen) and concentrated. Plasmid stocks of DNA templates for PCR
reactions were made by transforming into DH5alpha E. coli (New England Biolabs,
NEB) and purifying plasmid DNA (Qiagen) after overnight growth of a single colony
in LB-Miller growth medium (referred to as simply LB hereafter) in the presence of
either chloramphenicol or kanamycin. PCR primers were ordered from Integrated
DNA Technologies (IDT) and re-suspended in water to a stock concentration of 100
uM. PCR reactions were performed using a Phusion High-Fidelity PCR Kit (NEB)
with 0.5 uM of each primer and 50 ng of template plasmid for thirty cycles of 98 ∘C
for 45 s, 55 ∘C for 45 s and 72 ∘C for 2 min at a 300 uL scale per fragment. Fragments
were then run on a 1% agarose TAE gel and gel extracted (Qiagen, 3 columns per
241
fragment). Column eluates were concentrated to 30 uL in a Centricon 10 (Millipore)
at 10,000 rpm for 30 min. DNA concentrations were determined by absorbance at
260 nm using a NanoDrop spectrophotometer.
A DNA mixture sufficient for forty 5 uL reactions was made by combining DNA
and water to yield 125 fmol of DNA per reaction for each fragment. For these
reactions, 2.5 uL of DNA mixture was added to 2.5 uL of Gibson Assembly Master
Mix (NEB), mixed by pipette and then placed immediately on a preheated PCR
machine for 45 minutes at 50 ∘C, then cooled to 4 ∘C.
Antibiotic selection was performed as described above, except transforming into
chemically competent, high efficiency DH5alpha E. coli one-shot and plating onto LB
and chloramphenicol (15 ug / mL) after 2 hours of shaking. Assembled constructs
were then verified by picking individual colonies for screening, purifying plasmids
from each clone and performing restriction digestion with enzymes NcoI, XbaI, XhoI
and HindIII, resulting in 2262 bp, 1289 bp, 629 bp, 405 bp, and 143 bp fragments,
for the expected assembly product.
6.1.7 Gibson-assembled cell density dependent gene expres-
sion circuit biological validation
To test circuit function in cells, the assembled circuit was transformed into 10G
competent cells and plated on LB-agar plates containing 20 ug/mL chloramphenicol.
A single colony was inoculated into 5 mL of LB with 20 ug/mL of chloramphenicol
and grown overnight with shaking at 37∘C. The overnight cultures were inoculated
at an OD600 of 0.001 into cultures containing 1 mL of LB per time point. 1 mL
aliquots of the culture were taken at each time point and put on ice to halt bacterial
growth and quorum sensing. OD600 was measured for each aliquot using a NanoDrop
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2000c spectrophotometer and fluorescence was measured using the LSRFortessa cell
analyzer and FACSDiva software.
6.1.8 Golden Gate assembly protocol
Golden Gate assembly was utilized to construct a 5,571 bp aTc-inducible circuit for
GFP expression. Five plasmids were assembled to form the final construct in a 10
uL reaction. Plasmid part stocks were prepared by transforming into dcm- E. coli
(NEB) and midiprepping DNA (Qiagen) after overnight growth of a single colony in
LB in the presence of either ampicillin or spectinomycin.
A DNA mixture sufficient for twenty 10 uL Golden Gate assembly reactions with
40 fmol of each plasmid part per reaction, with BSA/Albumin (NEB) added to a
1.4x concentration. 7 uL of Golden Gate assembly master mix was added to 1 uL of
BsaI enzyme, 1 uL of T4 Ligase, and 1 uL of T4 Ligase buffer and mixed by pipette.
Reactions were then incubated at 37 ∘C for 10 min and then cycled at 37 ∘C for 2
min 30 s, 4 ∘C for 30 s and 16 ∘C for 5.5 min 45 times. After cycling, reactions were
incubated for 10 min at 37 ∘C and then 10 min at 80 ∘C before storing at 4 ∘C.
Antibiotic selection was performed as described above by transforming into DH5alpha
E. coli one shot cells and plating 1 uL of the 350 uL SOC mixture onto LB and ampi-
cillin (100 ug / mL) after 1 hour in the shaker. The 1 uL aliquot was then mixed
with 50 uL of SOC on the plate to allow even spreading of the mixture. Plates were
inverted and incubated at 37 ∘C overnight and then colonies were counted. Finally,
assembled constructs were verified by restriction digestion with enzymes HindIII and
NotI, resulting in 4222 bp, 936 bp and 413 bp fragments for the expected assembly
product.
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6.1.9 Golden Gate-assembled aTc-inducible GFP circuit bio-
logical validation
DH5alpha-PRO competent cells expressing TetR were transformed with the Golden
Gate-assembled plasmid using heat shock and plated on LB Agar (BD) plates con-
taining 100 ug/mL ampicillin (IBI Scientific). Frozen stocks of bacteria expressing
the plasmid were inoculated into 5 mL cultures of LB with 100 ug/mL of ampicillin
and grown overnight with shaking at 37 ∘C. Cultures were then inoculated into 1 mL
of LB containing ampicillin for each time point at a starting OD600 of 0.001. An-
hydrotetracycline (aTc) was added to cultures at a concentration of 100 ng/mL and
1 mL aliquots of the cultures were taken at each time point and put on ice. OD600
measurements were taken with a NanoDrop 2000c spectrophotometer and GFP flu-
orescence was assayed acquired using the LSRFortessa cell analyzer and FACSDiva
software.
6.1.10 Microfluidic device fabrication
Microfluidic devices were fabricated using multilayer soft lithography. Molds for
the “flow” channel layer (for assembly biochemistry) and “control” channel layer (for
microfluidic valving) were patterned by first spin coating two layers of AZ9260 pho-
toresist (AZ Electronic Materials) on a 3" silicon wafer (2 spins for 60 s at 800 rpm),
followed by a five minute bake on a hot plate at 90 ∘C. Photolithography of the coated
wafers was performed using high-resolution transparency masks (CadArt Services,
20,000 dpi) on a contact aligner (Karl Suss MJ-6). The photoresist was exposed with
the mask patterns (25 s x 4 exposures, 30 s rest between exposures) and developed in
1:2 Microchem 400K developer. After developing, the molds were baked at 120 ∘C to
round the channel molds and silanized with tri(choromethyl)silane (Sigma Aldrich)
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for ∼90 seconds in vapor phase to facilitate PDMS mold release and increase mold
lifetimes. The microchannel heights on the mold (30 – 40 um) were subsequently
measured using a profilometer (Dektak XTL, Bruker).
For the flow layer, 20:1 part A:B PDMS, either Sylgard 184 (Dow Corning) or
RTV 615 (Momentum) was spin-coated (1000 rpm, 50 s) to a thickness of - 50 um
while a 5 mm thick layer of 5:1 PDMS was poured on the control layer mold in a
Petri dish, followed by an initial thermal cure (20 min, 80 ∘C for Sylgard, 45 min, 80
∘C for RTV). After baking, both molds were removed from the oven for alignment.
The negative PDMS channel replica was released from the control mold and cut to
size (individual patterned devices) with a razor blade. A blunt-tipped 20G surgical
steel luer stub (Becton Dickinson and Company, BD) was used to punch flow inlet
and outlet ports in the PDMS, followed by an isopropyl alcohol wash to remove debris
and drying under a nitrogen stream. The processed thick PDMS control layer was
then aligned over the spin-coated flow layer under a dissecting scope. To bond the
aligned flow and control layers, the composite PDMS substrate was cured (30 min at
80 ∘C for Sylgard, 45 min at 80 ∘C for RTV). The composite devices were then cut
from the flow mold and the flow layer inlet/outlet holes were punched as previously
described. The assembled PDMS layers were subsequently bonded to 0.5 mm thick
glass coverslips (VWR) using oxygen plasma exposure (30 s/ 300W, Gasonics), and
then baked at 80 ∘C overnight.
6.1.11 Microfluidic controller
The PDMS device was controlled by a custom-fabricated microfluidic controller. The
controller contains four eight-channel solenoid valve arrays for pneumatic latching of
the microfluidic chip valves, as well as four eight channel banks of constant pressure
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outlets to provide driving pressure for fluids in the microfluidic flow channels. An
external lowpressure (0-50 psig) air compressor (Panther) provides constant pneu-
matic pressure to the solenoid valve arrays and constant pressure outlets, with a
secondary low-pressure regulator providing fine pressure control (0-10 psig) to the
constant pressure outlets. Programmable operation of solenoids that actuate the
microfluidic control valves, which function as latches and pumps, is achieved using
digital output signals from an integrated Arduino Mega board with an Atmel AT-
mega2560 microprocessor. Complete assembly information including circuit board
layouts and full design schematics are available in Metafluidics.
6.1.12 Microfluidic genetic circuit assembly
Automated microfluidic genetic circuit assembly reactions were conducted in the
ring-mixer device. The ring-mixer features 5 inlets and outlets for loading and col-
lecting reagents and 8 independently addressable control channels. A single assembly
reaction was conducted per device; devices were not re-used.
The full assembly protocol consisted of 7 stages, comprised of the four device
operations (stage number, device operation): (1, Incubate) Initially, all valves are
latched at 15 psi to prime the control channels with 1x TE buffer; (2, Flow) A
blocking agent, either 1x Bovine Serum Albumin (BSA) or 0.1% n-Dodecyl beta-
Dmaltoside (DDM), is flushed through the ring mixer to mitigate non-specific protein
adsorption. Blocking agents were loaded at 3 psi. (3, Incubate) All valves are latched
and the blocking agent is incubated in the ring mixer for 10 min; (4, Flow) The
blocking agent is purged from the ring mixer with compressed air at 3 psi; (5, Fill)
The three compartments of the ring mixer are filled with the desired reagents. In this
step compressed air at 7 psi backs the reagent loaded into each compartment inlet and
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pushes out existing air in the channel through the bulk PDMS until all air bubbles are
removed. This step typically takes 10-20 min. (6, Mix) Once reagents are loaded and
air bubbles are removed, the three mixing valves are actuated at 25 Hz for 1000 cycles
(4 min total) to achieve complete mixing. (7, Incubate) All valves are latched and
the device, which is placed on top of an Eppendorf Mastercycler thermocycler with
in situ adapter, is then temperature cycled according to the appropriate assembly
biochemistry protocol described above. Finally, (8, Flow) the sample is collected
from the ring mixer outlet in a several uL plug of 1x TE or distilled, deionized
H2O for storage or transformation. Typically two devices (and thus two assembly
reactions) were run in parallel; the microfluidic controller is capable of controlling
up to 4 devices simultaneously.
The assembly protocol was similar for each biochemistry, differing only in thermo-
cycling conditions, blocking agent (BSA for all reactions except DDM for Gateway)
and the reagents loaded in each of the three ring-mixer compartments. For ligation
reactions, “insert” DNA was loaded in compartment 1, “backbone” DNA was loaded
in compartment 2, and ligase and ligase buffer in equal proportion were loaded in
compartment 3. For Gateway reactions, BP Clonase was loaded in compartment 1,
while DNA master mix was loaded in compartments 2 and 3. For Gibson reactions,
DNA master mix (containing all 4 linear fragments) was loaded in compartments
1 and 2 (comprising half the ring mixer) while 2X Gibson enzyme mix was loaded
in compartment 3 (comprising the other half). Finally, for Golden Gate reactions,
BsaI, ligase, and ligase buffer were loaded in compartment 1, and DNA master mix
(containing all 5 plasmids) was loaded in compartments 2 and 3. Negative control ex-
periments were also conducted for each biochemistry where enzymes and associated
buffers were replaced with distilled, deionized water.
Circuits assembled in the microfluidic device were transformed into E. coli cells
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and processed as described in the protocols for larger-volume tube assembly, with
the exception that the full volume eluted from the device mixing chamber was trans-
formed. Restriction digestion and biological validation were conducted with the same
protocols.
All genetic circuit assembly reactions were performed in devices made of Sylgard
PDMS with the exception of Gateway reactions, which were performed in devices
composed of RTV PDMS. Microfluidic devices held either 300, 400, 560, 575, 600,
or 650 nL mixer volumes, depending upon which mold they were cast from.
6.2 Methods for miRNA activity measurements and
multi-input predictions
6.2.1 Construction of miRNA sensor library
A common low sensor backbone (LSB) plasmid was constructed using a Gateway-
Gibson strategy53 to enable assembly of miRNA low sensor libraries in a single Golden
Gate55 step. Long DNA oligonucleotides encoding miRNA target site repeats were
synthesized as ultramers by IDT, annealed and restriction-ligated via BbsI-mediated
Golden Gate. White/blue screening enabled selection of mostly correct clones which
were further verified by Sanger sequencing. Overhangs for Golden Gate steps are
listed in Table 2.4.
6.2.2 Construction of miRNA classifiers
Several new backbones were constructed to expedite assembly of miRNA classifiers.
JG107 and JG108 plasmids were assembled similarly to LSB and contain a LacZ
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cassette into which miRNA target sites were cloned using BbsI-mediated Golden
Gate. An important feature for these plasmids is that their miRNA target sites pos-
sess distinct overhangs when digested with BsaI. The low sensor backbone reverse
(LSBr) plasmid retains the same design of LSB but with BsaI and BbsI recognition
sites reversed. The LSBr-5and3UTR construct introduces a further addition of a
BsaI/BbsI-flanked mCherry selection cassette in the 5’ UTR of the mKate2 tran-
scription unit. miRNA target sites present in LSB, JG108, and JG107 were then
used as inputs to clone 3-input classifiers into LSBr using BsaI-mediated Golden
Gate. 4-input classfiers were cloned into LSBr-5and3UTR using a similar strategy,
with target sites for the 3’ UTR originating from LSB and JG108 plasmids while
JG107 encoded an inert sequence. Target sites were cloned into the 5’ UTR from
annealed oligonucleotides flanked by BsaI sites. White colonies were selected and
verified by Sanger sequencing
6.2.3 Cell culture
HEK293FT were purchased from Thermo Fisher, HeLa and HepG2 cells were ob-
tained from ATCC. HEK293FT and HeLa cells were grown in DMEM with 4.5 g/L
glucose, L-glutamine, and sodium pyruvate (Cellgro) supplemented with 10% char-
acterized FBS (HyClone). HepG2 cells were grown in DMEM with high glucose, 2
mM L-glutamine, without sodium pyruvate (HyClone) supplemented with 10% char-
acterized FBS (HyClone). All cell lines were grown at 37∘ C and 5% CO2. All cell
lines tested negative for mycoplasma.
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6.2.4 Transfection of miRNA sensors and classifiers into cell
lines
miRNA low sensor libraries were transfected into cells using a reverse transfection
method62. Example volumes are provided for a 100 uL mix which was sufficient for
roughly 25 wells in 96-well plate format. 2% or 0.2% gelatin (Sigma-Aldrich) was
diluted to 0.05% in sterile water. 1 volume of 2M sucrose was added to 9 volumes
of buffer EC from an Effectene transfection kit (Qiagen) to make a master mix
with total volumes depending on how much DNA was transfected. 37.5 uL Buffer
EC mixture was added to 2 ug of DNA sample for a final DNA concentration of
20 ng/uL after addition of all components (DNA, buffer EC, enhancer, Effectene,
gelatin). 3.75 uL of enhancer solution was added to the DNA/EC mixture, mixed
gently, and incubated at room temperature for 5 min. 12.5 uL of Effectene was
added and mixed followed by incubation for 10 min at room temperature. 53.75 uL
of 0.05% gelatin was added and mixed gently to obtain the final transfection mix. 4
uL of the mixture was added to each well in a 96-well plate, wells were covered with
sterile adhesive aluminum covers, and stored at -80C without dessication. Cells were
reverse transfected by dissociating and counting cells as normal, followed by seeding
of cells at usual concentration for forward transfection in 100 uL of cell media.
miRNA classifiers were transfected using forward transfection methods with lipo-
fectamine 3000 (Thermo Fisher) according to the manufacturer’s protocols. All
transfections were conducted with 400 ng of DNA, 1 uL of P3000 reagent, 1 uL
of lipofectamine 3000 in Opti-MEM (Thermo Fisher). HEK293FT cells were seeded
in 24-well plates at various densities in 0.5 mL volume of media (HEK293FT =
2× 105 cells/well, HeLa = 1× 105 cells/well, HepG2 = 1.5× 105 cells/well). For cell
mixtures, 5 × 104 of each cell type was seeded per well and a 1:3 ratio of DMEM
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high glucose:DMEM was used. miR-21-5p mimic was obtained from Sigma-Aldrich
and cotransfected using the same method as for DNA. Target site combinations for
4-input sensors are listed in Table 2.2.
6.2.5 Flow cytometry
Flow cytometry was conducted using an LSR Fortessa cytometer with 405, 488, and
561 nm lasers (BD Biosciences). Reverse transfected cells in 96-well plate format
were analyzed using the high throughput sampler option to collect >10,000 cells as
quickly possible. Forward transfected cells in 24-well plate format were analyzed in
tube format with >50,000 events collected per sample. mKate2 was detected using
a 561 nm laser with 610/20 filter and 235 PMT voltage, EBFP2 was detected using
a 405 nm laser with 450/50 nm filter and 240 PMT voltage, and EYFP was detected
using a 488 nm laser with 530/30 nm filter and 200 PMT voltage. For multi-input
circuits,
6.2.6 Model-based fitting and prediction of miRNA activities
Models and predictions were implemented in MATLAB with steady-state assump-
tions. Briefly, cytometry files for single-input sensors were read in, gated using
forward and side scatter, binned by EBFP2 fluorescence, and parameters fit to the
model using lsqcurvefit. Parameter fits were used to generate predictions either by
multiplication of fold repression (synergistic-only model) or taking the minimiza-
tion of mKate2 expression (antagonistic-only model) or a combination of the two
(Ant/Syn model). Rate constants used are listed in Table 2.3.
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6.2.7 Statistical analysis
Statistics are based on a log-normal distribution in fluorescence with a geometric
standard deviation of approximately 2.8, an assumption supported by all samples in
the flow cytometry data we collected. Greater than 50,000 events were chosen to
allow at least 100 data points per fluorescent bin, and binned data are presented as
medians. All error bars indicate standard deviations from three technical replicates.
For ROC curves, error bars were calculated using threshold averaging and again
indicate standard deviations from technical triplicates.
6.2.8 Data availability
All data files supporting this study are available on request from the corresponding
author. Plasmids will be available from Addgene.
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6.3 Methods for one-pot optimization
Detailed experimental methods and guidelines for designing poly-transfection exper-
iments may be found on Protocol Exchange under protocol #6667 “One-pot Op-
timization of Genetic Circuits using Poly-transfections” and a quickstart guide is
provided in Table 4.1.
6.3.1 DNA assembly framework
The plasmids used in this study were assembled by a hierarchical Golden Gate-
Gibson assembly method similar to previous hierarchical methods used in our lab.53
First, Golden Gate assembly was used to assemble plasmids for each transcription
unit (termed plasmid level 1 or pL1 plasmids) from a number of basic input parts
(termed plasmid level 0 or pL0) including insulators (pL0-I), promoters (pL0-P),
5’ UTRs (pL0-5), gene coding sequences (pL0-G), 3’ UTRs (pL0-3), and transcrip-
tional terminators/poly-A sequences (pL0-T). Then plasmids containing multiple
transcription units (termed pL2) were constructed from the assembled pL1 plasmids
using Gibson assembly. For the Gibson step, plasmids were linearized using I-SceI
endonuclease to generate overlapping regions, followed by assembly with Gibson As-
sembly Ultra Kit from SGI and electroporation into electro-competent cells. Typical
Golden Gate and Gibson reaction protocols are given in Protocol Exchange. As
a simplified alternative to hierarchical assembly, we have constructed plasmids that
utilize a single Golden Gate step to obtain plasmids encoding two transcription units
- one expressing the circuit part and the other expressing a fluorescent protein marker
(Fig. 4-19). Since the backbone vector already encodes fluorescent protein expres-
sion, Gibson assembly would no longer be required. DNA sequences and plasmids
comprising the simplified DNA assembly framework are available to researchers via
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Addgene (#109150-109154).
6.3.2 Cell culture
The HEK293FT cell line was obtained from Thermo Fisher and HeLa cells were
obtained from ATCC. Both cell lines were maintained in DMEM containing 4.5 g/L
glucose, L-glutamine, and sodium pyruvate (Cellgro) which was supplemented with
10% FBS (Cellgro) and were grown at 37C and 5% CO2. All lines used in this study
tested negative for mycoplasma.
6.3.3 Transfections
Unless indiacted otherwise, transfections were conducted using Lipofectamine 3000
(Thermo Fisher) and were performed according to the manufacturer’s dilution pro-
tocols with modifications for poly-transfections. Specifically we used 100-300 ng of
DNA per circuit component with 1 uL of P3000 reagent and 1 uL of Lipofectamine
3000, all prepared in 100 uL Opti-MEM per 24-well plate. In the 24-well plate for-
mat, 200,000 HEK293FT cells or 150,000 HeLa cells were transfected per well. For
poly-transfections each DNA-lipid mixture was prepared separately before being ap-
plied to cells, while for co-transfections DNA was mixed at the specified ratios and
added to the transfection reagent. The amount of DNA and transfection reagent per
component was scaled down according to the total number of circuit components
in order to maintain similar total amounts compared to traditional transfections.
For a quick reference for setting up poly-transfections, see Table 4.1. Reliability of
poly-transfections across different transfection reagents and protocols was assessed
by repeating poly-transfections using the same amount of DNA and the correspond-
ing amount of transfection reagent recommended by the manufacturer (Fig. 4-20,
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4-21).
6.3.4 Flow cytometry
Flow cytometery was performed using a BD LSRFortessa equipped with a 355nm
laser with 379/28nm filter at 410 PMT voltage for measuring fluorescence from Sir-
ius, 405nm laser with 450/50nm filter at 200 V for measuring TagBFP, 488 laser
with 530/30 filter at 180 V for measuring mNeonGreen, 561nm laser with 582/15nm
filter at 210 V for measuring mKO2, and 640 laser with 710/50nm filter at 320 V for
measuring iRFP720. For co-transfections >50,000 cells were collected per sample,
while for poly-transfections >200,000 cells were collected for two-component experi-
ments. For greater numbers of circuit components than two, roughly 10 times more
cells were collected per component.
To determine an orthogonal set of fluorescent proteins, we separately transfected
HEK293FT cells with 22 constitutively expressed fluorescent proteins and measured
signal from all available channels on the flow cytometer (Fig. 4-23). Fluorescence
score was calculated as log10(99th percentile channel fluorescence from sample)-
log10(channel background from untransfected). We then determined that Sirius,
TagBFP, mNeonGreen, mKO2, and iRFP720 formed a relatively orthogonal set.
6.3.5 Data analysis
We have developed a MATLAB pipeline to facilitate analysis of multi-dimensional
poly-transfection data. Code may be found on Github at https://github.com/
Weiss-Lab/MATLAB_Flow_Analysis. Generally, data was binned across fluorescence
corresponding to relevant input parts and statistics (e.g. median) for the output
calculated for each bin. In some cases, data was ‘sliced’ to only analyze data with a
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certain level of transfection marker prior to binning. Example analyses and associated
code from this study may be found within the Github repository.
For subsampling of poly-transfection data, a series of points sampling a ratiomet-
ric trajectory was determined and the distance between each cell and the trajectory
determined. To subsample, a number of cells were selected for inclusion based on
the distance between the cell and the trajectory according to a log-normal distribu-
tion. For our analysis, each length between points on the trajectory corresponded to
selection of approximately 310, 160, 100, 50, and 20 cells at a distances of 0.1, 0.2,
0.3, 0.4, 0.5 (logicle transformed units). Also, uniform subsampling may be used to
normalize poly-transfection data to reduce the effect of higher density of singly- and
doubly-transfected cells (Fig. 4-24).
To visualize the effects of each genetic component on system output, data were
binned according to fluorescent of each transfection marker and plotted as medians
in 2D, 3D, and 4D heatmaps to (Fig. 4-9-4-13, 4-25-4-26, 4-27 ). We then compared
performance of 3-component and 4-component high sensors by using an ROC-like
analysis, where each point within the ROC curve corresponds to the sensitivity and
specificity calculated within a fluorescent bin (Fig. 4-28).
We used random forest regression to generate design rules for the miR-21-5p
classifier from the poly-transfection data (Fig. 4-29). Briefly, we generated random
forests with different minimum leaf sizes to maintain low out of bag error while re-
ducing the number of branches in order to reduce the chance for overfitting. We then
determined parameter importances and generated partial dependence plots using a
minimum leaf size of 100.
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6.3.6 Statistical analysis
Statistical analysis for this study is based on log-normal distributions for production
of fluorescent proteins in cells. Data collected in this study supported the assumption
of geometric standard deviation of approximately 2.8. For co-transfections, >50,000
cells were collected such that at least 100 data points could be analyzed per trans-
fection bin. For poly-transfections, 10 times more cells were collected per circuit
component to minimize sample collection time while still allowing at least 99% and
83% coverage of parameter space in 4- and 5-color experiments respectively.
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